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Abstract
Paramecium tetraurelia is a ciliated single cell used as a model organism for the study of
ciliopathies. Ciliopathies are mammalian diseases involving the dysfunction of cilia, including
cilia maintenance, construction, and signaling. P. tetraurelia and its cilia provides an excellent
non-canonical system for the investigation and elucidation of proteins important for the
structure, maintenance and function of cilia and ciliary beating. We utilize features of this cell
such as its 1000’s of cilia and highly organized and patterned cell surface to observe changes in
swimming behavior or disruptions in the ordered cell surface which are not feasible in
mammalian cells. Here, we present research on three proteins in Paramecium, two of which are
homologs to human ciliopathy genes. Using combinations of epitope-tagging, RNA interference
(RNAi), immunofluorescence, immunoprecipitations, LC-MS/MS analysis and
electrophysiology, we have attempted to elucidate the location, function, and potential
interacting partners of these three proteins.
The first protein, meckelin (MKS3), is a contributing factor in Meckel-Gruber syndrome,
among other ciliopathies. Using epitope tagging, we identified the location of the Mks3 protein
above each basal body. Depletion of MKS3 using RNAi leads to global loss of cilia, a severe
disruption in the surface organization and a mislocalization of basal bodies out of the anteriorposterior axis of the cell. We show that depletion of Mks3 leads to abnormal backward
swimming in ionic stimuli and depleted secretion of trichocysts. Based on our data, we propose
two functions for Mks3 in P. tetraurelia. The first function is a transition zone component
important for proper regulation of ciliary protein content, consistent with MKS3 function in other
organisms. The depletion of MKS3 led to global ciliary loss, but also an imbalance in the ciliary
ion channels that was different from the loss of cilia due to interference with intraflagellar
transport as observed in cells depleted of IFT88. The second novel role for MKS3 is as a transient
connection to the kinetodesmal fiber which is important for basal body guidance when daughter
basal bodies migrate away from the mother basal body before cell division.
We also examine the contribution of the non-selective cation channel Polycystin-2 (Pkd2)
in Paramecium to Mg2+ permeability and Mg2+-induced behavior. When mutated in humans,
Pkd2 leads to 15% of the cases of Autosomal Dominant Polycystic Kidney Disease (ADPKD).
When PKD2 is depleted using RNAi in Paramecium, cells show short backward swimming in
Mg2+ solutions, a resistance to heavy metal paralysis, and depleted membrane permeability to
Mg2+. The channel-like protein XntA which is unique to Paramecium and Tetrahymena, is also
important for these phenotypes. Therefore, we utilized the Paramecium XntA1 mutant in our
studies, which lacks Mg2+-induced behavior. We demonstrate that both Pkd2 and XntA are
present in the cell membrane and in the cilia. Co-IP assays show that the IP of XntA-myc co-IPs
the Pkd2-FLAG channel, but not vice versa, possibly because of an occluded FLAG epitope due
to protein interactions. To tease apart the contributions of Pkd2 in the cilia and the cell
membrane, electrophysiology was used to measure membrane potential of ciliated and deciliated
cells. Depletion of BBS8 eliminates Pkd2 in the cilia, allowing us to examine Pkd2 activity
restricted to the cell membrane of ciliated cells. Depletion of Pkd2 or XntA decreases membrane
permeability to Mg2+. When Pkd2 was restricted to the cell membrane via BBS8 depletion, the
membrane permeability to Mg2+ increased, much like over-expressing the Pkd2 protein.
Depletion of Pkd2, especially in the deciliated XntA1 mutant, leads to a dramatic decrease in
Mg2+ membrane permeability. Based on these data, we propose that Pkd2 is the Mg2+ channel in
Paramecium and XntA is not a channel, but is perhaps important for stabilizing Pkd2 in
membrane microdomains.
We have uncovered novel function roles for the proteins mentioned here, leading to a
broader understanding of their function. These studies also highlight to usefulness and
importance of the model organism Paramecium tetraurelia to the study of human ciliopathy genes.
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I.

Paramecium tetraurelia

Structure
Paramecium tetraurelia is a ciliated single-celled eukaryotic protist that lives in fresh water
(Figure 1.1). These cells can be seen by the naked eye and are 100 to 200 µm in length. Paramecia
have a highly organized cell surface which is structured into hexagonal units called cortical
ridges. Each of the repeated cortical units contains one or two basal bodies with a cilium arising
and a parasomal sac. Parasomal sacs are used for endo- and/or exo-cytosis, but whether the
function is endocytosis, exocytosis, or both, is debated (Flotenmeyer et al., 1999, Plattner and
Kissmehl, 2003, Allen, 1988, Allen and Fok, 1980). Just beneath the cell membrane are alveolar
sacs which are membrane-bound calcium storage organelles. These sacs are believed to connect
between units, but have small openings for the basal bodies and for the trichocysts (Allen, 1971).
The alveolar sacs provide the majority of the calcium needed for the secretion of the trichocysts
(Stelly et al., 1991), although some calcium is also supplied from the extracellular space (Iwadate
and Kikuyama, 2001). Trichocysts are membrane-bound organelles containing an inner and
outer sheath. They can be ejected from the cell in the event of a predator encounter (Buonanno et
al., 2013). Below the alveolar sacs lies the epiplasm. The epiplasm is a continuous amorphous
layer containing perforations near the crests of the cortical ridges. It also has 9 equidistantspaced perforations around the outside of the bottom (proximal) surface of the basal body (Allen,
1971).
Behavior
The behavior of paramecia was first described by Jennings (Jennings, 1906). He
described in depth both their forward swimming patterns as well as the “avoidance reaction”.
The avoidance reaction occurs when a Parameicum encounters an unfavorable environment or a
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physical barrier (Jennings, 1906). The avoidance reaction is a rapid and coordinated change in
the ciliary beat pattern which is dependent upon calcium (Machemer and Eckert, 1973). This
reaction results in a rapid backward movement of the cell, quickly followed by a reorientation, at
which point the cell swims off in another direction.
Ionic changes in the environment can cause swimming reversal by bringing the
membrane potential of the cell above threshold for an action potential. Calcium that enters the
cilia during the action potential causes a change in the ciliary power stroke from a power stoke
toward the posterior of the cell to a power stroke toward the anterior, resulting in backward
movement of the cell (Machemer and Eckert, 1973). The calcium enters the cilia through the
voltage-dependent calcium channels (CaV) which are found exclusively in the ciliary membrane
(Dunlap, 1977). These action potentials are graded (Eckert and Brehm, 1979). Rapidly after the
calcium enters the cilia, an outward potassium current is produced (Eckert and Brehm, 1979).
The efflux of potassium ions occurs through the Ca2+-dependent K+ channels and the voltagedependent K+ channels (Figure 1.2). The majority of these channels are expected to reside in the
ciliary membrane to respond to high intraciliary calcium levels (Brehm et al., 1978). The cell will
maintain the ciliary power stroke toward the anterior of the cell, and therefore backward
swimming, as long as the calcium remains high in the cilia (Brehm et al., 1978, Eckert, 1972).
The electrical potential across the membrane of Paramecium governs both the swimming
speed and direction of the cell (Van Houten, 1979). Paramecia accumulate in areas of attractants
presumably in a search for their food. Paramecia are unable to orient and migrate directly
toward an attractant in a taxis as shown by Dictyostelium (Gerisch, 1982) and C. elegans
(Bargmann, 2006). Paramecia display a chemokinesis, a behavior by which the cells move up a
gradient of attractant by a biased random walk (Van Houten, 1979). Paramecia have a resting
membrane potential of approximately -25 to -40 mV (Machemer and Eckert, 1973, Machemer and
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Ogura, 1979, Preston and Van Houten, 1987, Brehm et al., 1978, Van Houten, 1979). As a cell
encounters strong attractants, the membrane will hyperpolarize (become more negative) by 8 to
10 mV and the cell will swim fast and smoothly forward (Van Houten, 1979). A strong repellent,
such as barium, will cause the cell to depolarize (become more positive) by up to 25 mV,
instituting more frequent turning and possibly bouts of long backward swimming and ciliary
reversal.
The receptors and channels necessary for these chemical cues are located in the cell
membrane, the cilia or both. The GPI-anchored (glycosyl phosphatidylinositol) folate receptor is
located at the tips and the bases of the cilia (Valentine et al., 2012, Weeraratne, 2007). Some
receptors are concentrated in the cilia and are not expected to be abundant in the cell membrane,
as in the case of the glutamate receptors (Valentine, unpublished data (Jacobs, 2007,
Romanovitch, 2012, Van Houten et al., 2000)). These receptors contribute to the membrane
potential changes that occur through second-messenger pathways. For the glutamate receptors,
the membrane becomes more negative by the activation of a K+ conductance and is maintained at
hyperpolarized levels by the plasma membrane calcium ATPase pumps (PMCAs; calcium
extrusion). The ciliary adenylyl cyclase that is also a potassium channel is activated by
glutamate, and cyclic AMP is a second messenger for this pathway. Protein Kinase A (PKA) is
activated by the cAMP. The substrate activated by the PKA is thought to be the PMCAs which
are activated by PKA phosphorylation (Van Houten et al., 2000, Schultz et al., 1992). These
changes in membrane potential help facilitate the swimming speed and direction of the ciliary
beat to assist Paramecium in locating their food (Van Houten, 1979).
Cell Membrane and Cilia
The cell surface membrane of Paramecium is often referred to as the “pellicle.” The
“pellicle” of Paramecium is comprised of the plasma membrane, the alveolar sacs, and the
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epiplasm. These components are very difficult to separate (Allen, 1988). The plasma membrane
is contiguous with the ciliary membrane, although they are compositionally different (Brehm et
al., 1978, Capdeville, 1993). The difference between the plasma membrane and the ciliary
membrane is true for both lipid and protein content. The cilia contain more phosphonolipids,
ester lipids, and sphingophospholipids than the cell membrane (Kaneshiro, 1987, Rhoads and
Kaneshiro, 1979). The channels and receptors differ between the two membranes. For example,
the voltage-dependent calcium channels are exclusively found in the cilia (Dunlap, 1977) while
the channels responsible for the mechanosensitivity of the cell reside in the cell membrane
(Ogura and Machemer, 1980). The rectifier channels and those channels responsible for the
resting conductances of the cell are also expected to be in the cell membrane (Machemer and
Ogura, 1979).
The entire surface of Paramecium is covered in cilia. There are approximately 1000 of
them on each cell (Machemer and Ogura, 1979). These organelles are 10 µm in length and 0.2 µm
wide (Machemer and Eckert, 1973). Cilia account for approximately 50% of the surface area of
the cell. Conveniently, the cilia can be easily removed from the cell through an ethanol treatment
and trituration (Machemer and Ogura, 1979) or treating the cell with 4 mM chloral hydrate
(Dunlap, 1977). Neither of these deciliation methods are permanent. The paramecia will regrow
their cilia over a period of hours, regaining full length and function in 10 hours. Deciliation also
permits the return of the graded calcium action potentials, although the return of channel
function is not linear. It has been inferred from electrophysiology studies that the distribution of
the CaV channels is non-uniform along the cilium, with more channels concentrated at the distal
end (Dunlap, 1977). After deciliation, the capacitance of the cell is decreased by 50% but the
resting membrane potential remains unaltered (Machemer and Ogura, 1979). When the cell is
deciliated, the cilia break above the axosome, leaving the proposed transition zone and ciliary
necklace with the cell body (Machemer and Ogura, 1979, Satir et al., 1976).
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Basal Bodies and Duplication
Basal bodies are highly conserved structures analogous to centrioles located just below
the cell surface that anchor the cilia (reviewed in (Beisson and Wright, 2003)). A basal body is
composed of nine triplets of microtubules that form a circle approximately 220 µm in diameter
and 400 µm long. The tubules, A, B, and C, form a cartwheel pattern where the A tubule is
connected to the C tubule of the neighboring triplet by a fiber. At the base of the cilium, the
triplet becomes a doublet of microtubules, as the A and B tubules continue to form the backbone
of the cilium, referred to as the axoneme (Ringo, 1967). Radial spokes and inner and outer dynein
arms fill the center of the axoneme along with a central pair of microtubules in some cases. The
radial spoke proteins are essential to the beating and bending of the cilium. Cilia are analogous
to flagella, similar in structure and function to flagella. The best described flagella are in the
green algae, Chlamydomonas (Yang et al., 2006).
Basal bodies are anchored in place below the cell surface by numerous rootlets. These
rootlets help to stabilize the basal body during ciliary beating and also in the division process
(Iftode, 1996, Iftode and Fleury-Aubusson, 2003). There are three rootlets that emanate from the
basal bodies in P. tetraurelia. As if a face of a clock, the striated rootlet (also known as the
kinetodesmal fiber) emanates from ~10 o’clock and projects anteriorly, connecting with other
kinetodesmal fibers traversing numerous cortical units. A post ciliary rootlet projects at 7 o’clock
and the transverse microtubule projects at 5 o’clock. Some cortical units contain two basal
bodies. In the case of two basal body units, the anterior of the two basal bodies is considered a
daughter basal body. The daughter basal body attaches to the kinetodesmal fiber and has a post
ciliary rootlet, but no transverse microtubule and no cilium arising from it (Iftode and FleuryAubusson, 2003, Iftode et al., 1989). (See Figure 1.3 for a schematic illustration.)
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The basal bodies, along with the other components in the cell, must duplicate when
Paramecium divides. The process of division is highly ordered and binary, producing two
identical daughter cells. Division begins by a cell becoming larger and producing extra basal
bodies. A fission furrow will form around the center of the cell and a new oral apparatus
develops. There are two waves of duplication of the basal bodies. The first wave has two rounds
of duplication. In the first round, a new basal body is produced in each cortical unit. The second
round creates another new basal body in each cortical unit. The second round of duplication
mostly takes place around the central midline of the cell, yielding three or four basal body units
which then separate and reform the cortical ridges to delineate each unit. During division, the
cytoskeletal structures, such as the kineties and the epiplasm, are broken down and elongated,
then rebuilt with the cortical units (Iftode, 1989, Iftode and Fleury-Aubusson, 2003, Ruiz et al.,
2005).
Paramecium as a Model Organism
Paramecium is an excellent model organism not just because they are easy to grow and
maintain, but they are also amenable to techniques such as electrophysiology and RNA
interference (RNAi) by feeding. These cells survive easily at room temperature (20 to 25°C) and
divide approximately every six hours. They can grow to great densities, upwards of 30,000 cells
per mL, which can be collected. The cilia and cell bodies can be collected separately for
biochemistry studies (Wright and van Houten, 1990, Adoutte et al., 1980). The genome for
Paramecium has been sequenced and annotated (ParameciumDB, http://paramecium.cgm.cnrsgif.fr/) (Arnaiz et al., 2007, Arnaiz and Sperling, 2011). There are numerous behavioral mutants
available for study, many of which, the affected protein has been identified (reviewed in (Kung
and Saimi, 1982, Preston and Kung, 1994b, Preston and Kung, 1994a)). There are many reasons,
not just the ones mentioned here, that make Paramecium an attractive model organism.
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II.

The Paramecium Mutant eccentric and Mg2+

Paramecium Reproduction and Creating a Mutant
Paramecia cells contain one somatic polyploidy macronucleus and two germ line diploid
micronuclei. Paramecia cells are able to divide both sexually and asexually. These cells divide
asexually by binary fission, creating two identical daughter cells. This process usually takes
place when the cells are well fed in a bacteria-rich environment. Paramecium can also exchange
genetic material by reproducing sexually through conjugation. During conjugation, two
paramecia cells of opposing mating types join and exchange genetic material. After the two cells
fuse, the micronuclei undergo meiosis and are exchanged between the cells. The micronuclei
then fuse and the old macronuclei of the conjoined cells are degraded. To complete conjugation,
each cell duplicates its micronuclei, develops a new macronucleus, then the cells separate
(Cronkite, 1974). In the last process of reproduction, cells are able to undergo autogamy, which
produces a diploid cell that is homozygous for all genes (reviewed in (Kung et al., 1975)). The
process of autogamy is very useful in genetic studies of these cells.
The multiple nuclei of these cells makes site-directed mutagenesis nearly impossible.
However, by forcing paramecia cells through the process of autogamy after the application of a
general mutagen, a genetically homozygous diploid cell is produced (Kung et al., 1975).
Autogamy is the rearrangement of the somatic macronucleus. It is a unique form of sexual
reproduction that the cell is able to perform by itself. During autogamy, the cell degrades the
polyploid macronucleus. The germ line micronuclei then go through meiosis to first separate
into haploid micronuclei which then duplicate. Of the four haploid meiotic products, three will
randomly degrade. The cell then progresses to mitosis where the one remaining haploid nucleus
divides and reunites to form a diploid cell. This division process produces a cell that is
completely homozygous in all genes. The resulting cell is genetically a diploid, but expresses the
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genes phenotypically because the genes are identical (Kung et al., 1975). The process of
autogamy after a mutagen is applied provides a stable cell line with two identical copies of each
gene. The cell lines can then be screened for mutants with the desired phenotype.
A commonly used mutagen applied to paramecia cell populations is N-methyl-N’-nitroN-nitrosoguanidine (MNNG). The mutagen MNNG can add methyl groups to guanine residues,
creating 7-methyguanine (Craddock, 1968). After the application of MNNG, approximately 50%
of the paramecia will die (Preston and Kung, 1994a). Those paramecia that do survive and
successfully go through autogamy can then be used for behavioral tests or screens. The cells that
have gone through autogamy would phenotypically display their genotype, as already described
for autogamy (Kung et al., 1975). Methods to rapidly screen large groups of cells for changes in
behavior allow for the desired phenotypes to be identified and isolated. The methods used often
rely on the ability of the cells to react to gravity by swimming upward in solution as well as to the
reaction to ionic stimuli (Preston and Kung, 1994b, Kung, 1971).
Screening for Mg2+ Mutants
Paramecia cells are reactive in Mg2+ solutions and will swim backward or jerk when they
are exposed to 5 mM MgCl2. A Mg2+ current in Paramecium was first described in 1990 (Preston,
1990). Soon after, researchers sought to isolate mutants defective in their reaction to Mg2+. After
exposing a population of cells to the mutagen MNNG and allowing the cells to go through
autogamy, the population was screened for cells unreactive to Mg2+ solutions. The initial
screening involved placing the mutagenized cells in a trough of a galvanotactic chamber. A 40V
pulse was applied to the trough every 50 msec at a frequency of 4 Hz. The controlled application
of an electrical pulse oriented the cells such that their anterior end was pointed toward the
cathode of the trough. When Mg2+ was added to the trough, the cells would react, and swim
backward toward the anode unless they were deficient in their response to Mg2+, in which case
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the cells would swim forward toward the cathode. The unreactive cells, those that swam
forward, were then cultured as single-cells for analysis (Preston and Kung, 1994b).
Although Preston and colleagues screened the mutants for cells that were unreactive in
Mg2+, some cells were just generally unresponsive to depolarizing ions. Other cell types that
were isolated included “pawn” mutants and “atalantas.” These mutants are unable to reverse
their cilia, therefore the deficiency was not Mg2+-specific. Because pawns and atalantas cannot
swim backward, they made it through the initial galvanotactic chamber screening using Mgsolutions because they were unable to reverse their cilia (Kung and Naito, 1973). Preston and
colleagues tested the newly created mutants in different ionic stimuli other than those containing
Mg2+. They also used back-crossing of these newly created mutants with other mutant lines to
determine the genetic relationship of these newly mutated genes (Preston and Kung, 1994b).
Eccentric Mutants (XntA and XntB)
The Mg2+-resistant mutants that were isolated harbor recessive mutations of two
different single mutations. The first demonstrated a strong resistance to Mg2+-induced behavior,
these were referred to as XntA mutants (XntA1, XntA2, and XntA3). The second group was
weakly resistant to Mg2+, referred to as XntB. The name “eccentric” comes from the odd behavior
of these cells which was very distinguishable from the wild type cells. The eccentric mutants,
while swimming in culture fluid, would display complex turns and bouts of long and rapid
backward swimming. The abnormal behavior was described as being eccentric, hence the
mutant’s name, eccentric (Xnt) (Preston and Kung, 1994b, Preston and Kung, 1994a).
The eccentric mutants have phenotypes other than an absence of Mg2+-induced behavior.
The Xnt mutants are also resistant to NiCl2 ciliary paralysis. Paramecium incubated in heavy
metals have been shown to decrease their ciliary motion or even become paralyzed, unable to
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move the cilia (Naitoh, 1966). Similarly, in mammalian cells, a concentration of 100 µM NiCl2
caused reduced metabolism in the cells and ciliary paralysis of rat, guinea pig, and hamster
tracheal explants. The exposure to NiCl2 did not change the morphology of the cilia (Gabridge et
al., 1982). When wild type and XntA paramecia were incubated for 24 hours in a 50 µM NiCl2
solution, all the wild type cells were dead or paralyzed while the XntA mutants were unaffected
(Preston and Kung, 1994b). The XntB mutants were also found to be resistant to this paralysis,
but to a lesser extent than the XntA mutants. The conclusion was that Ni2+ must enter the cells
through the same channel or using the same proteins as Mg2+ (Preston and Kung, 1994b).
There are two other phenotypes of XntA mutants that are not heavily researched or
discussed. These mutants have a very fast deactivation of the calcium-dependent sodium
current. This can be observed as very short backward swimming in sodiumtetraethylammonium (TEA) solutions or by using voltage clamp in the presence of 10 mM TEA
with 10 mM NaCl. The step-depolarization of the XntA cells elicits tail currents that decay twice
as fast as wild type tail currents under the same conditions (Preston and Kung, 1994a). XntA
mutants also have a slow deactivation of the depolarization-activated calcium current. These
mutants show long backward swimming in high K+ solutions, twice that of the wild type cells
(Preston and Kung, 1994b, Preston and Kung, 1994a). Under voltage clamp, the inactivation of
the depolarization-activated K+ current is seen in a slow recovery after depolarization steps from
-40 mV to -10 mV (Preston and Kung, 1994a).
Paramecium Intracellular Mg2+ Concentrations and IMg(Ca)
Over 300 enzymatic reactions require Mg2+, including binding ATP and ATP synthesis,
synthesis of proteins, fat, and nucleic acids, and neurotransmitter release, to name a few
(Maguire and Cowan, 2002). Therefore, the intracellular concentration of Mg2+ ions is very tightly
regulated. Techniques are still being developed to detect and calculate the concentrations of
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intracellular free Mg2+. The commonly accepted intracellular concentration of free Mg2+ in
mammalian cells is 0.3 mM (Maguire and Cowan, 2002). Not much different is the intracellular
free Mg2+ concentration in Paramecium, calculated to be 0.4 mM (Preston, 1990, Preston, 1998).
Paramecium also has an unknown intracellular Mg2+ store that has a concentration of 8 mM, far
higher than the intracellular concentration. These concentrations were determined using a Mg2+specific dye, Mag-fura-2 (Preston, 1998).
The membrane of Paramecium is permeable to Mg2+ and will depolarize. The
concentration of Mg2+ must be 0.5 mM or higher for a significant depolarization to occur
producing an action potential (Preston, 1990). The action potential is prolonged in solutions
containing Mg2+ because of the calcium-dependent Mg2+ conductance (IMg(Ca)). The XntA mutants
lack the IMg(Ca), showing no Mg2+-induced behavior (backward swimming) and very little
membrane depolarization, ~1 mV (Preston and Kung, 1994b, Preston and Kung, 1994a, Haynes et
al., 2002). Upon depolarizing Paramecium using voltage clamp in the presence of Ca2+ and Mg2+,
Ca2+ and Mg2+ will enter the cell. Once the cell is returned to -30 mV, a typical resting potential
for the cell, a tail current occurs. The tail current is the closing of the Mg2+ channel and its current
has been determined to purely Mg2+; it does not occur when Mg2+ is removed from the bath. The
tail current is 1-2 nA and is calcium-dependent (Preston, 1990). The source of the Ca2+ needed for
this conductance comes from the ciliary voltage-gated Ca2+ channels (VGCCs) (Dunlap, 1977). If
the paramecia cells are deciliated, they no longer elicit IMg under physiological conditions.
Similarly, pawn B mutants, which do not have VGCC’s in the cilia, also do not elicit IMg under
physiological conditions (Preston, 1990, Preston and Kung, 1994a, Preston, 1998).
XntA Protein and Gene (XNTA)
In 2002, the gene that cured the XntA mutants was found using phenotypic curing of the
mutant after microinjection of fragments of the DNA library of wild type cells. The locus was
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eventually mapped to a 2,427 bp fragment of DNA that cured the mutant when injected, but not
the mutant equivalent of the same fragment. The DNA sequence was eventually determined
using reverse transcriptase PCR (RT-PCR). The gene for XNTA is 1,707 bp long and contains two
introns. The other XntA mutants were cured by expressing this same gene, but the XntB mutant
was not (Haynes et al., 2002). The gene is translated into a predicted protein of 550 amino acids
with 11 predicted transmembrane spanning domains. The protein can be divided into two
regions, α1 and the α2, which are separated by a long intracellular domain. The α1 and the α2
regions show low levels of homology to the Na+/Ca2+ exchanger (NCX) and Na+/Ca2+/K+
exchanger (NCKX) proteins, respectively. The intracellular domain contains a possible PEST
sequence, which may target the protein for early degradation. The mutation creating XntA1 is a
deletion at cysteine 111 which generates a premature stop (Haynes et al., 2002). The premature
stop would severely truncate the protein, most likely rendering it useless.
The function of the XntA protein is unknown. XntA is described as a possible Mg2+specific channel-like exchanger protein. However, the authors do not specifically name the
protein as a channel or as an exchanger (Haynes et al., 2002). Although the authors were
successful in curing the mutant with the XNTA wild type gene for IMg and Mg2+-induced
behavior, they did not address either of the other behavioral phenotypes. The authors did not
test the backward swimming in high K+ or Na/TEA nor did they examine the heavy metal
paralysis resistance of the XntA mutant (Haynes et al., 2002). It has been speculated that the
XntA protein may be a regulatory protein of the Mg2+ influx (Haynes et al., 2002) or that eccentric
mutants may be a phosphatase or kinase mutant (Preston and Kung, 1994a, Preston and Kung,
1994b). There is still much more to learn about the function and regulation of the XntA protein
in Paramecium and its contribution to the conductance of Mg2+.
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III.

Cilia and Ciliopathies

Cilia Structure
Cilia are membrane-bound organelles that protrude from the surface of eukaryotic cells.
A cell may have one or many cilia. Cilia behave as an “antennae,” sensing the surrounding
environment and sending signals back to the cell. These organelles are typically characterized as
“9+0” or “9+2.” Primary non-motile cilia are typically a “9+0” configuration, lacking a central
pair of microtubules. Motile cilia are typically a “9+2” configuration and contain the central pair
of microtubules (reviewed in (Fliegauf et al., 2007)). There are exceptions to these rules, as
embryonic nodal cilia, which are motile with a configuration of “9+0,” are important for left-right
asymmetry determination (Nonaka et al., 1998). Non-motile kinocilia in the inner ear have a
“9+2” arrangement (Flock and Duvall, 1965). Motile cilia can also be sensory, as seen in
Paramecium. Numerous receptors that are important for locating food and interacting with the
surrounding environment are found in the cilia of this cell (Weeraratne, 2007, Jacobs, 2007).
Cilia do not contain the necessary machinery for protein production. Therefore, they
require proteins to be trafficked in from the cell to the cilium and along the axoneme. The
axoneme runs up the center of the cilium and contains the 9 outer pairs of A and B microtubules,
and in some cases, the central pair of tubules as well. The A and B tubules are extensions from
the basal body (Ringo, 1967). Cilia develop from the base to the tip (Johnson and Rosenbaum,
1992) using the B tubule as a highway for cargo movement up and down the cilium (Kozminski
et al., 1993). This transport system is called intraflagellar transport (IFT), first described in
Chlamydomonas (Kozminski et al., 1993). IFT moves the cargo in trains from the base to the tip
using anterograde transport with kinesin-2 motor proteins (Kozminski et al., 1995). The cargo
return from the tip to the base using retrograde transport and cytoplasmic dynein (Pazour et al.,
1999, Porter et al., 1999). For review of IFT and cargo interactions, see (Bhogaraju et al., 2013).
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A barrier exists between the cilia and the cell membrane called the transition zone. The
transition zone separates the ciliary compartment from the inside of the cell. As already
mentioned, the membrane of the cell surface and the cilia are contiguous, but they are
compositionally different. The transition zone is important to keep these compartments separate
by creating a selective filter, only allowing certain proteins to enter the cilium. This zone in cilia
with a “9+2” arrangement spans from the basal body, where the C tubule terminates, to where
the central pair of tubules begins in the cilium (Garcia-Gonzalo et al., 2011, Aubusson-Fleury et
al., 2012). Proteins in this zone form a filter that allows the selective passage of proteins into and
out of the cilium, regulating the contents (Figure 1.4). The filter is a complex and includes the
tectonic (Tctn) proteins, specifically Tctn 1, which is essential for ciliogenesis in some cell types.
Other proteins that comprise this filter in mammalian cells include MKS1, Tmem267, MKS3,
Cep290, Cc2d2a, B9d1, and Tctn 2 (Garcia-Gonzalo et al., 2011). In Paramecium, the conserved
centrosomal FOP family protein (FGFR1 Oncogene Partner) FOR20 is required for the building of
the transition zone, as well as the centrin protein Cen2 (Aubusson-Fleury et al., 2012).
Ciliary Defects and Ciliopathies
When cilia are defective or dysfunctional, the resulting pathology or disease is referred to
as a ciliopathy. The most common physiological abnormalities that arise from these diseases
include, but are not limited to, cystic kidneys, retinal degeneration, anosmia, liver fibrosis,
obesity, developmental delay, situs inversus, and infertility (reviewed in (Hildebrandt et al.,
2011)). Although the commonality among ciliopathies are dysfunctional cilia, these diseases are
very tissue- and cell-type specific. Some ciliopathies can be treated with medication, gene
therapy or transplantations while others can be fatal.
Advances in genetic screening have allowed much better diagnosis of patients with
ciliopathies. Large data bases of gene mutations are available for some diseases as well as
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information forums and support groups. Genetic testing is also available for many ciliopathy
diseases (see http://pkdb.mayo.edu, http://www.med.unc.edu/pulmonary/specialties/areasand-programs/pcd, or http://www.rarediseases.org/rare-disease-information/rarediseases/byID/20/printFullReport). The list of genes contributing to ciliopathies is evergrowing, emphasizing the importance of research on ciliary dysfunction to better understand the
contributions made by these ciliopathy proteins in their mutated and non-mutated forms. It is
important to identify the genes and proteins involved as well as identify their location, role
within the cell, as well as potential interacting partners within the systems and cells of which they
reside.
Meckel-Gruber Syndrome and MKS3
Meckel-Gruber Syndrome (MKS) is a ciliopathy disease caused by mutations in at least
three proteins leading to renal dysplasia, encephalocele, and polydactyly (Salonen and Norio,
1984, Salonen and Paavola, 1998). MKS is a rare recessive disorder with world-wide rates
ranging between 1 in 13,250 and 1 in 140,000 births. Geographic areas such as Finland, the
Middle East, and North Africa have higher rates of incident, 1:9,000 (Salonen and Norio, 1984).
MKS can be diagnosed early using an ultrasound at 11 to 12 weeks of gestation to detect
developmental abnormalities (Sepulveda et al., 1997). There is no treatment for this disease and
in severe cases of this syndrome, individuals may die before birth or may only live a few hours
after birth (Salonen and Paavola, 1998).
The MKS3 protein, or TMEM67, is one of the contributors to the MKS ciliopathy when it
is mutated. The MKS3 protein is highly conserved among organisms. In humans MKS3 is 995
amino acids in length, with a molecular weight of 108 kD. The protein is postulated to have three
or seven transmembrane spanning regions, although more current publications characterize the
protein as containing three (Dawe et al., 2007, Smith et al., 2006, Dawe et al., 2009). MKS3 is a
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component of the transition zone complex in mammalian cells, important for forming a filtration
barrier separating the ciliary compartment from that of the rest of the cell (Garcia-Gonzalo et al.,
2011, Chih et al., 2012, Czarnecki and Shah, 2012, Williams et al., 2011). MKS3 has also been
shown to play a role in the positioning of basal bodies and the formation of cilia (Dawe et al.,
2007). Continued research aims to further understand the MKS3 protein and its multiple roles in
the positioning of basal bodies and functioning as a ciliary gate-geeping transition zone complex
protein.
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Autosomal dominant polycystic kidney disease, or ADPKD, is one of the most common
and potentially lethal inherited human diseases in the world. ADPKD is characterized by kidney
cysts, rendering the kidney non-functional in approximately 45 to 50% of patients by the age of 60
(Gabow, 1993). Typically ADPKD is inherited as autosomal dominant gene mutations.
Spontaneous mutations leading to the disease occur in less than 10% of the cases (Gabow, 1993).
The first gene identified in ADPKD was PKD1, or polycystin-1, located on the short arm of
chromosome 16 (Reeders et al., 1985). Later, the second gene was identified, PKD2 or polycystin2 (TRPP2 or Pkd2), on chromosome 4 (Mochizuki et al., 1996). A third gene is thought to exist,
but has yet to be identified (Daoust et al., 1995).
Currently, a database to report the mutations and families associated and affected by
ADPKD is available (http://pkdb.mayo.edu). As of February 1st, 2015, there are 2,322 families in
the ADPKD database with 2,055 reported mutations in PKD1. Another 463 families with the
disease containing 278 different mutations in PKD2 (ADPKD, 2014). Mutations in PKD1 also
account for earlier-onset of end-stage renal failure (ESRF) from the disease compared to
mutations in PKD2. On average, ESRF for individuals with mutations in PKD1 occur at 58.1
years of age while those individuals with mutations in PKD2 have renal failure onset on average

17

at 79.7 years of age (Cornec-Le Gall et al., 2013). Also, truncation mutations are far more severe
with an earlier onset of ESRF. Truncation mutations of PKD1 led to ESRF at age 55.6 compared to
67.9 years of age for those mutations which were in-frame or missense (Cornec-Le Gall et al.,
2013).
Mutations in the PKD genes cause varying degrees of severity of ADPKD. The mutations
can cause missense mutations, splice site mutations, truncations, and can be as simple as amino
acid substitutions. Rarely are large deletions of PKD1 observed, accounting for approximately
4% of the cases of ADPKD (Ariyurek et al., 2004). Unfortunately the PKD1 gene is very complex,
duplicated multiple times on chromosome 16, so identifying mutations in PKD1 typically
requires direct sequencing. Mutations in the PKD1 and PKD2 genes can be analyzed to predict
the severity of the mutation. Interestingly, two mutations predicted to be “benign” mutations
identified in the PKD1 gene manifested as extremely severe in the patients with the mutations. In
these “benign” cases, the manifestation of the disease was apparent at birth and at 3 months of
age (Hoefele et al., 2011). In the same study, another predicted “benign” mutation in the PKD2
gene led to early onset of renal failure, however, the amino acid that was altered was shown to be
highly conserved evolutionarily (Hoefele et al., 2011). Other mutations in the PKD2 gene that lead
to more severe manifestations of the disease are truncation mutations that occur at the Cterminus. These truncation mutations effect the trafficking of the Pkd2 protein and are often
used in research, which will be discussed shortly (Cai et al., 1999, Tsiokas et al., 1997b, Hanaoka
et al., 2000).
Mutations in Pkd1 and Pkd2 mostly affect the kidneys, but other organs, such as the liver
and pancreas can develop cysts. Also, because PKD1 and PKD2 are expressed in vascular smooth
muscle, mitrial valve prolapses, artery dissections and aneurysms are not uncommon. Brain
aneurysms can also occur (Reviewed in (Torres et al., 2007)). Annual healthcare costs for
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treatment per patient (data collected from 2003 to 2006) range from $26,521 to $140,139. The
annual cost of dialysis, the most common form of treatment for the disease, is $131,890 per
patient. In-hospital stays for a kidney transplant, which is currently the only way to stop the
progression of the disease, costs $119,931 (Lentine et al., 2010). Recently, the use of tolvaptan, a
vasopressin receptor agonist which has been approved as a treatment for hyponatremia (low
blood sodium), has been investigated to slow the progression of the disease by slowing cyst
growth and development. There are risks to taking this medication, however. Liver function and
uric acid levels must be monitored and thirst and frequent urination can be a problem (Torres et
al., 2012).
Mammalian Pkd1 and Pkd2
The PKD1 and PKD2 genes and their proteins were identified and described in the mid1980’s 1990’s. The Pkd1 protein was described in 1995. Its sequencing was complicated by
chromosomal rearrangements that take place on chromosome 16 (Hughes et al., 1995). Pkd1 is a
450 to 460 kD protein, approximately 4300 amino acids in length (Hildebrandt et al., 2011, Chapin
and Caplan, 2010, Hughes et al., 1995). The protein sequence contains a very long extracellular
N-terminus consisting of over 2500 amino acids followed by 11 transmembrane spanning
domains and very short intracellular C-terminus (Hughes et al., 1995). The large extracellular
domain contains two leucine-rich repeats, followed by 16 repeats that resemble IgG folds, and a
calcium-dependent lectin domain. The last 1000 amino acids before the transmembrane domains
contains an amino acid sequence that is similar to that of the guanylyl cyclase receptor for egg
jelly, as seen in sea urchin spermatozoa. In human fetal kidney cells, the Pkd1 protein colocalizes with the catenins and E-cadherin, suggesting it is important for protein-protein and
protein-carbohydrate interactions and junctions between cells (Huan and van Adelsberg, 1999).

19

Although Pkd1 is considered a transient receptor potential (TRP)-like protein, it is not a member
of the TRP superfamily (Giamarchi and Delmas, 2007).
The human PKD2 gene, located in chromosome 4, encodes a 968-amino acid protein
which spans the membrane 6 times (Mochizuki et al., 1996). The Pkd2 protein contains
intracellular N- and C- termini with a C-terminal EF-hand (Mochizuki et al., 1996). The fulllength human version contains a 34-amino acid endoplasmic reticulum (ER) retention sequence
located at the C-terminus that contains two phosphorylation sites (Cai et al., 1999). A pore loop
exists between the fifth and sixth transmembrane domains that is predicted to have a helix-loop
structure with three negatively charged amino acids in the loop structure (Nomura et al., 1998).
These conserved negatively charged amino acids are important for the conductance of calcium
ions. The structure and negatively charged amino acids are similar to the α1 region of the voltage
gated calcium channels (Nomura et al., 1998).
Pkd2 is a member of the transient receptor potential channels (TRP channels), a member
of the P-type family (Giamarchi and Delmas, 2007). Pkd2 is a non-selective cation channel,
permeable to Ca2+, Mg2+, K+, Na+, Cs+ and Ba2+ (Gonzalez-Perrett et al., 2001, Koulen et al., 2002,
Hanaoka et al., 2000). These conductances were demonstrated using patch-clamp studies of
reconstituted proteins from human term syncytiotrophoblast (hST) cells (Gonzalez-Perrett et al.,
2001), ER vesicles from LLC-PK porcine kidney cells expressing human Pkd2 (Koulen et al.,
2002), and Chinese hamster ovary cells expressing human Pkd1 and Pkd2 (Hanaoka et al., 2000).
Pkd2 showed more permeability to Ca2+ over monovalent ions (Gonzalez-Perrett et al., 2001),
which was in agreement with earlier studies (Hanaoka et al., 2000). Gonzalez-Perrett and
colleagues also demonstrated that this channel was blocked by the Anti-PKD2 antibody, made to
recognize the last C-terminal 258 amino acids of human Pkd2 (amino acids 710 to 968), and also
by the addition of La3+, Gd3+, pH reduction and by Ca2+ itself (Gonzalez-Perrett et al., 2001).
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Localization of Pkd2
The Pkd2 protein has been found in the endoplasmic reticulum (ER) (Cai et al., 1999, Bae
et al., 2006, Kottgen et al., 2005), the cell membrane (Gonzalez-Perrett et al., 2001, Hanaoka et al.,
2000, Pazour et al., 2002, Luo et al., 2003), and the ciliary membrane (Nauli et al., 2003, Huang et
al., 2007, Pazour et al., 2002). Pkd2 is found in the ER where it is trafficked to other parts of the
cell or in some cases, returned to the ER. One study used a collection of different cells lines and
demonstrated that Pkd2 remains in the ER due to an ER-retention or ER-“retrieval” signal (Cai et
al., 1999). When human full-length Pkd2 is expressed in human embryonic kidney cells
(HEK293), a short 34 amino acid sequence between glutamic acid 787 and glycine 821 prevents
Pkd2 from leaving the ER (Cai et al., 1999) or causes Pkd2 to be quickly returned to the ER from
the cis-Golgi in a COPII-dependent manner (Hoffmeister et al., 2011, Cai et al., 1999). By
expressing truncated versions of the Pkd2 sequence in LLC-PK or HEK293 cells (R742X, R787X,
and R872X), this group demonstrated that full length Pkd2 and the R872X version, both that
contain the ER “retrieval” signal, remained in the ER. However, the two truncated Pkd2 versions
without this “retrieval” sequence (R742X and R787X) were found in the cell membrane (Cai et al.,
1999).
In some cell types, the Pkd2 protein requires recruitment by the Pkd1 protein to traffic to
different membranes. Investigation of full length human PKD1 and PKD2 expressed in Chinese
Hamster Ovary (CHO) cells suggested Pkd2 required Pkd1 for Pkd2 location in the cell
membrane and channel activity. When expressed alone, full length Pkd2 was found inside the
cell and the truncated Pkd2 protein R742X was found in the cell membrane (Cai et al., 1999,
Hanaoka et al., 2000). Full length PKD2 had to be co-expressed with PKD1 in CHO cells for Pkd2
to be found in the cell membrane. Interestingly, when the truncated Pkd2 (R742X) was coexpressed with Pkd1, no currents were produced in the CHO cells suggesting no channel activity
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even though both proteins were found in the cell membrane. The truncated Pkd2 (R742X) does
not co-IP with the Pkd1 protein (Hanaoka et al., 2000). These data support the interaction of
Pkd1 and Pkd2 at the C-terminus of Pkd2 and also suggest, as the authors mentioned, that even
full length Pkd2 containing the ER-retrieval signal can traffic to the cell membrane (Hanaoka et
al., 2000). Other work has shown that the Pkd1 and Pkd2 proteins interact between amino acid
positions 871 to 968 at the C-terminus of Pkd2 (Hanaoka et al., 2000, Tsiokas et al., 1997a) which
may interfere with the ER-retrieval signal, “masking” it (Cai et al., 1999).
Pkd2 is also located in the cilia, and, because of the involvement in ADPKD, some
researchers sought to examine Pkd2 trafficking and localization in the cilia of kidney cells. Initial
studies looked at the localization of the Pkd2 protein in cultured human and mouse kidney cells.
Using the YCC2 antibody (Cai et al., 1999), the Pkd2 protein was clearly localized to the cilia and
the cell body (Pazour et al., 2002). In another study using mouse kidney cells, the Pkd1 protein
was localized to the primary cilium. In the kidney cells from a mouse with a truncated version of
the Pkd1 protein, Pkd1del34/del34 (Nauli et al., 2003), Pkd1 was no longer in the kidney cilia. These
mice express a truncated form of Pkd1 which has deleted exon 34, truncating the Pkd1 protein
near amino acid 3467 (Delmas et al., 2004). The same study localized the Pkd2 protein to the
primary cilium in the wild type kidney cells but not in the mutant kidney cells from the
Pkd1del34/del34 mice (Nauli et al., 2003). These results suggested Pkd2 requires full length Pkd1 in
the mouse kidney cilia in order for Pkd2 to traffic there.
Another study of Pkd2 using a knockout mouse shed light on the movement of Pkd2
from the cilia back to the cell (Pazour et al., 2002). When Pazour and colleagues examined the
Tg737orpk mouse, a commonly used mouse model for kidney disease, they found that Pkd2
immunofluorescence was elevated in the cilia of the kidney cells from the Tg737orpk compared to
the wild type littermates. It turns out the gene mutated in the Tg737orpk mice is IFT88
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(intraflagellar transport protein 88) which is a vital component to anterograde transport and the B
complex. Pazour and colleagues concluded that Pkd2 does not require IFT88 for transport into
the cilia, but it does for the cycling of this protein back to the cell body. The cilia of these mutant
mice were short, contained high levels of Pkd2 staining, and had bulges at their tips (Pazour et
al., 2002).
There are instances where Pkd2 relies on other proteins for trafficking to the cell
membrane, to the cilia, and out of the cilia, as we have discussed. However, there are also
examples of Pkd2 trafficking independently of other proteins. In the nematode C. elegans, the
homologue for Pkd2 (pkd-2) does not require the Pkd1 homologue (lov-1) to traffic into the
ciliated neurons. Although both of these proteins are involved in the same pathway, they do so
through independent trafficking (Barr et al., 2001). Another example is in the green algae
Chlamydomonas reinhardtii. In this flagellated cell, Pkd2 is translated into a 210 kD protein.
However, it must be cleaved into two smaller proteins, 120 and 90 kD, before entering the cilia.
Pkd2 does not depend on the presence of Pkd1 for this to occur (Huang et al., 2007). What is
apparent from all of these studies is the versatility of the Pkd2 protein. The multitude of
differences highlights the adaptability of Pkd2 and that its location and movement between
membranes is very cell-type and species specific.
Pkd2 and Pkd1 Interactions
We have already mentioned the interactions of the Pkd1 and Pkd2 proteins. Because of
their dual involvement in ADPKD, these two proteins are commonly co-expressed in cells for
study. The interactions of Pkd1 and Pkd2 have been demonstrated to occur at the C-terminus of
both proteins. Using the Yeast two Hybrid screening system, the last 226 amino acids of Pkd1
were used as bait while the final 289 amino acids of Pkd2 were used as prey. Pkd1 interacted
with Pkd2 at the last 97 amino acids of Pkd2 but not with other prey proteins or with itself
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(Tsiokas et al., 1997a). The authors determined that Pkd1 and Pkd2 interact at their C-termini.
The same study demonstrated that amino acids 742 to 871 of Pkd2 are important for Pkd2
homodimerization. This section of amino acids in Pkd2 contains a proposed coiled-coil domain
and is independent of the proposed Pkd1 interacting domain (Tsiokas et al., 1997a).
The large C-terminal region of human Pkd2 (amino acids 679 to 968) was later analyzed
using a coiled-coil prediction program, PCOILS (http://toolkit.tuebingen.mpg.de/pcoils). Two
domains were identified. The first, CC1 (E769-L796) scored lower than the second predicted
domain, CC2 (S835-A873) (Giamarchi et al., 2010). Similar to the work just mentioned by Tsiokas
and colleagues (Tsiokas et al., 1997a), the later part of the C-terminus is essential for interactions
with the Pkd1 protein, meaning deletions or mutations to the CC2 domain (S835 to A873) abolish
heteromers with PKD1. However, deletions or mutations to CC2 do not interfere with Pkd2
forming homomultimers. The vast majority of the predicted CC2 domain, described as being
essential for Pkd1 interaction (Giamarchi et al., 2010), is absent from the original domain
described by Tsiokas and colleagues (1997). When addressed by the authors, Giamarchi et al
(2010) suggested that the CC2 domain, although essential for Pkd1 interaction, is not the direct
binding site for Pkd1, which is the area just distal to the CC2 domain, described by Tsiokas et al
(1997). Instead, the CC2 domain most likely helps facilitate the interaction of these two proteins
and is required for their interaction (Giamarchi et al., 2010).
Pkd2 and Other Interacting Proteins
Research has shown that the Pkd2 protein interacts with proteins other than Pkd1.
Interaction includes formation of heterotetramers (Kobori et al., 2009) which requires a cysteine
residue at position 632. The cysteine is located in the third extracellular loop, where it forms
important disulfide bonds between Pkd2 monomers (Feng et al., 2011). This cysteine, when
mutated to an alanine or an arginine (C632A or C632R), and expressed in HEK293 cells did not
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demonstrate any problems with Pkd1 interactions. However, when these mutated forms of Pkd2
were expressed in HEK293 cells, there was a diminished activity of the Pkd2-dependent calcium
release from the ER (Feng et al., 2011). Another study in HEK293 cells demonstrated that coexpression of PKD1 and PKD2 allowed these two proteins to from a junction. The same study
showed the Pkd1 protein in the cell membrane will interact with the Pkd2 protein in the ER
where Pkd2 will function as an intracellular calcium release channel (Giamarchi et al., 2010).
Also in the ER, Pkd2 has been shown to activate and interact with the Ryanodine receptor (RyR),
acting as an intracellular calcium release channel (Nauli et al., 2003, Anyatonwu et al., 2007,
Koulen et al., 2002).
The Pkd2 protein also acts in a complex with TRPV4, a member of the Vanilloid
subfamily of the TRP channels. The full length human genes encoding TRPP2 (Pkd2) and TRPV4
were expressed in MDCK cells and Xenopus oocytes. The TRPV4 channel co-localized with Pkd2
in the cilia of the MDCK cells. The expression of these two genes in oocytes showed an increased
conductance in response to osmotic swelling compared to single-expressing oocytes and the wild
type control cells. Interestingly, Kottgen et al (2008) observed that TRPV4 was important in the
MDCK cells for fluid-flow mechanosensation, but that it was not necessary in mice or zebrafish
for the same fluid-flow detection. Another finding of this study was that heterozygous TRPV4+/and TRPP2+/- mice showed a reduction in temperature sensitivity, tolerating 46°C, 2°C higher
than the control animals’ 44°C in tail-immersion tests. (A tail immersion test is a gently restrained
animal whose tail is place in a water bath for a maximum of 300 seconds and the time until the
tail is flicked by the animal is recorded)(Kottgen et al., 2008). These data suggest the two
proteins, Pkd2 and TRPV4, are important for mechanosensation and thermosensation. Further
investigation of epitope tagged versions of human Pkd2 and TRPV4 with atomic force
microscopy (AFM) support Pkd2 and TRPV4 function as a heterotetramer with a 2:2
stoichiometry (Stewart et al., 2010).
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The Pkd2 protein also interacts with the TRPC1 protein. Co-expression of epitope tagged
Pkd2 and TRPC1 proteins in HEK293 cells, again using AFM, demonstrated these two proteins
form a heterotetramer with a 2:2 stoichiometry (Kobori et al., 2009). The Pkd2 and TRPC1
channels were first shown to interact in the late 1990s by another group (Tsiokas et al., 1999).
The initial study co-expressed full length versions of N- and C-terminally epitope tagged Pkd2
and TRPC1 proteins, respectively, in HEK293T cells. The Pkd2 and TRPC1 proteins were shown
to co-immunoprecipitate, suggesting an interaction. Truncated versions of these expressed
proteins suggest the interaction occurs at their C-termini (Tsiokas et al., 1999).

The interaction of

Pkd2 with TRPC1 and TRPC4 were also demonstrated in glomerular mesangial cells (MC) where
these proteins were shown to physically interact to form a calcium-permeable channel in the
membrane (Du et al., 2008).
The Pkd2 protein has also been shown to interact with non-TRP channels. Just
mentioned was the interaction of Pkd2 with the ryanodine receptors of the ER to form
intracellular calcium release channels (Nauli et al., 2003, Koulen et al., 2002, Anyatonwu et al.,
2007). Pkd2 has also been shown to interact with 1,4,5-triphosphate receptors (IP3R) of the ER (Li
et al., 2005, Sammels et al., 2010). In LLC-PK1 cells expressing mouse wild type full-length PKD2,
co-immunoprecipitation (co-IP) assays show that Pkd2 co-immunoprecipitates with IP3R1 and
IP3R3. The reciprocal experiments are also consistent, that IP specifically for IP3R1 and IP3R3 coIP the Pkd2 channel. Using patch clamp experiments, the same group demonstrated that these
proteins act as an IP3- or Ca2+– induced calcium release pathway that helps to regulate
intracellular calcium concentrations (Sammels et al., 2010).
Regulation of the Pkd2 Channel
The Pkd2 channel is shown to be an important component for intracellular calcium
release in some cells. Pkd2 can also be regulated by intracellular calcium levels. Using LLC-PK1
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cells expressing human PKD2, cells were harvested and their isolated ER microsomes were
reconstituted in lipid bilayers. These reconstituted membranes were then used for single channel
recordings which found that the Pkd2 channel activity was responsive to changes in calcium
levels (Koulen et al., 2002). Pkd2 is regulated by calcium using the second of its two predicted EF
hands, which is thought to be the calcium sensor and important for calcium binding (Koulen et
al., 2002). A second study demonstrated that mutations in this second EF hand make the Pkd2
protein insensitive to intracellular calcium levels (Kuo et al., 2014). Normally, Pkd2 is functional
between 100 nM and 10 µM calcium (Kuo et al., 2014, Koulen et al., 2002). When the C-terminal
EF hands of Pkd2 bind calcium, it makes a conformational change which is expected to control
gating of the channel (Celic et al., 2012).
Pkd2 can be regulated by kinases and phosphatases as well. This regulation can be a change
in activity due to a phosphorylation/dephosphorylation event or these changes in
phosphorylation state can affect the trafficking of the protein. For example, in the nematode C.
elegans, phosphorylation at S534 by CKII in the male sensory ciliated neurons is facilitated by the
C. elegans version of Pkd1, lov-1. This phosphorylation activates the channel that leads to an
increase in intraciliary calcium levels. The excess calcium then activates tax-6, the C. elegans
homologue of calcineurin (CaN). The tax-6 protein in turn dephosphorylates Pkd2, deactivating
it (Hu et al., 2006). The constitutive phosphorylation of Pkd2 at S534 in C. elegans also leads to a
loss of this protein from the male sensory neurons, which are modified cilia. The mutation of
S534 to an alanine (S534A), which prevents phosphorylation, does not interfere with the
localization of Pkd2S534A to the cilia. A second form of Pkd2, where S534 is changed to an aspartic
acid (S534D), is a “phospho-mimetic” and does not traffic to the cilia (Hu et al., 2006). The
phosphorylation is not always important for trafficking of Pkd2, however. In mammalian renal
epithelial cells, CKII phosphorylation of Pkd2 at S812 has been shown to regulate the protein’s

27

activity and calcium sensitivity. However, it does not appear to be important for the trafficking
of the protein (Cai et al., 2004).

IV.

The BBSome and Trafficking to the Cilia

The BBSome Complex
The mammalian BBSome complex is comprised of eight proteins: BBS1, 2, 4, 5, 7, 8, 9 and
BBIP10 (Nachury et al., 2007). This complex of proteins forms an electron-dense coat around
vesicles and is morphologically distinct from other coat complexes, such as those formed by
COPI, COPII, and clathrin. The BBSome prefers acidic phospholipids, especially
multiphosphorylated phosphatidylinositol phosphates, for recruitment to liposomes. The
BBSome is recruited to liposomes by BBS3/Arl6, which is an Arf-like GTPase (Jin et al., 2010). To
determine how the members of this complex assemble before recruitment, the different BBSome
components were expressed in HEK293T cells in various combinations for IPs and co-IPs. Four of
the proteins have β-propeller domains (BBS1, 2, 7, and 9) which are important for protein-protein
interactions; two proteins have tetratricopeptide repeat domains (BBS4 and 8) (Zhang et al.,
2012). A thorough analysis of these BBSome components expressed in the HEK293T cells in
various combinations resulted in an explanation of the assembly order of this coat complex of
proteins. BBS9 is considered the central scaffold of the complex while BBS2 and 7 are core
components. BBS1 also has a strong association with BBS2 and 7, but it is added to the complex
later in assembly, along with BBS5 and 8 (Zhang et al., 2012).
To reach the cilia, the BBSome complex requires recruitment by other proteins. BBS4 is
thought to be the final addition to the complex and is the last component added before the
BBSome moves to the cilia (Zhang et al., 2012, Nachury et al., 2007). Once at the base of the
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cilium, the BBSome requires the GTPase Rab8 and the guanine nucleotide exchange factor Rabin
8 for association with IFT particles at the base of the cilia (Nachury et al., 2007). After the
addition of BBS4, the conserved centriolar satellite protein SSX2IP (synovial sarcoma X
breakpoint-2 interacting protein) is necessary for the recruitment of the BBSome into the cilia. In
retinal pigment epithelial cells (RPE-1 cells) induced to grow cilia, SSX2IP was knocked down
using small interfering RNA (siRNA) and the immunofluorescence of BBS components in the
cilia were observed. When SSX2IP was depleted, Rab8-GFP, which enters the cilia with the
BBSome (Nachury et al., 2007), was reduced significantly in the cilia compared to the control
treated cells (Klinger et al., 2014). Once in the cilia, the BBSome traffics up and down the cilium
using IFT (Nachury et al., 2007, Williams et al., 2014).
Trafficking by the BBSome
Certain proteins have been shown to require the BBSome for trafficking to the cilia, but
so far, not to the cell membrane. The somatostatin receptor 3 (SST3), a seven-transmembrane
spanning G-protein coupled receptor, has been shown to be BBSome-dependent for its trafficking
to the cilia. Recently, in RPE-1 cells depleted in SSX2IP and therefore ciliary BBS components, the
SST3 does not reach the cilia (Klinger et al., 2014). In BBS4-/- and BBS2-/- mice, the same is true.
Neurons from these knockout mice lack the SSTR3 and melanin-concentrating hormone receptor1 (Mchr-1) in the cilia of central neurons. The receptors will return to the neurons if the wild type
BBS gene is expressed in the cells, showing the dependence of these G-protein coupled receptors
on the BBSome for ciliary trafficking (Berbari et al., 2008).
There are other ciliary membrane proteins that are dependent on the BBSome for ciliary
localization. These other proteins are not seven transmembrane spanning proteins, but include
Pkd2 (Valentine et al., 2012, Hoffmeister et al., 2011) and a potassium channel, SK1a (Valentine et
al., 2012). Other studies have demonstrated that Pkd2 relies on BBSome trafficking to reach the
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cilia. First, the study by Hoffmeister and colleagues (2012) used IMPDH (inosine-5’monophosphate dehydrogenase) to interfere with GTP production in LLC-PK cells expressing
human full-length PKD2. Without GTP, the GTPase Rab8 would not be fully functional. As
mentioned, the BBSome requires Rab8 for ciliary entry (Nachury et al., 2007). The treatment of
the expressing cells with IMPDH prevented Pkd2 from reaching the cilia, but the smoothened
protein, which does not rely on the BBSome for ciliary trafficking, was unaffected (Hoffmeister et
al., 2011). A second study demonstrated that the depletion of BBSome components, namely
BBS7, 8, or 9, using RNAi in P. tetraurelia prevented Pkd2 from reaching the cilia. Although the
Pkd2 protein appears at the cell surface (Valentine et al., 2012). Lastly, a bbs-7 mutant of C.
elegans with a mutation in my13 shows abnormal male mating behavior. Further investigation
using my13 mutant worms expressing PKD2-GFP showed the Pkd2 protein accumulated at the
base of the cilia (Braunreiter et al., 2014).
Ciliary Targeting Signals
The idea of ciliary targeting signals or sequences has been proposed for numerous
proteins. For example, rhodopsin contains a VxPx motif at the C-terminus of the protein, that
when truncated, prevents this protein from reaching the cilia (Mazelova et al., 2009). A similar
proposed sequence in the human Pkd2 protein is sufficient for ciliary trafficking. The N-terminal
R6VxP motif, if mutated (R6G, V7A and P9A), prevents Pkd2 from trafficking to the cilia of
epithelial cells. Interestingly, the same study placed the first 72 amino acids of Pkd2 onto the Nterminus of PKD2L1, which does not localize to the cilia normally. When this chimeric form of
PKD2L1 was expressed in epithelial cells, the protein was found in the cilia (Geng et al., 2006).
Although these two sequences are very similar, they are found at separate termini. Other
proposed CTS sequences have been suggested, but there seems to be little consistency among
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them, suggesting that these sequences may be species-specific or may require a combination of
signals or proteins for recognition and trafficking.

V.

Experimental Approach

RNA interference (RNAi)
The use of RNA interference (RNAi) has become a highly utilized technique for the study
of gene function in numerous cell types. This technique to deplete cells of targeted mRNA was
first published in the nematode C. elegans (Fire et al., 1998). RNAi is now widely used in other
organisms, including but not limited to, Paramecium (Valentine et al., 2012, Picariello et al., 2014,
Galvani and Sperling, 2002), Zebrafish (Andrews et al., 2014), Chlamydomonas (Kim and Cerutti,
2009), Drosophila (Clemens et al., 2000), and in mammalian cells (reviewed in (Sui et al., 2002)).
The use of RNAi techniques provides a study model that is a knock down, not a knock out. A
knock out, especially in the case of Paramecium, is not usually available and would be challenging
to create. Using RNAi is simple in concept, providing a knock down model for study quite
rapidly, sometimes only taking a few weeks to obtain results. However, as with any technique,
there can be some pitfalls that need to be taken into account.
The basic idea of RNAi is to rely on a cell’s own natural defenses to degrade endogenous
mRNA which results in depleted protein amounts. The introduction of large amounts of doublestranded RNA (dsRNA) will trigger this response. By introducing dsRNA to a cell, the enzyme
complex Dicer will be activated. Dicer is an RNase-III protein with endoribonuclease activity
first described in Drosophila that cuts the long strands of dsRNA into smaller 21 to 25 length
strands of dsRNA (Bernstein et al., 2001). These smaller dsRNA fragments then catalyze the
formation of the RNA-Induced Silencing complex, RISC. One of the most important components
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of this complex is the endonuclease activity which is Mg2+-dependent (Schwarz et al., 2004) and
the protein Argonaute (Ago). RISC is responsible for binding the small dsRNA fragments and
unwinding them to create single strands. The small single strand of anti-sense RNA then guides
the RISC complex to the complementary strand of RNA. Once bound, in an ATP-dependent
fashion, the mRNA strand is cut by the PIWI domain of the Ago protein (reviewed in (Pratt and
MacRae, 2009)).
When using RNAi as a research approach, there are drawbacks that need to be
considered. One potential pitfall are inexact matching of the siRNAs to the mRNA which would
result in the wrong mRNA strand being degraded. Although miss-matching is a concern, it is not
expected to occur very often. One study has demonstrated that the first and last two positions of
the siRNA are the most tolerant of mismatches with A:C and C:A mismatches being the most
common (Du et al., 2005). There can also be off-target effects where a mismatch occurs or the
same sequence exists in an mRNA that is not the target strand. This incorrect recognition then
leads to the degradation of the wrong mRNA strand. Prediction programs are in place that help
with RNAi construct design to prevent this from occurring. Drosophila has a search engine
(http://www.flyrnai.org/DRSC-TOO.html) as well as Paramecium
(http://paramecium.cgm.cnrs-gif.fr/cgi/tool/alignment/off_target.cgi). Both of these sites
allow the user to search the genome using the sequence(s) to be used for RNAi. The search
engine will then provide the user an analysis including the potential off-target sequences. In
some search engines, the user is also given the opportunity to select the stringency of the filter,
selecting the length of the proposed siRNAs or the number of mismatches that will be tolerated.
Once the RNAi is designed and produced, for it to be effective it much be introduced into
the cells. Methods to get the dsRNA into the cells include soaking, feeding, electroporation,
transfection, injection, among others. The method of introduction is also dependent upon the
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organism being studied (reviewed in (Agrawal et al., 2003)). In P. tetraurelia, RNAi by feeding is
the most commonly used method because it is both simple and effective. Typically between 60
and 80% of the population of cells exposed to the dsRNA show an effect of the RNAi (Galvani
and Sperling, 2002). Although we are also able to use injection for expressing dsRNA within
paramecia, injection methods are far more time consuming and the plasmid that expresses the
dsRNA is diluted over time with the division of the cells (Galvani and Sperling, 2002), which
occurs approximately every six hours. Another method that is similar to RNAi is the use of an
Antisense plasmid. The plasmid is created to transcribe the antisense sequence for the mRNA to
be depleted (Yano et al., 2003). RNAi by feeding is a simple and quick method where paramecia
are fed bacteria filled with dsRNA. The bacteria are specially created E. coli variants called Ht115
bacteria that are RNase-III deficient are used. These bacteria are able to produce massive
amounts of the dsRNA without degrading it. Paramecia that have been purged to remove
contaminating bacteria from their surface and release from their cytoproct can be added to
cultures containing the special RNase-III deficient bacteria which they ingest, releasing the
dsRNA into the cell.
To produce the dsRNA in the bacteria, the Ht115 bacteria cells are transformed with an
engineered plasmid that contains two opposing T7 promoters and a lacZ domain for induction
with isopropyl-beta-D-thiogalactopyranosidase (IPTG). The plasmid also contains ampicillin
resistance for selective pressure during bacterial transformation. Restriction enzyme sites
between the two T7 promoters allows the sequence of interested to be ligated into place.
Over-expression of Exogenous Proteins in Paramecium
Paramecia are very amenable to the over-expression of genes and genes with an epitope
tag added to the 5’- or 3’- end. The sequenced genome allows an entire gene from start to finish
to be amplified and cloned into an expression plasmid. The plasmid pPXV has been instrumental
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in the tagging and expression of genes in Paramecium for study. This plasmid (Figure 1.5)
contains calmodulin promoters to ensure the gene is highly expressed. Calmodulin is a calcium
binding protein that is highly expressed in cells. By using these promoters when engineering
this plasmid ensures that the sequence in between them is expressed at very high levels. The
plasmid also contains Tetrahymena telomeres which flank the promoters and the sequence so that
the linear plasmid is maintained within the macronucleus of the cell. In between the two
promoters are a few restriction enzyme sites to allow for the insertion of the gene of interest.
The pPXV plasmid has been altered to provide different epitope tags and restriction
enzyme cut sites. The epitope tags have allowed the use of commercial antibodies to bind to and
immunoprecipitate (IP) the proteins that are being expressed. We have created an N- and Cterminal three-fold repeat of the FLAG epitope (DYKDDDDK) and a three-fold repeat of the myc
epitope (EQKLISEEDL). Lastly, we created an N-terminal 3×myc tag with a C-terminal 3×FLAG
tag (See Figure 1.5 for plasmid maps). We are able to amplify genes of interest utilizing
restriction enzyme cut sites and using long primers that create restriction enzyme cut sites and
the 5’- and 3’- ends of the genes with PCR. The PCR products and the pPXV plasmid can be
processed with the desired restriction enzymes. The plasmid and PCR products can be ligated
together and introduced into the macronucleus by microinjection after the plasmid-product is
linearized.
There are few antibodies available to identify Paramecium proteins. The evolutionary
distance between most of the available mammalian antibodies and Paramecium protein sequences
is too great for many antibodies to recognize the Paramecium proteins. However, antibodies
against highly conserved proteins, such as tubulin, or antibodies that were developed against
proteins in closely related organisms, such as the anti-centrin antibody made against a
Tetrahymena centrin protein (kind gift of Dr. Mark Winey, University of Colorado, Boulder, CO)
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have proven successful in recognizing Paramecium proteins. The use of these easily engineered
epitope sequences expressed on the 5’- or 3’- end of a gene has greatly enhanced our ability to
locate and visualize proteins within a cell.
Although the pPXV expression plasmid has been instrumental in our research and has
elevated our findings to new levels, the use of an injected plasmid with no selective pressure
prevents some challenges. First, the paramecia cells must be well-fed and cannot be allowed to
go through autogamy. During autogamy, the macronucleus is broken down and reformed using
the micronuclei. The destruction of the macronucleus would also destroy the exogenous plasmid
(Godiska et al., 1987). Once the plasmid is injected, the cells are maintained as individual clones
and are screened by genomic extraction and PCR to amplify the endogenous gene and the
exogenous plasmid for comparison. Only those cells that contain the injected plasmid in a level
the same or higher than the endogenous gene are maintained.
The over-expression of the gene can sometimes cause a dominant negative effect,
interfering with the function of the endogenous protein and generating a silencing effect. The
placement of the epitope tag can also prevent the proper placement of the expressed protein or
interfere with the function or the trafficking. The ability to have the epitope tag expressed at the
N- or the C- terminus of the protein has allowed for some flexibility. Once the plasmid is
injected, it is typically stably expressed for three to six weeks. By using this technique, we are
able to use techniques including, but not limited to, immunoprecipitation (IP), co-IP, purification
for LC-MS/MS, Western blot, and immunofluorescence.
Swimming Assays and Electrophysiology
The speed the cilia beat and therefore the speed the cell swims is governed by the
membrane potential of the cell. The membrane of these cells is permeable to ions in the
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environment, some ions more than others. Paramecium’s membrane potential is primarily
determined by K+, allowing the cell to act like a potassium electrode. The membrane is also
permeable to Na+ and Mg2+, but it is very selective concerning the passage of Ca2+ and Cl(Hansma, 1979, Machemer-Rohnisch and Machemer, 1989, Naitoh, 1968, Naitoh et al., 1972,
Preston, 1990).
Paramecia cells, when depolarized beyond threshold, open the voltage-gated calcium
channels of the cilia causing an action potential. The opening of these channels allows Ca2+ to
enter the cilia and will reverse the beating of the cilia sending the cell backward. As long as Ca2+
remains high in the cilia, the cell will continue to move backward. The influx of Ca2+ is countered
by the efflux of K+ by the fast-acting voltage dependent K+ conductance and the slower activated
Ca2+-dependent K+ conductance (Brehm et al., 1978, Satow and Kung, 1980). The action potential
is prolonged by the ions in the solution bathing the cell resulting in prolonged backward
swimming. Therefore, we use the length of time the cell spends swimming backward (seconds)
as a proxy measurement of ion conductance. Short backward swimming therefore indicates a
reduced conductance of an ion while prolonged backward swimming may indicate a larger
conductance of an ion.
The permeability of the membrane to certain ions determines the resting membrane
potential of Paramecium. Already mentioned is that the resting membrane potential of the cells is
mostly governed by K+. However, if the concentration of K+ remains constant and a new ion is
introduced to the cell, the cell may depolarize or hyperpolarize the membrane depending on the
permeability of the membrane to that ion. If no change in the membrane potential occurs, or
perhaps only small changes occur, that may indicate that the membrane is impermeable to that
ion, as in the case of ciliated XntA1 mutants to Mg2+ (Preston and Kung, 1994a). Therefore, by
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observing changes in membrane potential in potassium solution with and without an additional
ion can be used to measure the permeability of the membrane to that ion.
Measuring membrane potential (Vm) is relatively straight forward. It can be performed
on either ciliated or deciliated cells. Paramecia can be temporarily deciliated by trituration in a
5% ethanol v/v bath (Machemer and Ogura, 1979). A pulled glass electrode is back-filled with
500 mM KCl and the resistance is then tested in the resting bath the cell will be placed in.
Typically the resistance is between 40 and 100 MΩ. The main chamber bath is connected to a
smaller reference bath filled with 3 M KCl using a 3% agar in 3 M KCl bridge. The recording
chamber bath on the stage of an inverted microscope can then be drained and a single cell placed
in the center with very little fluid. A micromanipulator is used to impale the cell membrane with
the glass recording electrode. After the cell is impaled, the bath chamber is quickly, but gently,
filled with the resting solution. Figure 1.6 shows a ciliated and deciliated Paramecium on the end
of a glass electrode for recording. The bath requires a peristaltic pump for a controlled and steady
flow rate so the cell is not disturbed, which could activate mechanoreceptors. The membrane
potential of the cell is recorded continuously.
Experimental Approach
We have utilized the ciliated cell Paramecium for the study of ciliopathies and to better
understand the role of proteins in a non-canonical system. In the second chapter, which was
published in 2014 (Picariello et al., 2014), we have again used Paramecium to elucidate other roles
of a ciliopathy gene, this time MKS3. The highly ordered cell surface and sub-surface structures
of Paramecium has allowed for the possible identification of a new role for the MKS3 protein. In
Paramecium, this protein may be involved as a transition zone component, but we also
hypothesize that the Mks3 protein is vital to the guidance of daughter basal bodies as they
migrate away from their mother basal body before cell duplication process begins. Using RNAi
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and epitope-tagging, we have localized the Mks3 protein in Paramecium and have used LCMS/MS analysis and GST-fusion proteins to identify the potential interaction with the
kinetodesmal fibers below the cell surface. It is this interaction that may cause basal bodies to
migrate off their path leading to a disrupted cell surface.
The third chapter of this work examines the non-specific channel protein Pkd2, a protein
that when mutated in humans, can lead to Autosomal Dominant Polycystic Kidney Disease
(ADPKD). Although we found three possible orthologs for Pkd2 in Paramecium using human and
mouse sequences, we are focusing on two paralogs. Based on preliminary findings that RNAi to
deplete cells of PKD2 led to short backward swimming in Mg2+ solutions, we include the use of
the Paramecium mutant eccentric (XntA1) in our studies. We use a combination of techniques
involving epitope-tagging and RNAi to examine the Pkd2 channel function, trafficking, and
location in Paramecium. We hypothesize that Pkd2 and XntA are both involved in Mg2+-induced
behavior and that the Pkd2 protein is the Mg2+ channel in Paramecium.
Lastly, this review and our use of Paramecium tetraurelia highlights the importance of
using a non-mammalian system to elucidate new roles and functions of proteins that are
involved in ciliopathies. These studies help to understand the full potential of the discussed
proteins and to identify novel roles and potential interacting partners. The continued pursuit of
knowledge surrounding these genes, namely PKD2, may contribute to new studies and disease
treatments. Paramecium continues to prove itself as an approachable, useful and powerful model
for the study of human ciliopathy genes.
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Figure 1.1. Scanning Electron Micrograph of Paramecium tetraurelia.
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Figure 1.2. Swimming behavior and membrane potential of P. tetraurelia. Paramecia typically
display forward swimming with the ciliary power stroke toward the posterior of the cell. This
occurs with the membrane at rest, which is about -30 mV. When the cell encounters a repellent,
high ionic concentrations, or sometimes a random event, the membrane will become depolarized
enough to produce an action potential. This depolarization beyond threshold cause the voltage
gated calcium channels of the cilia to open allowing calcium to enter. The depolarization is
countered by the activation of the calcium-dependent and voltage-dependent potassium
channels. As long as calcium remains high, the cilia will remain with their power stroke toward
the anterior of the cell, causing backward swimming. Once the calcium is remove and the
membrane potential returns to its resting state, the cilia will revert back to the power stroke
toward the posterior of the cell and forward swimming. This figure was adapted from Figure 1
in (Kung et al., 1975).
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Figure 1.3. Schematic depiction of a Paramecium one (A) and two (B) basal body units with
accompanying rootlets. The cortical units of Paramecium contain one (A) or two (B) basal bodies
(red). (A) One basal body units contain a single basal body with a striated rootlet or
kinetodesmal fiber (green), a transverse microtubule (purple), and a post ciliary rootlet
emanating from the basal body. (B) Two basal body units contain a mother basal body and a
daughter basal body. The mother basal body is structured like the basal bodies in (A) and the
daughter basal body is attached to the striated rootlet and contains the transverse microtubule,
but not a post ciliary rootlet. Anterior to posterior orientation can be seen on the right.
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Figure 1.4. Structure of a Paramecium cilium and basal body. (A) A schematic line illustration of
a paramecium cilium. Basal body is comprised of nine triplets of microtubules below the cell
surface (red). The transition zone (yellow bracket) is shaded in yellow and is the area between
where the C tubules of the basal body triplet terminate and the central pair of microtubules in the
axoneme of the cilium begins. The cilium proper is approximately 10 µm in length (green
bracket). Anterograde and retrograde directions of intraflagellar transport (IFT) are indicated by
the blue arrows. Illustration not drawn to scale. (B) A transverse section through a paramecium
basal body (red bracket), transition zone (shaded in yellow) and the beginning of a cilium (green
bracket). Large empty spaces (as) on either side are the alveolar sacs. Scale bar is 50 nm.
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Figure 1.5. Plasmid maps for pPXV over-expression plasmids. (A) Plasmid map for N-terminal
epitope tag FLAG (DYKDDDDK)x3 or myc (EQKLISEEEDL)x3. (B) Plasmid map for C-terminal
epitope tag FLAG or myc. (C) Plasmid map for N-terminal myc epitope tag and C-terminal FLAG
epitope tag. All epitope tags are in the pPXV plasmid (Gift of W. John Haynes). The plasmid
contains Tetrahymena telomeres (blue), a Not I linearization site, calmodulin promoters (green),
and ampicillin resistance (pink). All plasmid maps show relevant restriction enzyme cut sites for
insertion of the gene of interest.
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Figure 1.6. Electrophysiology recording from a ciliated and deciliated cell.
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Abstract
Background. Meckelin (MKS3), a conserved protein linked to Meckel Syndrome, assists in the
migration of centrioles to the cell surface for ciliogenesis. We explored for additional functions of
MKS3p using RNA interference (RNAi) and expression of FLAG epitope tagged protein in the
ciliated protozoan Paramecium tetraurelia. This cell has a highly organized cell surface with
thousands of cilia and basal bodies that are grouped into one or two basal body units delineated
by ridges. The highly systematized nature of the P. tetraurelia cell surface provides a research
model of MKS and other ciliopathies where changes in ciliary structure, subcellular organization
and overall arrangement of the cell surface can be easily observed. We used cells reduced in
IFT88 for comparison, as the involvement of this gene’s product with cilia maintenance and
growth is well understood.
Results. FLAG-MKS3p was found above the plane of the distal basal body in the transition zone.
Approximately 95% of those basal bodies observed had staining for FLAG-MKS3. The RNAi
phenotype for MKS3 depleted cells included global shortening and loss of cilia. Basal body
structure appeared unaffected. On the dorsal surface, the basal bodies and their associated
rootlets appeared rotated out of alignment from the normal anterior-posterior rows. Likewise,
cortical units were abnormal in shape and out of alignment from normal rows. A GST pull down
using the MKS3 coiled-coil domain suggests previously unidentified interacting partners.
Conclusions. Reduction of MKS3p shows that this protein affects development and maintenance
of cilia over the entire cell surface. Reduction of MKS3p is most visible on the dorsal surface.
The anterior basal body is attached to and moves along the striated rootlet of the posterior basal
body in preparation for duplication. We propose that with reduced MKS3p, this attachment and
guidance of the basal body is lost. The basal body veers off course, causing basal body rows to be
misaligned and units to be misshapen. Rootlets form normally on these misaligned basal bodies
but are rotated out of their correct orientation. Our hypothesis is further supported by the
identification of novel interacting partners of MKS3p including a kinetodesmal fiber protein,
KdB2.
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Background
Ciliopathies are human disorders caused by abnormalities in the assembly, maintenance,
or function of cilia and include developmental defects leading to cystic kidneys, vision problems,
polydactyly, obesity, encephalocele, and even death (reviewed in [1]). In order to improve our
understanding of the wide array of cellular processes affected in these disorders, the function and
involvement of the genes and gene products involved in ciliopathies should be defined [2-4].
Toward this end, we have investigated the protein Meckelin (MKS3) in Paramecium tetraurelia, a
multi-ciliated cell.
MKS3 is one of at least three genes commonly associated with the ciliopathy Meckel
Syndrome (MKS), and has been found to be dysfunctional in other ciliopathy syndromes
including Bardet-Biedl [5], COACH [6, 7] and Joubert [8]. The three most common characteristics
of MKS are renal dysplasia, encephalocele, and polydactyly [9, 10]. The MKS disease is
autosomal recessive and has high occurrence rates in Finland, the Middle East, North Africa, and
Asia [9-12].
Recently it was shown that MKS3 is a component of a multi-protein complex that
contributes to the function of the transition zone to separate the ciliary compartment from the rest
of the cell [13]. Other cellular disruptions caused by a reduction of MKS3 have not been closely
examined, such as changes in the sub-surface scaffolding or in cell surface polarity and surface
organization.
P. tetraurelia have large numbers of cilia and basal bodies arranged in polarized rows of
hexagonal cortical units whose shape is created by a ridge of surface membrane covering an
outer lattice. Each cortical unit contains one or two basal bodies. There is one cilium in each of
these polarized cortical units (even in units with two basal bodies) as well as one parasomal sac
(site of endo- and exo- cytosis) [14-16], and secretory vesicles (trichocysts) at the apex of the

60

ridges [17-19]. Basal bodies have rootlets emanating from them in a stereotypical orientation
relative to the anterior-posterior axis of the cell. The rootlets most likely help secure basal bodies
and distribute the forces generated by the beating cilia [20, 21]. In units with one basal body,
there is a striated rootlet coursing anteriorly, and a transverse and post ciliary rootlet projecting
at 5 and 7 o’ clock, respectively. In units with two basal bodies, the posterior basal body has a
cilium and all three rootlets while the anterior basal body has no cilium and only a transverse
microtubule [21, 22].
The division process in Paramecium is complex and begins with basal body duplication.
As the cell elongates, it accommodates for new basal bodies and cilia. The organization of the
cortical units and their contents are determined by the “old” already existing units [23].
Disrupting this organization or development of these cortical units causes growth arrest and even
cell death [19, 24, 25]. It is this highly repetitive patterned surface organization that allows
identification of subtle changes in ciliary and surface organization in P. tetraurelia.
The results of epitope tagging and RNA interference (RNAi) to perturb the ciliopathy
protein MKS3 in Paramecium tetraurelia presented here suggest previously unidentified roles for
this protein in maintaining the cell and ciliary membrane surface and cytoskeletal organization.
Tagged MKS3 protein is consistently found above the plane of the basal body, in the transition
zone of Paramecium, which spans from the proximal surface of the epiplasm to the ciliary
necklace [26, 27]. Dawe and others [28] have published observations of short and missing cilia
upon reduction of MKS3 mRNA levels, similar to our findings of short and missing cilia with
RNAi. Our study shows new findings, most notably that reduction of MKS3 causes
misalignment of longitudinal rows of basal bodies, rotation of the orientation of basal bodies with
their microtubule rootlets, and distortion of the cell and ciliary surfaces. We also have evidence
of new potential interacting partners of MKS3 relevant to these microtubule rootlets, suggesting
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important interactions of MKS3 with these structures. The depletion of Intraflagellar Transport
88 (IFT88) mRNA, used as a control to observe global ciliary loss, causes short and missing cilia
but does not cause disarray of basal body rows or of the cell surface. We propose that MKS3p in
Paramecium acts as a transient guide in the movement of basal bodies prior to duplication
through an interaction with the microtubule rootlet system and that its localization at the base of
the cilium is consistent with an involvement at the transition zone as a filter.

Materials and Methods
Stocks, Cultures and Chemicals
Cells (Paramecium tetraurelia; 51-s, sensitive to killer) were grown in wheat grass medium
inoculated with Klebsiella pneumoniae or Aerobacter aerogenes (adapted from [29]).

All chemicals

were from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise noted.
Sequence Analysis and Construct Design
BLAST searches in the Paramecium Annotated Genome were completed using the human
sequence for TMEM67 (Q5HYA8) for MKS3 and the human IFT88 (NP_783195) and Mouse Tg737
(NP_033402) sequences for IFT88 orthologs. Searches identified GSPATG00015939001 as a
potential ortholog for MKS3 which was used to create the RNAi construct. Five potential
orthologs (GSPATG00038505001, GSPATG00021390001, GSPATG00011771001,
GSPATG00022644001, and GSPATG00039556001) were identified for IFT88. The construct to
target IFT88 mRNA was designed from GSPATG00038505001. Homology of these genes to those
in other organisms can be seen in Supplemental Tables 2.1 and 2.2.
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All constructs were created from genomic DNA, which was collected using organic
extraction. Briefly, 100 µL of cells were mixed 1:1 with Denaturing Buffer (Promega, Madison,
WI, USA), mixed 1:1 with phenol:chloroform:isoamyl alcohol (25:24:1), and centrifuged for 5
minutes at 12,000 x g (Eppendorf Centrifuge 5424, Hauppauge, NY, USA). The aqueous phase
was removed, and mixed 1:1 with chloroform:isoamyl alcohol (24:1) and spun again. The DNA
was precipitated 2:1 with cold isopropanol for 20 min at -20°C and spun for 10 minutes at 4°C
(Eppendorf Centrifuge 5424, Hauppauge, NY, USA). Pellets were rinsed twice with 75% ethanol,
dried, and resuspended in water.
FLAG-tag of MKS3
To localize MKS3p, we added the coding sequence for a three-fold repeated FLAG
(DYKDDDDK) sequence to the 5’ end of the genomic DNA sequence for GSPATG00015939001 in
the pPXV plasmid using the restriction enzymes Apa I and Sac I (USB/Affymetrix, Cleveland,
OH, USA). These cut sites were created using large primers to add them to either end of the
sequence: forward (5’- gcggggcccatgctaatttatatcg -3’) and reverse (5’cgcgagctctcatattagaaaccttttgtc -3’). Platinum®Pfx Polymerase (Invitrogen/Life Technologies,
Grand Island, NY, USA) was used per the vendor’s instructions to amplify the sequence. A total
of 75 ng of genomic DNA was used in each PCR reaction: 94°C for five minutes; 5 cycles of 94°C
for 1 minute, 40°C for 1 minute, 68°C for 3 minutes; 5 cycles of 94°C for 1 minute, 48°C for 1
minute, 68°C for 3 minutes; 10 cycles of 94°C for 1 minute, 58°C for 1 minute, 68°C for 3 minutes;
17 cycles of 94°C for 1 minute, 65°C for 1 minute, 68°C for 3 minutes; once cycle of 68°C for 15
minutes (Techne TC-4000 Thermal Cycler, Krackeler Scientific, Albany, NY, USA). The products
were cleaned using the PrepEasy™ Gel Extraction kit (Affymetrix, Cleveland, OH, USA). The
resulting DNA was treated with restriction enzymes, cleaned again using the PrepEasy™ Gel
Extraction kit and ligated into the pPXV-5’-3xFLAG plasmid using the Ligate-IT™ kit
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(Affymetrix). The mixture was then transformed into OneShot® competent cells (Invitrogen/Life
technologies, Grand Island, NY, USA) and the resulting colonies were screened for positives.
Positive clones were sequenced at the Vermont Cancer Center DNA Analysis Facility (University
of Vermont, Burlington, VT).
Plasmid Injection
Approximately 200 µg of pPXV-3xFLAG-MKS3 was linearized with Not I (Affymetrix)
overnight at 37°C and then cleaned using an organic extraction method modified from that
described earlier. This procedure required 2 washes in phenol:chloroform:isoamyl alcohol
(25:24:1) followed by 2 washes of chloroform:isoamyl alcohol (24:1). The final pellet was
resuspended in 50 µL of MilliQ water and the concentration was checked using a
spectrophotometer (Agilent Technologies, Santa Clara, CA, USA). The sample was spun at
16,000 x g (Eppendorf Centrifuge 5424) for 10 minutes to pellet debris. The top 45 µL was
carefully removed and placed in a fresh RNase/DNase-free 1.5 mL Eppendorf tube and was
again dried in a speed vac. The final pellet was resuspended in MilliQ water to obtain a
concentration between 3 and 9 µg/µL and stored at 4°C until injection.
Approximately 20 cells which had recently undergone autogamy were placed under
high temperature silicon oil to immobilize them. Approximately 5 to 50 pg of the plasmid was
injected into the macronucleus of each cell using a pulled capillary and a Narishige
micromanipulator (Narishige International USA, Inc., East Meadow, NY, USA). Individual
injected cells were transferred to 750 µL of inoculated culture fluid in depression slides and
incubated in a humidifying chamber at RT for two days, allowing the cells to recover and divide.
Cells were then transferred to test tubes with inoculated culture fluid and maintained at 15°C as
individual clones. Genomic DNA was extracted from the clone cultures as described previously
(see Sequence analysis and Construct design) and tested with PCR using plasmid-specific
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primers: the forward primer for the plasmid pPXV (5’- taagatgaatggaatataatg -3’) and a reverse
primer (5’- gaaaacccaagccaatcaatac – 3’), which was sequence-specific for MKS3. One µL
(approximately 400 ng) of DNA was used in each PCR reaction: one cycle of 95°C for 5 minutes
followed by 30 cycles of 95°C for 1 minute, 40°C for 1 minute, and 72°C for 3 minutes, followed
by one last 15 minute cycle at 72°C.
Localization, Visualization, and Analysis of FLAG-MKS3p
We tested small cultures of individual clones to ascertain whether the cells expressed the
protein and where it was localized. A 10 mL culture of injected cells was added to 50 mL of
inoculated culture fluid and grown at 22°C for approximately 48 to 72 h. The cells were
immunostained and imaged as described below. Images were analyzed for colocalization using
SoftWoRx™ Pro software (Applied Precision, Issaquah, WA, USA). Experiments were repeated 5
times.
To isolate pellicle membrane and whole cilia membrane, wild type (51-S) cells expressing
FLAG (control) or FLAG-MKS3 (Test) were maintained in large culture (3 to 6 L of culture fluid)
at 22°C until at a density of 8,000 to 12,000 cells per mL. For pellicle membrane, cells were
harvested as described in [30]. In separate experiments, cilia were separated from cell bodies and
collected as described in [31] up to the point of separation of the ciliary membrane from the
axoneme. Protein concentrations were determined using a BCA Protein Assay (Thermo
Scientific, Rockford, IL, USA) and equalized between the test and control. Samples were
separated on a 12% SDS-PAGE gel after adding 1 µL B-Mercaptoethanol and boiling for 5
minutes. One hundred µg of pure pellicle membrane and 400 µg of whole cilia were loaded
along with 10 µL Pierce 3-color prestained protein molecular weight marker (Thermo Scientific).
Proteins were transferred onto nitrocellulose membrane (Pall Gelman Corp., Krackeler Scientific,
Albany, NY, USA) and blocked for one hour using 5% non-fat dry milk, 2% Telost gelatin from
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fish, 3% Normal Goat serum (Vector Labs, Burlingame, CA, USA), in TBS-T (15 mM Tris-Cl, 140
mM NaCl, 0.1% v/v Tween-20, pH 7.5). Blots were probed with a 1:2500 dilution of rabbit AntiFLAG M2 clone or 1:10,000 mouse Anti-Tubulin in the blocking buffer. Blots were incubated
overnight while rocking at 4°C. Buffers were removed, the blots rinsed three times in TBS-T and
then incubated for 1 h in 1:10,000 goat Anti-rabbit or Anti-mouse AP-conjugate secondary
antibody. Blots were rinsed again four times in TBS-T, 15 minutes each wash, and developed
using NBT/BCIP Alkaline Phosphatase (Moss, Inc., Pasadena, MD, USA).
RNAi by feeding construct
Constructs for RNAi were created from genomic DNA using the following primers:
MKS3 forward, 5’- gaaaacccaagccaatcaatac -3’ and reverse, 5’- ggtcgacaatctgaaggataag -3’; IFT88
forward, 5’- caattaaggaaaaccacctg-3’ and reverse, 5’- aaaactaacaggattgtcatct-3’. All PCR
conditions began with an initial step at 95°C for 5 minutes and ended with a final stage of 72°C
for 20 minutes. The MKS3 RNAi construct was amplified by 30 cycles of 95°C for 1 minute, 52°C
for 1 minute, and 72°C for 2 minutes. The IFT88 construct was amplified by 5 cycles of 95°C for 1
minute, 47°C for 1 minute, and 72°C for 2.25 minutes; followed by 25 cycles of 95°C for 1 minute,
50°C for 1 minute, and 72°C for 2.25 minutes (Techne Thermal Cycler). The final PCR products
were analyzed on a 0.75 or 1.0 % agarose gel (Invitrogen/Life Technologies, Grand Island, NY,
USA) and visualized with ethidium bromide. Resulting PCR products were cloned directly into
pCR®2.1-TOPO® vector (Invitrogen/Life Technologies), transformed into OneShot® cells
(Invitrogen/Life Technologies), and sequenced. Correct sequences were cut from the pCR®2.1TOPO® vector and ligated into the double-T7 promoter vector L4440 (AddGene, Cambridge,
MA, USA) using the Ligate-IT™ Kit (USB/Affymetrix, Cleveland, OH, USA), as per the kit
instructions. Escherichia coli strain Ht115 (DE3), which lacks RNase-III, were transformed with 50
ng of plasmid DNA for either MKS3 or IFT88. As a control, Ht115 cells were transformed with
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L4440 with no insert. Bacterial cultures were maintained with tetracycline (12.5 µg/mL) and
ampicillin (AMP) (100 µg/mL).
RNAi by Feeding
Overnight cultures of Ht115(DE3) transformed with RNAi or control plasmids were used
to inoculate 50 mL of LB-AMP (100 µg/mL) and grown until the O.D.595 reached 0.3 to 0.4, at
which point, IPTG (Isopropyl β-D-1-thiogalactopyranoside) (RPI, Corp., Mount Prospect, IL,
USA) was added to a final concentration of 0.125 mg/mL. Cultures were incubated with shaking
for 3 h at 37oC to induce the production of double-strand RNA. Paramecia that had recently
undergone autogamy were collected by centrifugation and resuspended in 10 mL of Dryl’s
solution (1 mM Na2HPO4, 1 mM NaH2PO4, 1.5 mM CaCl2, 2 mM Na-citrate, pH 6.8) to purge
bacteria from their surface and food vacuoles.
The induced bacteria were collected by centrifugation at 4,000 x g (Beckman J2-21
centrifuge, JA-14 rotor, Beckman Coulter, Brea, CA, USA) at 4°C and resuspended in 100 mL of
wheat culture medium containing an additional 8 µg/mL stigmasterol, 0.125 mg/mL IPTG (RPI,
Corp.), and 100 µg/mL AMP. Approximately 50 to 100 of the purged paramecia were added to
the control culture. In the case of the MKS3 and IFT88 RNAi cultures, 4000 and 8000 cells were
added to 100 mL, respectively. Cultures were maintained at 28°C, and after 24 h, an additional
0.125 mg/mL of IPTG (RPI, Corp.) and 800 µg of stigmasterol were added. Growth rates of
cultures were determined by counting cells at 24, 48, and 72 h of growth. All experiments were
repeated a minimum of three time and all cultures were harvested or observed after
approximately 72 h of growth, unless noted.
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Immunofluorescence
100 mL of cultured cells were collected by centrifugation (IEC clinical centrifuge,
Damon/IEC Division, Needham Heights, MA, USA) and rinsed twice in 100 mL of Dryl’s
solution. The cell volume was reduced to approximately 100 µL in a 1.5 mL Eppendorf tube
before 1 mL of PHEM buffer [60 mM PIPES (1,4-Piperazinediethanesulfonic acid), 25 mM HEPES
(2-[4-(2-hydroxyethyl)piperazin-1-yl] ethanesulfonic acid), 2 mM MgCl2, 10 mM EGTA (ethylene
glycol tetraacetic acid), and 0.1% or 0.5% Triton X-100) was added. Cells sat undisturbed for 1 to
4 minutes, spun at 250 x g (IEC Clinical centrifuge), the supernatant was removed and the pellet
(cells) was mixed with 1 mL of Fixation buffer [2% or 4% paraformaldehyde (Electron
Microscopy Sciences, Hatfield, PA, USA), 2 mM NaH2PO4·H2O, 8 mM Na2HPO4, 150 mM NaCl,
pH 7.5]. Samples were undisturbed for 10 minutes or rocked for 1 h at RT and washed three
times in 1 mL of Blocking Buffer (2 mM NaH2PO4·H2O, 8 mM Na2HPO4, 150 mM NaCl, 10 mM
EGTA, 2 mM MgCl2, 0.1% Tween-20, 1% or 3% BSA, pH 7.5).
Primary antibodies for the immunostaining for localization were: FLAG-MKS3: mouse
Anti-FLAG, M2 clone at a 1:300 dilution (Sigma), Anti-centrin at a 1:1000 dilution (AntiTetrahymena centrin, gift from Dr. Mark Winey, University of Colorado, Boulder, CO). For ciliary
measurements we used mouse Anti-alpha-tubulin at a dilution of 1:200 (Sigma). For
visualization of basal bodies we used Anti-centrin at a dilution of 1:1000. For cortical unit
visualization we used Anti-2F12 at a dilution of 1:200 (Gift, Dr. Jean Cohen, Gif-sur-Yvette,
France). For the visualization of the kinetodesmal fibers, we used Anti-KDF at a 1:400 dilution
(gift from Dr. Janine Beisson, Centre de Génétique Moléculaire, Gif-sur-Yvette, France) and AntiGlu-α-Tubulin at a 1:500 dilution (Synaptic Systems, Goettingen, Germany). Primary antibodies
in 100 µL of blocking buffer were mixed with the cells and rocked at RT for 1 h. Cells were
washed three times in blocking buffer or Wash buffer (2 mM NaH2PO4·H2O, 8 mM Na2HPO4, 150
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mM NaCl, 0.1% Tween-20, 1% BSA, pH 7.5). The cells were mixed with 100 µL of blocking buffer
with a 1:200 dilution of secondary antibodies. Secondary antibodies (Molecular
Probes/Invitrogen, Grand Island, NY, USA) included: AlexaFluor® goat anti-mouse 488 or 555
and AlexaFluor® goat anti-rabbit 488 or 568. After 30 minutes to 1 h of incubation while rocking,
cells were washed three to five times with blocking or wash buffer and, to the final 20 µL of cells,
one drop (~15 µL) of VectaShield® (Vector Labs, Burlingame, CA, USA) was added. Tubes were
wrapped in aluminum foil and stored at 4°C until use.
Imaging of the immunostained cells was done using a DeltaVision® Restoration
Microscopy System (Applied Precision, Issaquah, WA, USA) consisting of an inverted Olympus
IX70 microscope and a Kodak CH350E camera. Seven µL of prepared cells were placed under a
glass coverslip and imaged at 20-22°C using either a PlanApo 60x or 100x /1.40 oil-immersion
objective and deconvolved and analyzed using SoftWoRx® Pro software (Applied Precision).
Co-localization of FLAG-MKS3 and Centrin (basal bodies) was analyzed using
SoftWoRx® Pro software or ImageJ [32]. Eleven cells were analyzed for the co-localization of
these two proteins. To examine the staining patterns and calculate the number of basal bodies
with FLAG-MKS3 staining, 15 µm x 15 µm grids were chosen from both the ventral and the
dorsal surface of each of three cells. Basal bodies within that grid were counted and noted
whether they had FLAG-MKS3 staining. A total of 463 basal bodies were analyzed on these three
cells.
Scanning Electron Microscopy (SEM)
200 mL of RNAi cultured cells were collected by brief centrifugation at 800 x g (IEC
Clinical centrifuge, Damen Division, Needham Heights, MA, USA), washed twice in Dryl’s
solution, and fixed as described in Lieberman et al. [33]. After critical point drying, cover slips
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were glued onto an aluminum chuck using colloidal graphite cement and allowed to dry in a
desiccator overnight. The samples were sputter coated and stored in a desiccator until imaged
using a JEOL 6060 Scanning Electron Microscope (JEOL USA, Peabody, MA, USA).
Transmission EM
100 mL of RNAi cultured cells were collected by brief centrifugation at 800 x g (IEC
Clinical Centrifuge), washed twice in 100 mL Dryl's, and approximately 100 µL of the cell pellet
was removed and placed in 1.5 mL Eppendorf tubes. One mL of Fixation Solution A (1%
gluteraldehyde (Electron Microscopy Sciences, Hatfield, PA, USA), 0.05M sodium cacodylate, pH
7.2) was added, rocked for 30 minutes on ice, and washed three times for 10 minutes under the
same conditions. Cells were resuspended in post-fix Solution B (1% gluteraldehyde (Electron
Microscopy Sciences), 0.05M sodium cacodylate buffer, 1% osmium tetroxide, pH 7.2) and again
washed and rinsed as described. Cells were pre-embedded in 2% agarose (Invitrogen/Life
Technologies) in 0.05M sodium cacodylate buffer, allowed to set, then sliced into 1 mm x 1 mm
blocks. Blocks were placed in glass vials with 50% ethanol and rocked on a specimen rotator for
30 minutes during each of the following washes: 50% ethanol, 70%, 90%, two times with 100%,
the two washes in propylene oxide. Cells were left overnight on specimen rotator in 1:1
propylene oxide and Spurr’s solution (Electron Microscopy Sciences). The next day, samples
were placed in fresh Spurr’s (Electron Microscopy Sciences) for 6 h, and placed in flat embedding
molds with fresh Spurr’s (Electron Microscopy Sciences) at 60°C for 48 h. Sections were cut to 90
nm thick, placed on copper 200 mesh grids, contrasted on droplets of 2% Uranyl acetate in 50%
ethanol for 6 minutes followed by lead citrate (120 mM sodium citrate, 2.66% lead nitrate and 0.65
% sodium hydroxide in water) for 4 minutes. Sections were imaged using a JEOL JEM-1210
Electron microscope. These studies were repeated 3 times.

70

GST Pull Down and Mass Spectrometry Analysis
The coiled-coil domain of MKS3 was expressed with a GST tag for use in a GST pull
down. The construct was created by amplifying position +2183 to +2273 of GSPATG00015939001
using the following forward and reverse primers, respectively: 5’-gcgggatccatgaattttgtcgatctc-3’
and 5’-gcggaattctgatggattttctccatg-3’. The PCR product was treated with BamHI and EcoRI (New
England Biolabs, Ipswich, MA, USA), cleaned using gel purification and the PrepEasy™ Gel
Extraction Kit (Affymetrix, Santa Clara, CA, USA), then ligated into pGEX-2TK (GE Healthcare
Life Sciences) using the Ligate-IT™ kit (Affymetrix). The pGEX-2TK plasmid had already been
opened using the same restriction enzymes, treated with 1U of calf-intestinal alkaline
phosphatase at 37°C for 5 minutes to remove the phosphate groups followed by heat-inactivation
with 5 mM Na2EDTA at 72°C for 20 minutes. The GST-MKS3 coiled-coil domain and GST were
expressed in BL-21 cells and bound to glutathione sepharose beads (GE Healthcare Life Sciences,
Pittsburg, PA, USA) as described in [34]. After beads were collected from bacterial cell lysates,
they were washed in a 1 M MgCl2 buffer to remove bacterial proteins from the GST and GSTMKS3 proteins. Protein-bound beads were stored at 4°C in PBS buffer for up to 2 weeks.
51-s Paramecium tetraurelia were cultured and harvested as described in [35] for whole cell
extract (WCE). Glutathione sepharose beads (GE Healthcare Life Sciences) were prepared by
washing three times in LAP200 (50 mM HEPES, 200 mM KCl, 1 mM EGTA, 1 mM MgCl2,
pH=7.4) buffer with 1% Triton X-100. 200 µL of washed beads were added to 20 ml WCE. This
pre-cleared WCE was then split in half and incubated with 200 µL of glutathione sepharose beads
attached to either GST or GST-MKS3. Beads in the supernatant were allowed to rock on ice at
4°C for 1 h. Control and test beads were recovered and washed 3x in LAP200 buffer with 1%
Triton X-100. Samples were run on a 7-14% gradient acrylamide gel, silver stained and gel slices
were trypsin digested as described in [35].
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Samples were analyzed by LC-MS/MS on a linear ion trap (LTQ) Mass Spectrometer
(Thermo Fisher). Half the material was loaded onto a 100 um x 120 mm capillary column packed
with MAGIC C18 (5 um particle size, 20 nm pore size, Michrom Bioresources, CA) at a flow rate
of 500 nL/min. Peptides were separated by a gradient of 5-35% CH3CN/ 0.1% formic acid over
30 minutes, 40-100% CH3CN /0.1% formic acid in 1 minute, and 100% CH3CN for 10 minutes.
Product ion spectra were searched using the SEQUEST search engine on Proteome
Discoverer 1.4 (Thermo Fisher Scientific, MA) against a curated Paramecium tetraurelia database
with sequences in forward and reverse orientations. The 13 raw files from “control” and the 13
raw files from “test” samples were searched as one contiguous input file and a single result file
was generated for each. The database was indexed to allow for full trypsin enzymatic activity,
two missed cleavages, and peptides between the MW of 350-5000. Search parameters set the mass
tolerance at 2 Da for precursor ions and 0.8 Da for fragment ions. The result files were then
searched against the Scaffold software 4.0.5 (Proteome Software, OR). Cross-correlation (Xcorr)
significance filters were applied to limit the false positive rates to less than 1% in both data sets.
The Xcorr values were as follows: (+1): 1.8, (+2): 2.7, (+3): 3.3, (+4): 3.5. Other filters applied were
a minimum peptide cutoff of 2 as well as DeltaCN >0.1. Ultimately, the confidence parameters
resulted in 0% false discovery rate (FDR) at the protein and peptide level for both the control and
test results.

Results
Sequence Analysis
The sequence for MKS3 in Paramecium (GSPATG00015939001, 4e-57, 23% identical) was
found using the human sequence for TMEM67 (Q5HYA8) and the annotated Paramecium genome
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(ParameciumDB, http://paramecium.cgm.cnrs-gif.fr/). Paramecium MKS3 (TMEM67) codes for
2906 nucleic acids and 951 amino acids. The RNAi construct design for Paramecium MKS3
comprises bases from position +1101 to +2019.
Five potential homologues for IFT88 were found using the human IFT88 (NP_783195)
and mouse Tg737 (NP_033402) sequences. The best match was GSPATP00038505001 (e-146, 38%
identical), which codes for 2341 nucleic acids, and 743 amino acids. The RNAi construct for
Paramecium IFT88 spans position +48 to +2121. Using a feature of ParameciumDB to identify
potential off-target effects [36], we found that the MKS3 RNAi plasmid will target only
GSPATG00015939001, while the RNAi plasmid for IFT88 will target all five homologues, but no
other gene sequences outside this gene family. Included in the supplemental material are tables
comparing Paramecium IFT88 and MKS3 (Supplemental Tables 2.1 and 2.2) with sequences from
other organisms. To further document the conservation of these proteins in Paramecium, amino
acid alignments of full length and conserved regions in each protein have also been included in
Supplemental Figures 2.1 and 2.2.
FLAG-MKS3p Immunostaining and Localization
We used a 5’-3xFLAG-tag (FLAG-MKS3) expression vector to produce FLAG-MKS3p in
order to localize the MKS3 protein. Control paramecia were derived from cells that were injected
with the empty FLAG vector in order to confirm that cells were unaffected by the expressed
FLAG peptide. Cells were permeabilized, stained with Anti-centrin and Anti-FLAG, and
imaged. In Figure 2.1, images are stacks to ensure that basal bodies and FLAG-MKS3p staining
are visible. Cells expressing FLAG or FLAG-MKS3 showed similar centrin staining patterns
across the cell surface (Figure 2.1A). The control cells show almost no staining by Anti-FLAG but
the FLAG-MKS3 expressing cells show very clear FLAG staining near the basal bodies and faint
staining in the cilia (Figure 2.1A and arrows in 2.1C). Supplemental Movie 2.1 demonstrates this
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pattern of FLAG-MKS3p staining above the staining of centrin; when scanning through the same
cell, starting from the surface, the green FLAG staining can be seen prior to the red staining of the
centrin. Figure 1B also demonstrates the FLAG-MKS3p staining at the distal side of the centrin
staining, i.e. above the staining of the basal body. The Anti-centrin antibody recognizes
Tetrahymena Centrin 1, which is homologous to Paramecium Centrin 2, which is found in the basal
body along the shaft [25]. The transition zone of the Paramecium cilium has been defined as
stretching from the basal body, near the proximal surface of the epiplasm, to the base of the
cilium where the triplets of microtubules become doublets and the central pair of microtubule
doublets begins [26, 27]. The localization of the MKS3 protein is therefore consistent with that of
the transition zone for these cells.
To quantify the basal body and FLAG-MKS3 staining, 15 µm x 15 µm squares on the
dorsal and ventral surface of 3 different cells expressing FLAG-MKS3 were randomly chosen. Of
the 463 basal bodies observed, 95.2 ± 2.2 % of them had FLAG-MKS3 staining. These data
suggest that where a basal body is present, we would expect to find MKS3 protein. To quantify
the extent of co-localization of the centrin and FLAG-MKS3p staining, the images were analyzed
using the softWoRx® software to obtain a Pearson’s coefficient (r). Eleven FLAG-MKS3p cells
showed an average co-localization score of 0.46 ± 0.11 (r ± SD), indicating partial co-localization.
FLAG-MKS3p staining is clearly seen in the oral groove (Figure 2.1A, yellow arrows), but we
were unable to differentiate individual basal bodies in this region due to their close packing and
the spatial limitations of fluorescence microscopy. Therefore these oral groove basal bodies were
not included in our analysis.
Ultrastructure
We utilize RNAi by feeding of paramecia because of its ease of use and the creation of
knock-outs by homologous recombination is not possible. RNAi allows us to observe the cells in
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a depleted state of a targeted protein quickly and effectively in a wild type background. RNAi
that is estimated to be 80% effective [37]. RNAi allows us to leave variable amounts of the
targeted protein in the cells and thereby protect them from lethal effects of complete loss of
MKS3p. We found that very aggressive RNAi treatment quickly leads to cell death. In this way,
RNAi has an advantage for us over gene knock out.
Scanning electron micrographs (SEM) show that the control cells were covered in cilia
and displayed a highly organized cell surface with one cilium protruding from each cortical unit
(Figure 2.2A, B). The cilia on the control cells appeared normal as shown in the representative
cell in Figure 2.2A. The MKS3 depleted cells displayed very short and sparse cilia (Figure 2.2C2.2F) and look dramatically different from the controls. The cilia that were present did not
resemble the control cilia; they had wrinkled surfaces and bulges at the tips (Figure 2.2E and
2.2F). Of the 23 MKS3 depleted cells observed, 56.5% displayed the “blebby” cilia. This was not
observed on any of the control cells. (The control cell in Figure 2.2A was fixed with the
metachronal wave intact, but the MKS3 depleted cell in Figure 2.2B was not, which is far more
common. This difference between the two cells is not a consequence of the reduction of MKS3
mRNA.) The disturbance to the cell and cilia surface by reduction of MKS3 mRNA is more
evident at higher magnification (Figure 2.2D and 2.2F). We used RNAi to reduce mRNA for
IFT88 that is known to cause loss of cilia by failure of intraflagellar transport (IFT), a mechanism
that is specific to ciliary development and maintenance. The IFT88 depleted cells displayed a
normal patterned cell surface (Figure 2.2G and 2.2H), with very few and short cilia present on the
surface of the majority of the cells (Figure 2.2G; yellow arrows).
MKS3 RNAi resulted in cells that appear, by SEM examination (Figure 2.2), to have
missing or shortened cilia everywhere on the cell except in the oral groove. The reduction of
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MKS3 using RNAi also causes severe distortions in the cell surface in contrast to the surfaces of
cells depleted of IFT88 that show missing cilia, but no other disruptions.
Transmission EM (TEM) was employed to examine the ultrastructure of basal bodies to
determine whether they were structurally equivalent in control and MKS3 depleted cells. This
demonstrates that the loss of cilia that we observed were not due to their inability to properly
form basal bodies. Cross-sections of basal bodies observed using TEM were measured for both
height and width using ImageJ software [32]. No differences were observed between control
basal bodies that were 379.6 ± 42.4 nm in length and 202.9 ± 22.8 nm wide (± SD, N=13) and
MKS3 depleted basal bodies that were 367.7 ± 35.5 nm long and 191.8 ± 21.9 nm wide (± SD,
N=14). In addition, no obvious differences in basal body docking were observed.
Immunofluorescence: Basal Bodies and Cortical Units
Immunostaining of the MKS3 depleted cells with Anti-centrin revealed a basal body
pattern that differed from that of the control and IFT88 depleted cells. The images in Figure 3 are
stacks of Z-sections, approximately 10 µm thick, to ensure all basal bodies could be visualized.
The representative views shown are of the anterior dorsal surface of the cells. The control cell
shows rows of basal bodies that run from anterior to posterior (Figure 2.3). The basal body rows
at the midline of the typical MKS3 depleted cell show disorganization and twisting (Figure 2.3,
white arrows). Distortions of rows can be seen elsewhere on the dorsal side of the cells but are
most commonly observed at the dorsal midline. The control and IFT88 depleted cells maintain
straight organized rows.
The ridges of the cortical units were highlighted using Anti-2F12 and observed at 60x
magnification (Figure 2.4). Light staining of a basal body can be seen at the center of each unit.
The dorsal surface of a control cell (Figure 2.4A) demonstrates the high level of organization of
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the cortical units. An area of the control cell has been enlarged (yellow box) to better highlight
this (Figure 2.4a). The lower images in Figure 2.4a-2.4c have been traced for clarity and are to the
right of each image. The contractile vacuole pores are pointed out using gray arrows. The two
MKS3 depleted cells (Figure 2.4B and 2.4C) show two major types of differences from the control:
an insertion of cortical units that incorporates a short row into another row of units (a kinety)
(Figure 2.4B; yellow arrows) and clustering of basal bodies that should be organized in a row
(Figure 2.4C; yellow arrows). The MKS3 depleted cell with the insertion of an abbreviated kinety
has a basal body for almost every cortical unit (Figure 2.4b) while the complete surface
disruption, the clustering, shows a chaotic organization of the cortical units, some of which are
missing a basal body (Figure 2.4c). Of the MKS3 depleted cells observed, 70% show kinety
disruptions. Of those, 90% showed clusters of basal bodies as shown in Figure 2.4C and 10%
showed an insertion of a partial kinety row, as shown in Figure 2.4B. These changes in ridge
patterns were always observed on the dorsal surface of the cell often near the midline and never
at the extreme poles of the cell in over 30 control and 70 MKS3 depleted cells observed.
Each cortical unit has one or two basal bodies with its corresponding microtubule
rootlets. The transverse microtubule (TM) and the post ciliary microtubule (PCM) are oriented at
5 o’clock and 7 o’clock, with the anterior end of the cell pointing to 12 o’clock. We examined the
orientation of TMs and PCMs using an Anti-α-tubulin antibody and the basal bodies using the
Tetrahymena Anti-centrin antibody. The MKS3 depleted cells lost most of their cilia, which
facilitated the imaging of the basal bodies and cortical microtubule cytoskeleton. However, the
cilia on control cells obscured the image of the cortical microtubules that were visualized with the
Anti-α-tubulin antibody. Therefore, we used IFT88 depleted cells as a control because they lose
their cilia but do not lose alignment of basal bodies in orderly rows of cortical units (Figure 2.3).
Figure 2.5 shows representatives of both IFT88 (2.5A) and MKS3 (2.5B) depleted cells. Basal
bodies of the control IFT88 depleted cell showed organized rows and microtubule rootlets that
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maintain their polarity and orientation. In contrast, the representative MKS3 depleted cell
showed twisting of a basal body row and with it, a new alignment of the TM and PCM rootlets.
The organized pattern of the IFT88 depleted cell has been enlarged (Figure 2.5A; yellow box) and
traced to show the basal bodies (red) and their microtubule rootlets (black). The same has been
done for the MKS3 depleted cell (Figure 2.5B; yellow box) where the orientation of the
microtubule rootlets, as well as the basal bodies, can clearly be seen. The angle between the TM
and PCM ribbons that emanate from the basal body was maintained in the MKS3 depleted cells
(Figure 2.5C), but the orientation of the rootlets relative to the anterior-posterior axis was
changed. Both of the images of representative cells shown in Figure 2.5 are of the dorsal surfaces
and the enlarged areas are from near the dorsal midline. Note that the microtubule rootlet
misalignments coincide with basal body misalignments, but not vice versa. The third rootlet, the
striated rootlet (SR), also called kinetodesmal fiber, was visualized using Anti-Kinetodesmal fiber
(KDF) [38] and the basal bodies with Anti-Glu-α-Tubulin. Figure 2.6A shows a control RNAi fed
cell with basal bodies (red) forming clear organized rows, or kineties, along the cell. Emanating
from the left side of each basal body is a striated rootlet (green). These fibers extend toward the
anterior pole of the cell and will span two or more cortical units [22]. The control cell clearly
demonstrates the anterior orientation of the SRs. In the case of two basal body units, this fiber
only projects from the posterior of that basal body pair (Figure 2.6A; yellow arrows; the large red
structures in Figure 2.6A and 2.6B are the contractile vacuoles and are not the subject of this
study). In the MKS3 depleted cell, within the areas of basal body misalignment, the SRs do not
always project toward the anterior and often veer in oblique directions (Figure 2.6B, b, and b’).
The basal bodies are no longer maintained in their kinety rows, and much like the twisted
orientation of the PCMs and TMs from Figure 2.5, the SRs are chaotic in their orientations. These
data, in conjunction with the TM and PCM data (Figure 2.5), suggest that these rootlets develop
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from the basal body normally, but the basal body has lost its orientation and does not maintain
its position along the anterior-posterior axis of the cell (See also Supplemental Figure 2.3).
Mass Spectrometry and potential interacting partners
Whole cell extract was collected from wild type cells, solubilized, and probed using
either expressed GST or expressed GST fused with the coiled-coil domain of MKS3. Samples
were separated on SDS-PAGE gels, silver stained, and the entire test (GST-MKS3 coiled-coil) and
control (GST) lanes were analyzed by tandem mass spectrometry. We only considered those
proteins unique to the test lane. In total, five proteins unique to the test sample were identified
(Table 2.I). These proteins had a minimum of two unique peptides and included two Paramecium
centrin binding proteins (PtCenBP1), a SERCA pump (PtSERCA1), a Ran-GTPase activating
protein, and a kinetodesmal fiber protein (KdB2).

Discussion
Reduced MKS3 leads to abnormal and missing cilia
We expressed FLAG tagged MKS3 protein to localize it within the Paramecium cell and
used feeding RNAi to explore for new functions of this protein. IFT88 served as a control for our
approach because reduction of IFT88 mRNA would inhibit ciliary transport and help us to
determine whether short and missing cilia were sufficient to explain the RNAi phenotype for
MKS3. Both IFT88 and MKS3 depleted cells showed shortening and loss of cilia over the entire
cell except in the oral groove. These results for MKS3 depletion are in agreement with those of
Dawe et al. [28], who reported that siRNA duplexes against MKS3 caused short or missing cilia in
inner medullary collecting duct cells (IMCD3). In the same study, siRNA duplexes were used
against IFT88 in IMCD3 cells, leaving >90% of the cells without a primary cilium. The authors
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concluded that loss of MKS3 disrupts polarity of centrioles and their migration to the cell surface
for cilium formation [28]. Other studies have found a variety of changes in ciliary number and
length, possibly because of differences among cell types and methods of interfering with MKS3
expression through reduction in amount or mutation [28, 39-42].
We found that aspects other than short and missing cilia differed between the
Paramecium MKS3 RNAi phenotypes and IFT88 RNAi phenotypes. For example, the cilia that
remain on the IFT88 depleted cells appeared short but not misshapen, while those on MKS3
depleted cells were short with bulging membranes, giving a “blebby” appearance, especially at
the tips.
In other systems, MKS3 (TMEM67) functions as part of the filter or as a gate keeper in the
transition zone, the region between the basal body and the ciliary necklace [13, 43-45]. Failure of
transition zone function to control ciliary structure and membrane composition can lead to short
and bulbous cilia [46] similar to our observed “blebby” cilia on cells depleted of MKS3 by RNAi.
Our immunofluorescence data of paramecia expressing FLAG-MKS3 suggest that FLAG-MKS3p
is in the transition zone, which in Paramecium has been defined as an area which spans from the
epiplasm to the base of the cilium below the ciliary necklace [26, 27] (Figure 2.1 and
Supplemental Movie 2.1). The antibody we used to label basal bodies recognizes Tetrahymena
Centrin 1, which is most homologous to Paramecium Centrin 2, and stains the full length of the
Paramecium basal body below the cell surface [25]. The transverse section through the surface of
the cell shows Anti-FLAG labeling for FLAG-MKS3p near the cell surface and at or above the
distal end of the basal body. This location of MKS3p in P. tetraurelia is also consistent with the
observations by Dawe et al. [28] who were the first to show the localization of MKS3p at the base
of the primary cilium at the transition zone in IMCD3 and HEK293 cells transfected with Nterminal tagged proteins. Other groups have made similar findings [13, 47].
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We propose that the depletion of MKS3p from the transition zone accounts for the loss of
cilia and blebbing of the membrane of the short remaining cilia by causing a failure of the
transition zone to regulate ciliary structure and membrane composition. We have also data that
suggest the presence of MKS3p in the distal portion of the cilium (Western blot, Supplemental
Figure 2.4). The cilia for the Western blot preparations are severed from the cell body above the
ciliary necklace, which means that if MKS3p is in the cilia the proteins on blot come from above
the transition zone [48].
New phenotypes of MKS3 mRNA depletion suggest interaction with basal body striated
rootlet (SR)
The repetitive stereotypical rows of cortical units of P. tetraurelia allowed us to identify
subtle deviations due to reduction of MKS3p. RNAi for MKS3 led to basal bodies out of kinety
rows on the dorsal surface, mostly at the midline. The disorganized basal bodies were in patches,
mostly in clusters or less often in small extra rows, and with misshapen morphology of cortical
ridges. These phenotypes were not seen in the IFT88 depleted cells indicating that the shortening
and loss of cilia are not sufficient to explain these changes in MKS3 depleted paramecia.
Cortical units across the surface of Paramecium contain either one or two basal bodies
(mono- or di- kinetids respectively). In preparation for cell division, basal bodies duplicate and
the cell must enlarge and elongate. This first stage of division involves the conversion of all
dikinetids to monokinetids [21], with the exception of those in the invariant zones at the extreme
anterior and posterior ends of the cells [21, 22]. This conversion of di- to mono- kinetids is the
earliest stage in preparation for cell division and once complete, the cell will begin basal body
duplication and formation of the fission furrow at the midline of the cell [21]. For both the
conversion of di- to mono- kinetids and basal body duplication, where a new basal body is
produced anterior to the parental basal body, the anterior basal bodies or the new basal bodies
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move away from the parental basal bodies using the striated rootlet (SR) as a guide, thus
maintaining orderly rows [21, 22]. While basal bodies in all areas outside the “invariant” zones
must duplicate for cell division, we do not see a distortion of the kinety rows of basal bodies
except on the dorsal side and primarily at the midline. Therefore, we propose that the MKS3
RNAi phenotype of disorientation of basal bodies and rootlet orientations that we observe is
primarily from failure of the anterior basal body of two basal body units to appropriately migrate
along the SR and thereby maintain a straight kinety row. The conversion from di- to monokinetids is prior to basal body duplication happens first on the dorsal surface of the cell, where a
large number of randomly distributed dikinetids exist [20], and at the midline because the
anterior movement is in advance of basal body duplication, which begins at the midline.
The posterior basal body in the dikinetid has a cilium and full complement of rootlets
(TM, PCM and SR) projecting in stereotypical orientations. The anterior basal body of the pair
has no cilium and only the transverse microtubules associated with it. In addition to the rootlets,
a set of three cytoskeletal “nodes” link the basal bodies of a dikinetid to each other and to the
striated rootlet [20, 21]. While moving, the anterior basal body remains linked to the SR, which
extends for two or more cortical units toward the anterior and appears to act as a guide that
keeps the migrating basal bodies aligned with the cortical row. Once the anterior basal body has
separated from the posterior basal body it develops a PCM and a SR in addition to its preexisting
TM [21]. A schematic of this process is shown in Figure 2.7.
We propose that misguidance in the early movement of the anterior basal body of
dikinetids can account for the observed RNAi phenotype of misalignments primarily near the
dorsal midline. We also propose that all newly forming basal bodies which also use the SR as a
guide could require MKS3p for their attachments to the SR. We expect that only the errors in
anterior basal body movements in the di-kinetics are noticed in MKS3 RNAi depleted cells
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because they occur early, before basal body duplication, and because cells stop growing and do
not proceed further with basal body duplication and cell division. Indeed, these RNAi treated
cells stop growing after 24 h of RNAi feeding (data not shown).
This hypothesis of interaction of MKS3p with the SR is strongly supported by the results
of a GST pull down assay. Using the MKS3p coiled coil domain as bait, we have identified a
kinetodesmal fiber protein (KdB2: GSPATG00008129001).
MKS3p bait also pulls down two Paramecium Centrin binding protein 1s (PtCenBP1:
GSPATG00034434001 and GSPATG00034433001) which has been shown to be the main
component of the infraciliary lattice (ICL). The ICL is a contractile cortical cytoskeletal network
that is nucleated from the basal body region [49, 50]. An interaction of MKS3p and PtCenBP1
could help to stabilize the basal body within the cortical unit allowing a cilium to be properly
established.
GST pull down results included a Ran GTPase activating protein 1 (RanGAP:
GSPATG00009639001). An interaction of RanGAP1 with MKS3p is interesting if the ciliary pore
functions in a fashion similar to the nuclear pore complex, which has been suggested [51, 52]. A
RanGTP/GDP gradient between the cilia and cell compartments has been suggested to be
involved in for the entrance of select proteins into the cilia, such as Kif17, in mammalian cells
[53]. The interaction of MKS3 with RanGAP may prove to be a reflection of MKS3p function in
the transition zone and part of the explanation for loss and deformation of cilia in MKS3
depletion.
It might be suggested that the misalignment phenotypes in MKS3 depleted cells results
from inappropriate development of the rootlets around the basal body. We do not favor this
explanation because in areas of disruption, the PCM and TM rootlets form with a normal angle
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between them and kinetodesmal fibers develop. These results suggest that the entire basal body
unit with rootlets appears to be mis-directed and not aligned with the anterior-posterior axis of a
kinety as opposed to a dysfunction in rootlet development.
We did not identify a second location for MKS3 in our immunofluorescence studies of
tagged MKS3p outside the transition zone. Although physical interactions of basal bodies and
the SR were identified in structural studies [21], the transient nature of the attachments have
made it difficult to identify the interacting components. Our findings open a new opportunity to
dissect these transient but critical interactions.

Conclusion
There appear to be dual roles for MKS3 in Paramecium. We have shown that MKS3p in P.
tetraurelia is located at the cell surface near each basal body’s transition zone where it most likely
helps to filter and import (or retain) proteins into the cilia. When MKS3p is reduced from this
location, cilia are lost and the cell surface and ciliary membranes become distorted. Secondly, a
pool of MKS3 may be required in di-kinetid units to guide the anterior basal body of the
separating pair along the striated rootlet. A reduction in this pool of MKS3 may lead to the basal
body becoming twisted and misaligned from its polarized row.
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Table 2.I. Unique proteins to the test lane from GST-MKS3 coiled coil domain pull down.

Paramecium DB
Accession number
GSPATG00034434001

Molecular
Weight
146 kDa

Peptides
(control)
0

Peptides
(test)
2

PtCenBP1

GSPATG00020240001

115 kDa

0

2

PtSERCA1

GSPATG00034433001

85 kDa

0

2

PtCenBP1

GSPATG00009639001

39 kDa

0

2

GSPATG00008129001

36 kDa

0

3

Ran-GTPase
activating protein 1
KdB2
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Name

Figure 2.1. Localization of FLAG-MKS3p. Cells expressing FLAG (control) or FLAG-MKS3
were immunostained with Anti-Centrin (red) and Anti-FLAG (green); representative cells are
shown here. The oral grove (mouth) is indicated by yellow arrows (A). FLAG staining in the test
cell expressing FLAG-MKS3 (A) shows a punctate pattern at each basal body with partial colocalization (B). This staining is above the plane of the basal body (C) (See also Supplemental
Figure 4 for Western blots and Supplemental Movie 1 for individual Z sections). Images are
stacks of Z sections, either 10 to 15 µm (A and B) or 4 µm (C) thick. Scale bars are 15 µm (A), 5 µm
(B), or 2 µm (C).
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Figure 2.2. MKS3 depleted cells have sparse cilia and distorted cell and ciliary surfaces. SEMs
of representatives of control (A and B), MKS3 depleted (C-F), and IFT88 depleted (G and H) cell
populations (the cell in G has been rotated). Whole cell images of control (A), MKS3 depleted (C
and E), and IFT88 depleted (G) cells. Scale bars: 10 µm. The control cell (A) is covered in cilia
while the MKS3 depleted cells show sparse and short cilia (C and E). The IFT88 depleted cell (G)
has almost no cilia remaining, although a few short cilia are visible (yellow arrows). Higher
magnifications of the cell surfaces from A, C, E, and G, (yellow boxes) are shown in B, D, F and
H, respectively (scale bars: 2µm). Control cell surface (B) shows cilia arising from the cortical
units while the MKS3 depleted cells show short and missing cilia (D and F). Over 50% of the
MKS3 depleted cells had cilia that were severely misshapen and “blebby.” The cell surface of
these cells also becomes heavily wrinkled and distorted (F). The IFT88 depleted cell (H) shows
normal organization of cortical units.
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Figure 2.3. Basal bodies of MKS3 depleted cells are misaligned primarily at the dorsal midline.
Cells were stained using Anti-centrin to visualize the basal bodies. Images represent stacks of Z
sections, approximately 10 µm thick. The images shown are the dorsal surface of the anterior side
of the cell. Basal bodies should be arranged in organized rows, as seen in the control and IFT88
depleted cells. The MKS3 depleted cell (center panel) shows the basal bodies not aligned and no
longer in straight rows (white arrows) at the midline of the cell. Scale bars: 10 µm.
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Figure 2.4. Disruptions of the cortical units correspond to the areas of basal body
misalignment. Control (A) and MKS3 depleted cells (B and C) were stained using Anti-2F12 to
visualize the cortical ridges. These images are of the dorsal surface and are stacks of Z sections,
approximately 10 µm thick. The green bright spots are the intense fluorescence of the oral
grooves. The control cell (A) shows the high degree of organization of the outer lattice across the
cell surface. The presence of a basal body in each unit can be seen in the enlarged area (a; yellow
box) and the traced image below (black dot inside hexagonal unit). The MKS3 depleted cells
illustrate an insertion of several cortical units forming an abbreviated kinety (B, b; yellow arrows)
or a disruption type caused by the insertion of multiple cortical units resulting in the formation of
a cluster (C, c; yellow arrows). The contractile vacuole pores are pointed out using gray arrows.
Scale bars: 10 µm.
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Figure 2.5. The microtubule ribbons have an altered orientation in MKS3 depleted cells. IFT88
(A) and MKS3 (B) depleted cells were stained using Anti-centrin (red; basal bodies) and Antitubulin (green; microtubule rootlets). Images are stacks of Z sections approximately 10 µm thick.
All images are the anterior dorsal surface. Areas in (A) and (B) (yellow box) have been enlarged
and below each is a tracing to depict the basal body (red) and the emanating rootlets (black). The
rootlets are organized into the basal body rows (kineties) as a 5 o’clock (TM) and 7 o’clock (PCM)
orientation relative to the basal body. In the disrupted region of the MKS3 depleted cell (B), the
microtubule rootlets are present and maintain the angle between them (C), but do not maintain
the regular orientation along the anterior-posterior cell axis as seen in the control cell. Scale bars:
10 µm. The angles between the TM and PCM were measured (C) and these angles were
maintained in the MKS3 depleted cells (35 cells from both test and control cells; error bars are ±
SD).
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Figure 2.6. Chaotic orientation of the striated rootlet (SR) in MKS3 depleted cells. Control (A)
and MKS3 depleted (B) cells were stained with Anti-Glu-α-Tubulin (red; basal bodies) and AntiKDF (green; striated rootlets). Yellow arrows in (A) and (B) indicate the contractile vacuoles on
the dorsal surface of these cells. SRs project from the basal bodies; in two basal body units, SRs
project only from the posterior basal body (a; dotted yellow arrows). SRs project toward the
anterior of the cell in a highly organized manner along the kinety. Cells depleted of MKS3 depict
chaotic organization of the SRs, which project in every direction (b and b’). Scale bar is 10 µm.
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Figure 2.7. The upper portion of the panel diagrams the normal transition of a dikinetid to a
monokinetid in a control cell prior to basal body duplication. In this case, the anterior basal body
of the pair is linked to and uses the SR as a guide during movement. MKS3p is shown at each
basal body near the cell surface (Transition zone associated MKS3p) and also at the attachment of
the anterior basal body to the SR (striated rootlet associated MKS3p). We propose that this
second location of MKS3p is temporary because MKS3p is not required as a guide once the
anterior basal body has moved away from the posterior one sufficiently to develop its rootlets
and foster the growth of another basal body. The lower portion of the panel diagrams the
transition from a dikinetid to a monokinetid in MKS3 depleted cells. We propose that in the
absence of MKS3p, the anterior basal body loses its ‘mooring’ and can no longer utilize the SR as
a guide for migration. Without guidance the basal body wanders out of alignment resulting in
skewed rootlets, disorganized basal body rows, and muddled cortical ridge organization.
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Supplement Table 2.1.Comparison of Paramecium IFT88 with other organisms.

Gene
(GSPATG…)

Nucleic
acids

743

Amino
acids

Salmo Salar
(ACN11151)

Best nonciliate
match

Salmo Salar
(ACN11151)

2341

726

Salmo Salar
(ACN11151)

00038505001

736

Danio rerio
(CAQ14425)

2319

730

00021390001

2342

566

2346

00022644001

1727

00011771001

00039556001

Salmo Salar
(ACN11151)

1.00e-107

7.00e-128

2.00e-136

4.00e-145

1.00e-150

e-value

9e-116
(39% identical)

2e-138
(37% Identical)

1e-153
(39% identical)

1e-163
(42% identical)

2e-170
(42% identical)

Chlamydomonas
match
(XP_001700100.1)

2e-116
(38% identical)

9e-140
(35% Identical)

3e-156
(37% identical)

2e-159
(40% identical)

6e-168
(38% identical)

Human match
IFT88 Isoform 2
(NP_006522.2)

107

Supplement Table 2.II. Comparison of Paramecium MKS3 with other organisms.

00015939001

Gene
(GSPATG…)

2906

Nucleic
acids

951

Amino
acids

Rattus norvegicus
(NP_001101386.3)

Best non-ciliate
match

8e-164
(24% identical)

e-value

5e-60
(24% identical)

Mus muscullus
(NP_808529.2)

2e-56
(25% identical)

Human match
(NP_001135773.1)
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Supplemental Movie 2.1
Movie is the FLAG-MKS3 injected cell shown in Figure 1 and begins outside the cell, with the
anterior on the right. As the movie plays, each frame is one z-section, showing the FLAG stain
(green) in the frame before the centrin stain (red). Notice the FLAG stain appears before (above)
the basal bodies, which are positioned slightly below the membrane, and is positioned to the side
and posterior.
(Go to: http://www.ciliajournal.com/content/3/1/2 , Additional File 5: Movie S1 to view)
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Supplemental Figure 2.1
An alignment of the full-length Paramecium, Mouse and Human MKS3 amino acid sequences
are shown (A). Shown in (B), the cysteine rich domain and coiled coil domain show conservation
across all species. The Paramecium cysteine rich domain shows 23% identity to both the Mouse
and Human sequences and the majority of the cysteines in this region are conserved across all
three species. The MKS3 coiled coil domain of Paramecium shows 59% identity to the Mouse
MKS3 coiled coil domain and 55% identity to the Human MKS3 coiled coil domain. For all
alignments, red indicates 100% amino acid identity, green indicates and amino acid consensus
match and white indicates a mismatch.
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Supplemental Figure 2.2
An alignment of the full-length Paramecium, Mouse and Human IFT88 amino acid
sequences are shown (A). Four of the predicted tetratricopeptide repeat (TPR) domains of IFT88
are conserved in the Paramecium sequence and are shown in (B). TPR1 shows 44% and 42%
identity, TPR2 shows 45% and 51% identity, TPR3 shows 54% and 53% identity and TPR4 shows
43% and 44% identity to the Mouse and Human TPR domains, respectively. For all alignments,
red indicates 100% amino acid identity, green indicates and amino acid consensus match and
white indicates a mismatch.
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Supplemental Figure 2.3
Images of control and MKS3 RNAi cells stained with Anti-KDF (green) and Anti-Glu-αtubulin (red) that show a larger section of the dorsal surface. Normal kinety and kinetodesmal
fiber alignment can be seen across the entire surface of the control cell. The MKS3 depleted cell
shows clustering disruptions in multiple regions of the dorsal surface (yellow arrows).
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Supplemental Figure 2.4
To help determine the localization of this protein, we examined its presence in isolated
whole cilia and pure cell (pellicle) membrane from cells expressing FLAG-MKS3 or, as a control,
FLAG. The isolated proteins were then separated on SDS-PAGE and transferred to
nitrocellulose. The nitrocellulose blots were then probed using Anti-FLAG or Anti-Tubulin
(Tubulin Loading Control). The FLAG-MKS3 protein can be seen at 105 kDa in the cell
membrane (blue arrowhead) and at 105 and 77 kDa in the whole cilia (Cilia; blue arrowheads).
There are non-specific bands present in both the test and control lane, in the whole cilia blot
(Cilia; gray arrowheads, ~107 kDa), most likely due to the large amount of protein loaded (250
µg). Anti-tubuling blot is a representative loading control indicating the test and control samples
contained the same amount of protein.
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Abstract
Polycystin-2 (Pkd2), a non-selective cation channel, is a versatile human ciliopathy gene.
Known for its interactions with other TRP channels and Pkd1, we used the ciliated organism
Paramecium tetraurelia to explore the location and activity of Pkd2 in a non-canonical system
lacking most of the previously published interacting partners. Combinations of RNAi, overexpression, and epitope-tagging were utilized for immunofluorescence, behavior assays, and
electrophysiology. Depletion of Pkd2 led to a similar phenotype as eccentric (XntA1), a
Paramecium mutant lacking the calcium-dependent Mg2+ conductance. Pkd2 and XntA localize to
the cilia and cell membrane, but are not dependent on one another for trafficking. Restricting
Pkd2 to the cell membrane by depleting cells of BBS8 did no inhibit Mg2+-induced behavior and
mostly increased depolarizations in Mg2+ solutions. The XntA protein co-IP’s Pkd2 from cell
membrane and cilia, further supporting their cooperation. Electrophysiology of ciliated and
deciliated cells showed that depletion and over-expression of Pkd2 led to smaller and larger
depolarizations in Mg2+ solutions, respectively. We propose that Pkd2 in P. tetraurelia
collaborates with XntA for Mg2+-induced behavior and membrane permeability to Mg2+.
Furthermore, we propose Pkd2 is sufficient and necessary for IMg, membrane permeability to
Mg2+, and that Pkd2 is a Mg2+ channel.

121

Introduction
Polycystin-2 (Pkd2 or TRPP2) is a member of the transient receptor potential family of
proteins which contains at least 56 members grouped into seven subfamilies. The 56 members of
the TRP family share the structural homology of six predicted transmembrane-spanning regions
with a pore region between S5 and S6 (Giamarchi and Delmas, 2007, Tsiokas et al., 1999). Three
of the subfamilies, TRPC, TRPV, and TRPM which comprise the canonical, vanilloid, and
melastatins, are related in their predicted structure and in their sequence homology. The
remaining subfamilies are more divergent in their sequence and predicted structures including
the TRPP subfamily of polycystins. In humans, there are eight members of the TRPP subfamily,
one of which is TRPP2, or Pkd2 (Giamarchi and Delmas, 2007). Mutations in the human PKD2
gene or protein lead to 15% of the cases of Autosomal Dominant Polycystic Kidney Disease
(ADPKD) (Gonzalez-Perrett et al., 2001), one of the leading causes of adult-onset renal failure in
the United States and affecting one out of every 800 live births (Wilson, 2004).
Pkd2 is a versatile ciliopathy protein from an ever-growing list of genes that when
mutated, leads to the dysfunction of cilia (reviewed in (Hildebrandt et al., 2011)). The Pkd2
channel is a non-selective cation channel (Hanaoka et al., 2000). Human Pkd2 protein expressed
in reconstituted human term syncytiotrophoblasts (hst), Chinese hamster ovary (CHO) cells, or
LLC-PK porcine kidney cells is capable of conducting Na+, Ca2+, K+, Cs+, Ba2+ or Mg2+ ions
(Gonzalez-Perrett et al., 2001, Koulen et al., 2002, Hanaoka et al., 2000). The Pkd2 channel
operates as a homo- or hetero- tetramer (Kobori et al., 2009, Zhang et al., 2013, Stewart et al., 2010,
Feng et al., 2011, Zhang et al., 2009) with an ion-passing pore of at least 11 Å (Anyatonwu et al.,
2007).
The Pkd2 protein is promiscuous, with numerous interacting partners, one of which is
another ciliopathy protein, Polycystin-1 (Pkd1) (Tsiokas et al., 1997, Hanaoka et al., 2000,
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Giamarchi et al., 2010, Nauli et al., 2003, Delmas et al., 2004). Pkd1 is not considered a member of
the TRP superfamily. At ~468 kD, Pkd1 is a large protein with an extensive extracellular Nterminus (over 2500 amino acids) followed by 11 predicted membrane spanning domains and an
intracellular C-terminus (Hughes et al., 1995). The other 85% of ADPKD cases not caused by
mutations in Pkd2, come from mutations in Pkd1 (Igarashi and Somlo, 2002). In addition to
interacting with Pkd1, the Pkd2 channel interacts with other channels and proteins, including
other TRP channels such as TRPC1 (Tsiokas et al., 1999, Du et al., 2014, Bai et al., 2008, Zhang et
al., 2009), TRPC4 (Du et al., 2008), and TRPV4 (Kottgen et al., 2008, Du et al., 2014, Zhang et al.,
2013). Pkd2 will also bind to itself (Zhang et al., 2009, Feng et al., 2011). Non-TRP family
proteins that Pkd2 has been shown to interact with include the inositol 1, 4, 5-triphosphate (IP3)
receptor (Li et al., 2005) and ryanodine receptor (RyR3) (Anyatonwu et al., 2007), both for
intracellular calcium release.
The location of mammalian Pkd2 is cell-type specific and membrane-specific. Pkd2 has
been shown to localize to and be active in the cell membrane (Gonzalez-Perrett et al., 2001, Luo et
al., 2003, Hanaoka et al., 2000), the cilia (Yoshiba et al., 2012, Nauli et al., 2003) and the
endoplasmic reticulum (ER) (Cai et al., 1999, Bae et al., 2006). Pkd2 has been shown to require
Pkd1 for its trafficking to another membrane. In Chinese hamster ovary (CHO) cells expressing
human PKD1 and PKD2, the Pkd1 protein recruits Pkd2 to the cell membrane where these
proteins form a functional channel (Hanaoka et al., 2000). In mouse embryonic kidney cells,
changes in fluid stress cause Pkd1 to activate Pkd2 present in the ciliary membrane (Nauli et al.,
2003). There are instances of Pkd2 not requiring Pkd1 for trafficking to the cell membrane or
cilia. This is demonstrated in C. elegans, where the homologue of Pkd1, lov-1, is not required for
pkd-2 to be trafficked to the membrane of ciliated neurons (Barr et al., 2001). Another instance is
in the green algae Chlamydomonas reinhardtii where the Pkd2 protein is cleaved from a 210 kD
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protein into two smaller 120 and 90 kD proteins before entering the cilia completely independent
of Pkd1 (Huang et al., 2007).
The trafficking of Pkd2 within cells, to the Golgi, the cell membrane, and the cilia
membrane requires different routes and accompanying proteins. The full length human Pkd2
sequence contains an ER retention signal at the C-terminus (amino acids E787 to S820). When
expressed in HEK293 cells, Pkd2 is retained in the ER. When the retention signal is masked or is
absent, Pkd2 moves to the cell membrane (Cai et al., 1999) or returns it to the ER after briefly
traveling to the Golgi via COPII (Hoffmeister et al., 2011). In Xenopus oocytes expressing human
Pkd2 and mutated forms of human Pkd2, the phosphofurin acidic cluster sorting proteins (PACS)
1 brings Pkd2 back from the cell membrane to the Golgi and PACS2 is needed to transport Pkd2
to the ER along with COPII (Kottgen et al., 2005). The movement of Pkd2 between membranes is
clearly part of the regulatory or recycling system for the Pkd2 channel.
Another mode of transportation for Pkd2 is the BBSome coat complex which is vital for
the transport of Pkd2 from the Golgi to the cilia. The BBSome complex consists of 8 proteins,
BBS1, 2, 4, 5, 7, 8, 9 and BBIP10 (Nachury et al., 2007). The formation of this coat is regulated by
Arl6GTP, an Arf-like GTPase, also known as BBS3. The coat itself is electron-dense and
morphologically distinct from coats formed by COPI, COPII, and clathrin (Jin et al., 2010). The
depletion of BBSome coat complex components, namely BBS7, 8, or 9, leaves Pkd2 unable to
traffic to the cilia, but the protein appears present at the cell surface (Valentine et al., 2012).
Hoffmeister and colleagues suggest Pkd2 traffics to different points within the Golgi before being
trafficked to the ER, cell membrane, or cilia (Hoffmeister et al., 2011). If Pkd2 is destined for the
cell membrane, it will travel through the Golgi. However, if Pkd2 is destined for the cilia, it will
leave from the cis-Golgi in a Rab8a-dependent manner. Pkd2 then reaches and enters the cilia in
a BBSome-dependent process (Hoffmeister et al., 2011). These studies provide evidence of
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multiple trafficking pathways and the dependence of Pkd2, at least in some cases, on other
proteins for its localization and function.
The single-cell ciliated eukaryote Paramecium tetraurelia provides a useful platform for
further investigations of the Pkd2 protein and its potential interacting partners. These cells are
covered in a thousand or more cilia that can be easily separated from the cell bodies for
investigation. The cells are amenable to RNA interference (RNAi) and over-expression of
epitope-tagged proteins for localization studies using immunoprecipitation or
immunofluorescence. Electrophysiology and behavioral assays are often used to investigate ion
channel function or cell attraction (Van Houten, 1979, Van Houten et al., 2000, Machemer and
Eckert, 1973, Machemer and Ogura, 1979). The fully annotated genome is available and
searchable for homologous proteins as well as RNAi off-target sequences (ParameciumDB,
paramecium.cgm.cnrs-gif.fr/) (Arnaiz et al., 2007, Arnaiz and Sperling, 2011). Interestingly,
paramecia do not have homologous sequences for Pkd1, but do have sequences homologous to
Pkd2, which we use and discuss in this study. We provide here the results of RNAi and epitopetagged protein studies to investigate potential and novel interacting partners for the Pkd2 protein
in both the cell membrane and the cilia. We demonstrate that the unique Paramecium protein
eccentric, XntA (Haynes et al., 2002, Preston and Kung, 1994b, Preston and Kung, 1994a), is a
potential interacting partner for Pkd2. Both of these proteins are located in the cell membrane
and in the cilia and function in Mg2+-induced behavior for these cells. Further, we propose that
Pkd2 is the magnesium channel in the cell membrane and most likely in the cilia, demonstrating
for the first time in vivo that Pkd2 functions as a magnesium-permeable channel.
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Materials and Methods
Cell Culture
All research was done using Paramecium tetraurelia, 51-s (sensitive to killer) or the mutant
XntA1 (Haynes et al., 2002, Preston and Kung, 1994b, Preston and Kung, 1994a). Paramecia
stocks were maintained at 15°C, 22°C, or at room temperature. Culture media, discussed in
(Sasner and Vanhouten, 1989), was inoculated with Klebsiella pneumoniae or Aerobacter aerogenes
and incubated at 37°C for 24 to 48 hours prior to use, unless otherwise noted (see RNAi
experiments).
All chemicals were obtained through Sigma (St. Louis, MO), unless otherwise noted.
BLAST searches, RNAi Construct Design and mRNA Depletion Using RNAi by Feeding
The sequence for XNTA (PTETG4300006001) is published (Haynes et al., 2002). This is a
very unique nucleic acid sequence with no other closely related sequences within the Paramecium
genome. To find potential homologues of Pkd2, the Paramecium Genome (ParameciumDB) was
searched using the human and mouse sequences for Pkd2, Accession numbers NP_000288 and
NP_032887, respectively. Three potential PKD2 sequences were identified (GSPATG00005599001,
GSPATG00024265001, and GSPATG00012640001) which we identify as PKD2a, PKD2b and
PKD2L. PKD2a and PKD2b are paralogs, over 84% identical at the nucleic acid level. The
sequence designed for RNA interference (RNAi) targets both of these paralogs. PKD2L is less
similar, 47% identical at the nucleic acid level to PKD2a and b. PKD2L is not presented in this
study.
Primers used to create the RNAi construct for PKD2 were: forward 5’GGCAGCTAATTATTAAGGAAC-3’ and reverse 5’-CAGAATTTATTCCCTACTTTTC-3’ which
amplify position +781 to +2613 in GSPATG000055990001. The primers used to create the RNAi
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construct for XNTA (PTETG4300006001) were forward 5’-ATGACCTACAGAGAATTAGTCCC-3’
and reverse 5’-GTAAATCCTTTAGCTAATGC-3’ and amplify position +1 to +1559. Constructs
were created from genomic DNA isolated using organic extraction as described previously
(Picariello et al., 2014).
The PCR conditions to create the RNAi constructs were: 95°C for 5 min; 5 cycles of 95°C
for 1 min, 42°C for 1 min and 72°C for 3 min; 27 cycles of 95°C for 1 min, 43°C for 1 min and 72°C
for 3 min; and final extension of 20 min at 72°C. Single bands were identified in 1% agarose gels
stained with ethidium bromide. Two µL of the PCR products were cloned into the TOPO®pCR
2.1® cloning vector (Invitrogen/Life Technologies, Grand Island, NY) as per the kits instructions.
OneShot ™Competent cells were transformed with the plasmid on LB plates containing
ampicillin (AMP) and 40 ug/mL of X-GAL [5-bromo-4-chloro-3-indolyl-beta-Dgalactopyranoside (RPI corp., Mount Prospect, IL)].
Plasmid Extraction and RNA interference (RNAi) Construct Creation
Potential positive colonies were grown overnight while shaking at 37°C and plasmids
were extracted using the Wizard® Plasmid extraction kit (Promega, Madison, WI) as per the kit
instructions. DNA was eluted using 25 µL of MilliQ water and the concentration was
determined using an Agilent spectrophotometer (Agilent, Santa Clara, CA) (O.D. of 260 and 280
nm) and stored at -20oC for later use. Twenty µL of the plasmid at a concentration of 50 ng/µL
was sequenced (Vermont Genetics Center DNA Facility, University of Vermont, Burlington, VT)
using a commercial M13 forward primer. Positive inserted sequences were removed from
TOPO®pCR2.1® plasmid (Life Technologies) using the restriction enzymes SacI and XhoI (New
England BioLabs, Ipswich, MA). Fragments were ligated into the double-T7 promoter RNAi
plasmid L4440 (Addgene, Cambridge, MA) using the Ligate-IT™ Rapid ligation kit (Affymetrix)
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as previously described (Valentine et al., 2012). The RNAi construct for BBS8 was created
previously and is described in Valentine et al., 2012.
Preparation of RNAi Cultures
RNase-III deficient Ht115 E. coli bacteria were used for RNAi experiments to express
double-stranded RNA. Overnight Ht115 bacteria cultures that had been transformed with the
test (PKD2, XNTA, or BBS8 sequence in L4440) RNAi plasmid or the control plasmid (L4440
vector) were used to inoculate a 50 mL culture (50 mL of LB with 100 µg/mL of AMP). That
culture was grown to an O.D.600 of between 0.3 to 0.4, at which point the bacteria were induced
by adding 125 µg/mL IPTG (isopropylthio-β-galactoside; RPI, corp.). Cultures were induced for
4 hours then the bacteria were pelleted by spinning the cultures in at 3440 x g (JA-14 rotor; 5000
RPM) (Beckman-Coulter, Brea, CA) for 10 minutes at 4°C. The supernatant was discarded and
the pellet resuspended in 100 mL of wheat grass medium supplemented with 100 µg/mL AMP,
125 µg/mL IPTG, and 8 µg/mL stigmasterol. A 50 to 100 mL culture of starved paramecia cells
were collected and allowed to swim for at least one hour in 10 mL Dryl’s solution [1 mM
Na2HPO4 (Thermo Fisher Scientific, Pittsburgh, PA), 1 mM NaH2PO4 (Thermo Fisher Scientific),
1.5 mM CaCl2, 2 mM Na-citrate, pH 6.8] to purge them of bacteria. One hundred to 250 of the
purged cells were then used to start the RNAi cultures which were incubated at 22°C or room
temperature. The cultures were supplemented with an additional 125 µg/mL IPTG and 100
µg/mL AMP at 24 and 48 hours.
For the large-scale BBS8 depleted cell study, cells were grown in 1.5 L cultures. Bacteria
were grown in 250 mL LB-AMP cultures from a 10 mL overnight culture to the same density
before inducing with IPTG. Induced bacteria were pelleted as before. RNAi cultures were started
with 10,000 to 14,000 purged cells and maintained at room temperature. Cultures were re-fed
every 24 hours by resuspending the collected pellets of freshly induced test and control bacteria
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in the large culture flasks. Paramecia cultures were again supplemented with fresh AMP and
IPTG. Three 1.5 L flasks were maintained for each cell type (FLAG expressing paramecia fed
L4440 RNAi; PKD2-FLAG expressing paramecia fed L4440 RNAi; and PKD2-FLAG expressing
paramecia fed BBS8 RNAi). Cells were tested for behavior (backward swimming assays, see
below) before harvesting. One of the flasks of each cell type was used to isolate cell membrane
while the other two flasks of each cell type were used to harvest cilia (see procedures below).
Backward Swimming Assays
Solutions to test for backward swimming were made containing the base buffer 1 mM
calcium citrate and ~1.3 mM Tris Base (Satow and Kung, 1976, Valentine et al., 2012). Additional
salts were then added and the pH adjusted to 7.02 to 7.05 using 100 mM Tris Base. The following
solutions were made using the base buffer: 30 mM KCl, 25 mM TEA (tetraethylammonium
chloride) with 10 mM NaCl (Na/TEA); 25 mM TEA with 5 mM MgCl2 (Mg/TEA); and the resting
buffer contained 4 mM KCl.
To test behavior, the RNAi-fed or over-expressing paramecia were allowed to grow for
72 hours at room temperature or 22°C. Cells were transferred, approximately 25 at a time, to 500
µL of resting buffer (4 mM KCl in base buffer) and allowed to acclimate for at least 15 minutes.
Cells were transferred one at a time using specially made glass micropipettes to 100 µL of a test
solution and the time each cell spent swimming backward was timed using a stop watch. Once
the cells returned to a forward swimming pattern, the stop watch was stopped and the time
recorded. Test solutions were changed after ~5 cells had been tested in it. All tests were done in
glass depression slides using dissecting microscopes.
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Heavy Metal Resistance
To test cells for heavy metal resistance, NiCl2 was used because of previous work done
with this solution (Preston and Kung, 1994b). Paramecia cells fed the RNAi bacteria for 72 hours
were tested for short backward swimming in 25 mM TEA with 5 mM MgCl2 to ensure the RNAi
was effective. The cells were briefly washed in depression slides of Dryl’s solution and placed in
resting buffer (see above). A total of 30 cells per cell type were placed in three separate wells of a
depression slide; there were ten cells in each well. The wells contained varying concentrations of
NiCl2 (25, 50, 100, and 250 µM) in the base buffer above. The depression slides were maintained
in a humidification chamber to prevent excessive drying. The number of cells swimming in each
of the depressions was counted every 30 minutes. That number when then compared to the
starting number of cells in that depression.
Creation of -FLAG and -myc Tagged Proteins
The creation of the N-terminal and C-terminal FLAG tag in the pPXV plasmids have been
described previously (Valentine et al., 2012, Picariello et al., 2014). The C-terminal myc tag was
created in a similar manner as previously published (Valentine et al., 2012). Briefly, a 3× myc
sequence (three repeats of EQKLISEEDL) was inserted into the pPXV plasmid (Courtesy of W
John Haynes, University of Wisconsin, Madison, WI) that had been treated with the restriction
enzymes Nhe I and Kpn I (New England BioLabs). The following primers were used to create
the insert: Top primer 5’-CTAGC[GAACAAAAATTGATTTCAGAAGAAGATTTG]×3GGTAC-3’
and bottom primer 5’-C[CAAATCTTCTTCTGAAATCAATTTTTGTTC]×3G-3’ which were
annealed together and ligated into the linearized pPXV plasmid. Resulting colonies of bacteria
were screened and two plasmids were selected to be sequenced using the pPXV sequence-specific
primer, pPXV 5’: 5’-TAAGATGAATGGAATATAATG-3’. Correct plasmids were then mutated
using the QuikChange Site-Directed Mutagenesis kit (Stratagene/Agilent, Santa Clara, CA) to
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create a stop codon as per the kits instructions. The following primer was used for the mutation
(sequence in parentheses is the existing sequence, bold letters indicate the mutation): 5’CAGAAGAAGATTTGTGA(GGT)ACCCTTATCTAAATGAAC-3’.
The epitope-tagged sequences used in this study were created using the following
primers. PKD2-FLAG (pPXV-FLAG, C-terminal FLAG tag): Forward, 5’GCGGGGCCCATGAAAAACCTATAGG-3’, reverse,
5’CGCGAGCTCATTTTCTGTTGCAGAATTTATTCCC-3’, using the enzymes Apa I and Sac I.
The PCR conditions were 95°C for 5 minutes; 5 cycles of 95°C for 1 min, 47°C for 1 min, 72°C for 3
min; 25 cycles of 95°C for 1 min, 49°C for 1 min, 72°C for 3 min; and then 72°C for 15 min and was
done using a standard Taq polymerase (Affymetrix). XNTA-myc (pPXV-myc, C-terminal myc
tag): Forward, 5’-GCGACTAGTATGACCTACAGAGAATTAG-3’, reverse, 5’CGCGCTAGCCTTTTAAATATTCAATCC-3’, Spe I and Nhe I. The PCR conditions were 94°C
for 2 min; 5 cycles of 94°C for 30 sec, 38°C for 30 sec, 68°C for 3 min 30 sec; 5 cycles of 94°C for 30
sec, 45°C for 30 sec, 68°C for 3 min 30 sec; 10 cycles of 94°C for 30 sec, 55°C for 30 sec, 68°C for 3
min 30 sec; 23 cycles of 94°C for 30 sec, 60°C for 30 sec, 68°C for 3 min 30 sec and was performed
using the proof-reading Taq polymerase Pfx (Life Technologies). XNTA-FLAG (pPXV-FLAG, Cterminal FLAG tag) was created using the same primers, PCR conditions, and restriction
enzymes as the XNTA-myc plasmid. FLAG-PKD2 (pPXV N-FLAG, N-terminal FLAG tag):
Forward, 5’-GCGGGGCCCATGAAAAACCTATAGGGG-3’, reverse, 5’CGCGGTACCTCAATTTTCTGTTGCAG-3’, using the restriction enzymes Apa I and Kpn I. The
PCR conditions were as follows: 94°C for 2 min; 5 cycles of 94°C for 30 sec, 46°C for 30 sec, 68°C
for 3 min 30 sec; 5 cycles of 94°C for 30 sec, 50°C for 30 sec, 68°C for 3 min 30 sec; 10 cycles of
94°C for 30 sec, 55°C for 30 sec, 68°C for 3 min 30 sec; 17 cycles of 94°C for 30 sec, 59°C for 30 sec,
72°C for 3 min 30 sec and was performed using the proof-reading Taq polymerase Pfx (Life
Technologies). In all cases, the resulting plasmids were sequenced from start to finish using
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sequence-specific primers as well as the pPXV5’ primer (already described) and pPXV 3’, 5’TTATTTAAGTGTTGTTCATTTA-3’.
The preparation of the plasmid for injection and screening of the injected paramecia was
done as previously described (Picariello et al., 2014, Valentine et al., 2012). Sequence-specific
primers used to screen the isolated genomic DNA from those injected cells were as follows:
PKD2-FLAG and FLAG-PKD2, endogenous used PKD2 5’ untranslated region (UTR)
5’GGTGAGTCTTTGTAGGATT-3’ and PKD2 RT R 5’-CTTATTCTATACCTTCAATTG-3’ and
exogenous used the same reverse primer and pPXV 5’. XNTA-FLAG and XNTA-myc,
endogenous primers were XNTA RT F 5’-CTTGAAATGCCTAAAGAATC-3’ and XNTA 3’UTR
5’-AGATATTGTTCTTAAATGAAC-3’, exogenous used the same forward primer and pPXV3’
reverse primer.
Immunofluorescence
Cells were cultured for immunofluorescence at 22°C or at room temperature. Cells were
collected and immunostained as previously published (Valentine et al., 2012). Antibodies used
for immunostaining were rabbit anti-centrin, 1:1000 (Tetrahymena centrin, gift from Dr. Mark
Winey, University of Colorado, Boulder, CO) and mouse anti-Flag, M2 clone, 1:300 (Sigma).
Secondary antibodies used were AlexaFluor® goat anti-mouse 488, AlexaFluor® goat anti-rabbit
488, AlexaFluor® goat anti-mouse 555, and AlexaFluor® goat anti-rabbit 568 (Molecular
Probes/Life Technologies). Cells were examined and images recorded using the DeltaVision
Restoration Microscopy System (Applied Precision, LLC, Issaquah, WA). This system consists of
an inverted Olympus IX70 microscope and a Kodak CH350E camera (system and analysis
equipment available through the Neuroscience COBRE Program, University of Vermont,
Burlington, VT). All images were taken using a 60x oil-immersion objective and images were
deconvolved and analyzed using SoftWoRx Pro software (Applied Precision).
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Cell and Membrane Isolations
For all preparations, control cells were expressing the epitope tag(s) and test cells were
expressing the desired plasmid(s). Cells were grown in 1.5 L volumes of fortified wheatgrass
medium at 22°C or room temperature until cell densities reached approximately 8,000-12,000
cells per mL.
I.

Cell Membrane:

Cell membranes were collected as previously published (Wright and van Houten, 1990) with
some changes. Cells were homogenized and washed as previously described, but final cell
membrane pellets were resuspended in IP500 buffer without detergents (500 mM NaCl, 100 mM
Tris-Cl, 1 mM EDTA, 1 mM EGTA, 0.2 mM sodium vanadate, 10% sucrose, pH 7.5) (Tsiokas et
al., 1999) or Lap200 buffer (adapted from (Nachury, 2008, Valentine et al., 2012): 50 mM HEPES,
200 mM KCl, 1 mM EGTA, 1 mM MgCl2, pH 7.8). Protein concentrations were determined using
a BCA protein assay (Pierce/Thermo Scientific) followed by equalizing the volume and protein
concentrations of the control and test samples. Five µL was removed from each of the test and
control samples for a loading control Western blot developed using Anti-Tubulin. Enough Triton
X-100 and Nonidet P-40 (NP-40) (Affymetrix) were added to make the final concentrations 1%
and 0.5%, respectively. Fresh protease inhibitors, 1 mM PMSF, 1 µg/mL Leupeptin (RPI corp.),
and 1 µg/mL Pepstatin A (RPI, corp.), were added to the samples. Samples were rocked on ice in
the cold room for one hour before centrifugation at 100,000 × g at 4°C in a Beckman L8-80
Ultracentrifuge for 45 minutes to remove the insoluble proteins. The resulting supernatants were
placed in sterile 15 mL disposable centrifuge tubes to be used for immunoprecipitation (IP).
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II.

Whole Cilia:

To isolate the whole cilia, procedures already published (Adoutte et al., 1980) were modified.
Cilia were not heavily vortexed to separate the membranes from the axoneme. Instead, cilia
pellets were resuspended in a small volume (100-200 µL) of membrane buffer (8 mM Tris, 50 mM
KCl, 5 mM MgCl2, 1 mM EGTA, pH 7.4). The whole cilia were then frozen at -80°C for no more
than two weeks after 10 µL was removed for a BCA protein assay to determine the concentration.
This was done to ensure enough protein was isolated, a minimum of 1 mg was required for the
IPs. For IPs, previously frozen control and test whole cilia samples were pooled from a 2 to 3
preparations to obtain sufficient protein (1 to 5 mg). The samples were brought to equal
volumes and concentrations using Lap200 or IP500 buffer (described above). Five µL of protein
was removed for a Western blot probed with Anti-tubulin for a loading control. Subsequently,
enough Triton X-100 and NP-40 was added to bring the final concentrations to 1% and 0.5%,
respectively. Fresh protease inhibitors were added to the concentrations above. As with the cell
membrane preparation, whole cilia rocked on ice in the cold room for one hour. This was
followed again by centrifugation at 100,000 × g for 45 minutes to remove the insoluble proteins
and the supernatant was reserved for IP.
Immunoprecipitations (IP)
IPs were adapted from previously described work (Valentine et al., 2012). Briefly,
between 10 to 75 mg of cell membrane protein and 1 to 5 mg of whole cilia were used for
solubilizations. Supernatants from the cell membrane and whole cilia isolations described above
were pre-cleared with prepared protein A beads (GE Healthcare Life Sciences, Pittsburg, PA).
Approximately 30 µL of beads per sample were prepared by washing three times in 1 mL of the
appropriate buffer (Lap200 or IP500) containing 1% Triton X-100 and 0.5% NP-40. Fresh protease
inhibitors were added to the samples along with 30 µL of prepared Protein A beads and rocked

134

on ice for one hour at 4°C. Beads were removed using an IEC clinical centrifuge spun at 250 × g
for 1 minute. Supernatants were removed and placed in fresh tubes to which new protease
inhibitors were added. Freshly prepared affinity agarose, either Anti-FLAG M2 affinity agarose
to IP FLAG-tagged proteins or Anti-c-myc affinity agarose to IP myc-tagged proteins (Sigma),
were then added. Affinity agaroses were prepared by washing approximately 25 µL of agarose
per sample with four 1 mL washes of the appropriate buffer containing detergents and 1% BSA
followed by four 1 mL washes of the appropriate buffer with the detergents. Supernatants with
affinity agarose were rocked on ice at 4°C for 2 hours. For two consecutive IPs, the agarose from
the first IP was removed before adding the second type of affinity agarose. Affinity agarose was
collected by centrifuging at 250 × g for 1 minute in an IEC clinical centrifuge. The supernatant
was transferred to a new tube (consecutive IP) or discarded (single IP). For consecutive IPs, fresh
protease inhibitors were added along with the second affinity agarose. Samples were rocked on
ice at 4°C overnight. After IP, the affinity agarose was washed three times with 1 mL of the
appropriate buffer containing detergents. After the final wash, as much of the remaining wash
was removed as possible before adding 25 – 40 µL of 2× Sample buffer (approximate final
concentration: 6.25 mM Tris Base, 1.5% SDS, 1% glycerol, 0.001% Bromophenol Blue, pH 6.8).
Samples were stored at -80°C until further use.
SDS-PAGE, Immunoblots, and Silver Staining
Proteins present in the IPs were separated on 7-15% agarose gels followed by
transblotting onto BioTrace™ Nitrocellulose paper (Pall Gelman, Port Washington, NY) or silver
staining. Before running on the gel, β-mercaptoethanol was added to 1% v/v and samples were
boiled for 5 minutes. Samples containing affinity agarose were spun at 14,000 × g for 5 minutes
at 4°C to pellet the agarose. Ten µL of PageRuler™ prestained protein ladder (Thermo Fisher
Scientific) was added to each gel for estimation of molecular masses and in gels that were silver
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stained, 30 µL of diluted Benchmark™ protein ladder (Life Technologies) was used. Gels were
run with a constant voltage of 170 mV until the dye front reached or ran off the bottom of the gel.
Proteins were transferred to Nitrocellulose at 250 mA for 1 hour 15 min, followed by 390 mA for
1 hour 15 min using a Hoefer TE22 Mighty Small Transfer Tank (Hoefer, Inc., Holliston, MA).
Blots were developed using either Enhanced Chemiluminescence (ECL) or alkaline phosphatase
(AP). For ECL, blots were blocked in 10 to 20 mL 5% Non-fat Dry milk in TBS-T (15 mM Tris-HCl,
140 mM NaCl, 0.1% w/v TWEEN®-20 (Sigma), pH 7.5). For AP blots, 2% v/v Telost gelatin from
fish (Sigma) and 3% Normal Goat Serum (Vector Labs, Burlingame, CA) was added to the milk
and TBS-T mixture. Blots were blocked for one hour at room temperature. ECL blots were
rinsed three times, 1× 15 minutes, 2× 5 minutes, with approximately 20 mL of TBS-T. Primary
antibodies were added directly to the milk blocking buffer for AP blots. For ECL, primary
antibodies were added to 10 to 20 mL of TBS-T after rinsing. Primary antibodies and their
dilutions included: rabbit or mouse Anti-FLAG M2 clone (Sigma) 1:2500; rabbit or mouse Anti-Cmyc (GenScript, Piscataway, NJ), 1:2000; mouse Anti-Tubulin, acetylated (Sigma), 1:10,000.
Primary antibody incubation was done overnight at room temperature (TBS-T) or 4°C (milk
blocking buffer). The antibody mixture was removed and blots washed three times as before in
~20 mL TBS-T while rocking at room temperature. Secondary antibodies were added in 1:10,000
dilutions in 10 to 20 mL TBS-T and rocked for 1 hour at room temperature. Secondary antibodies
used included donkey Anti-rabbit IgG HRP conjugate (GE Healthcare), goat Anti-rabbit IgG AP
conjugate (Sigma), goat Anti-mouse IgG HRP conjugate (Thermo Fisher Scientific), and goat
Anti-mouse AP conjugate (Sigma). After one hour, blots were washed 4× with ~20 mL TBS-T
and then developed using 15 mL BCIP/NBT substrate (Moss, Inc., Pasadena, MD) or SuperSignal
West Pico Chemiluminescence Substrate (Thermo Scientific) as per the kit’s instructions.
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Silver staining was completed as previously described (Valentine et al., 2012) using the
FASTSilver™ staining kit (G-Biosciences, St. Louis, MO). After stopping the reaction with 2%
acetic acid, gels were stored at 4°C in fresh 2% acetic acid until processed for trypsin digest.
Mass Spectrometry analysis
Samples were analyzed at the Vermont Genetics Network Proteomics Facility at the
University of Vermont. The silver stained gel lanes, from both test and control samples, were cut
into slices, approximately 15 to 20 slices per lane. The slices were cut into ~ 1mm x 1 mm cubes,
placed in sterile low-adhesion Eppendorf tubes and covered with MilliQ water. Silver D-stain™
(G-Biosciences) was used by mixing equal parts component A and component B then placing 500
µL of the mix over the gel slices after the water was removed. Gel slices were incubated at room
temperature with occasional vortexing for 20 minutes to remove the silver stain. After 20
minutes, the D-stain™ was removed and more was added if needed. Samples were washed for
15 minutes three to five times in 500 µL 50 mM ammonium bicarbonate at room temperature to
remove the yellow D-stain™. Clean samples were spun briefly, any ammonium bicarbonate was
removed. 200 µL of 100% acetonitrile was added to dehydrate the gel slices. After 20 minutes,
the acetonitrile was removed and an additional 100 µL was added if gel slices were not
completely opaque, indicating they were dehydrated. After the samples were completely
dehydrated and all acetonitrile removed, the samples were placed in a speed vac for 20 minutes
to completely remove the acetonitrile. Approximately 20 µL of trypsin digest solution (40 mM
ammonium bicarbonate, 0.6 ng/µL Trypsin, and 5% acetonitrile) was placed on the gel slices
(enough to cover them) and samples were placed on ice. After 30 minutes on ice, additional
buffer was added (40 mM ammonium bicarbonate and 5% acetonitrile) to ensure gel slides were
covered. The samples were incubated at 37°C overnight. The following morning, any fluid was
removed and placed in separate 0.6 mL Eppendorf tubes. The gel slices were then covered in
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~100 µL extraction solution (5% formic acid and 50% acetonitrile) for 45 minutes at room
temperature. After a brief spin in a table-top centrifuge, the extraction buffer was removed and
added to the 0.6 mL Eppendorf tube from earlier. The gel slices were then completely
dehydrated by adding 100 µL of 100% acetonitrile at room temperature for 15 minutes. The
acetonitrile was also removed, added to the same 0.6 mL Eppendorf tubes. If gel slices were not
opaque, an additional 100% acetonitrile was added to completely dehydrate the gel slices. The
0.6 mL Eppendorf tubes were then placed in a speed vac to evaporate all the fluid, leaving the
peptides behind. Samples were then stored at 4°C until needed for LC-MS/MS.
Samples were analyzed by LC-MS/MS on a linear ion trap (LTQ) Mass Spectrometer
(Thermo Fisher Scientific). Half the material was loaded onto a 100 µm x 120 mm capillary
column packed with MAGIC C18 (5µm particle size, 20 nm pore size, Michrom Bioresources,
Auburn, CA) at a flow rate of 500 nL/min. Peptides were separated by a gradient of 5-35%
CH3CN/0.1% formic acid over 30 minutes, 40-100% CH3CN/0.1% formic acid in 3.5 minutes, and
100% CH3CN for 10 minutes.
The product ion spectra were searched using the SEQUEST search engine on Proteome
Discoverer 1.4 (Thermo Fisher Scientific) against a curated Paramecium tetraurelia database with
sequences in the forward and reverse orientations. The raw files from the “control” and “test”
samples were searched as one contiguous input file and a single result file was generated for
each. The database was indexed to allow for full trypsin enzymatic activity, two missed
cleavages and peptides between the MW of 350-5000. Search parameters set the mass tolerance at
2 Da for precursor ions and 0.8 Da for fragment ions. The result files were then searched against
the Scaffold software 4.0.5 (Proteome Software, OR). Cross-correlation (Xcorr) significance filters
were applied to limit the false positive rates to less than 1% in both data sets. The Xcorr values
were as follows: (+1): 1.8, (+2): 2.7, (+3): 3.3, (+4): 3.5. Other filters applied were a minimum
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peptide cutoff of 2 as well as DeltaCN>0.1. Ultimately, the confidence parameters resulted in
false discovery rate (FDR) of >1% at the protein and peptide level for both the control and test
results.
Electrophysiology
Cells used for electrophysiology were in early logarithmic growth phase. Glass
electrodes were pulled using a Narishige pipet puller (Japan) using 1 mm borosilicate glass
capillary tubes with filament (World Precision Instruments, Sarasota, FL). Pulled electrodes were
back-filled with 500 mM KCl. They showed a resistance between 40 and 110 MΩ. Resting
membrane potentials were measured using a Warner Intracellular Electrometer IE-251A (Warner
Instruments, Hamden, CT) processed through AD Instruments PowerLab 4/35 and LabChart Pro
(AD Instruments, Colorado Springs, CO). Cells were placed on a slide mounted to a 2-well
chamber. The chambers were connected by a 3M KCl 3% agar bridge. The reference chamber
was filled with 3M KCl. The experiment commenced with 5 mM KCl in base buffer (see
backward swimming assays) in the main chamber. The fluid in the chamber was under constant
flow with a controlled rate of ~3 mL/ min using a Buchler polystaltic pump (Buchler, Fort Lee,
NJ). Membrane potential (Vm) was recorded continuously and Vm was noted at 4 minutes after
each change of the solution, which is when the Vm had stabilized. All solutions contained the
base buffer mentioned in Backward Swimming Assays along with 5 mM KCl, 1 mM KCl, or 0.5
mM MgCl2 with 1 mM KCl. The change in membrane potential (∆Vm) was calculated as the
difference in Vm in 1 mM KCl versus 0.5 or 1 mM MgCl2 with 1 mM KCl.
Both ciliated and deciliated cells were examined. Cells that were deciliated were used
within 15 minutes and any deciliated cell that was moving or produced an action potential
during or after the recording was not included in the analysis. Cells were deciliated by pipetting

139

up and down in 5 mM KCl with 5% (v/v) ethanol for 1 minute. Cells were then transferred to
fresh 5 mM KCl before being transferred to the chamber for recording.

Results
RNA interference (RNAi) Phenotypes
Paramecium swims by beating its cilia toward the posterior of the cell. The speed of the
beating is dependent on the cells membrane potential (Vm), which is governed by the cell’s
permeability to ions in their environment. The Vm of Paramecium tetraurelia is primarily
determined by the potassium ion concentration of the bath. This allows P. tetraurelia to act like a
potassium electrode. The cells are also permeable to Na+ and Mg2+, but less so to Ca2+ and Clions (Naitoh, 1968, Hansma, 1979, Machemer-Rohnisch and Machemer, 1989, Naitoh et al., 1972).
Depolarization of the cells by high potassium, other cations, or injected current open the
voltage gated calcium channels (CaV) of the cilia causing an action potential (AP). This AP allows
Ca2+ to enter the cilia and reach the axoneme in sufficient amounts to change the power stroke of
the cilia. The change in power stroke causes transient backward swimming for as long as calcium
remains high in the cilia. The K+ depolarization-induced AP is short, ending quickly by the
activation of the K+ channels of the cilia (Eckert, 1972, Brehm et al., 1978). Since Pkd2 is a nonselective cation channel (Hanaoka et al., 2000), we examined cells depleted of the potential Pkd2
channel in different ionic stimuli to measure the effect of the loss of this channel on the APinduced backward swimming of the cells. Mg2+ depolarization, especially when combined with
TEA+ to inhibit the K+ channels, prolongs the plateau of the AP and the subsequent backward
swimming.
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After cells were treated for 72 hours in RNAi bacteria for PKD2, their swimming
behavior was compared to the control cells fed the empty RNAi vector, L4440. In some cases the
data were normalized for comparisons across multiple experiments, as shown in Supplement
Table 3.I. All data are written as averages ± standard deviation while all graphs show averages ±
standard error of the mean. Because the RNAi construct for PKD2 targets both PKD2a and
PKD2b, we simply refer to these as PKD2 depleted cells. The PKD2 depleted cells showed
significantly shorter backward swimming in Mg/TEA compared to control cells (4.8 ± 4.1 sec and
9.6 ± 4.2 sec, respectively). In two other solutions, 30 mM KCl and Na/TEA, the cells were no
different compared to the controls (Supplement Table 3.I).
The data suggested a Mg2+-specific phenotype, reminiscent of the Paramecium mutant
eccentric (XntA1) which has no inward Mg2+ current (Preston and Kung, 1994b, Preston and Kung,
1994a). The XntA1 mutant (gift of Dr. R. Preston), was created by incubating a population of cells
in the mutagen N-methyl-N’-nitro-N-nitrosoguanidine followed by screening the cells for Mg2+
behavioral defects (Preston and Kung, 1994b). It is possible that during this incubation with the
mutagen, other genes may have been altered. The XntA protein is coined a magnesium-specific
channel-like exchanger (Haynes et al., 2002) that is specific to Paramecium and Tetrahymena.
Expression of the wild type XNTA gene cures the mutant, returning the Ca-dependent Mg2+
current (IMg(Ca)) to the cells and Mg2+-induced behavior (Haynes et al., 2002). Two other
swimming behavior changes that are displayed by the XntA1 mutant are long backward
swimming in high K+ and short backward swimming in Na/TEA (Supplement Table 3.I). These
were explained previously by a prolonged activation of the Ca2+ current and a quickly
deactivating Na+ current, respectively (Preston and Kung, 1994a). However, these other
phenotypes were not addressed when the mutants were expressing wild type XNTA. Therefore,
we are unsure if these behaviors are because of the premature truncation of XNTA in the mutant
making XntA a non-functional protein or other unknown mutations. For this reason, and
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because RNAi is a knock down, not a knock out, an RNAi construct to depleted wild type cells of
XNTA seemed an appropriate comparison for PKD2 depletion. The use of both the XNTA
depleted cells and the XntA1 mutant provide two useful comparisons for PKD2 depleted cells.
As shown in Figure 3.1A, the depletion of XNTA in the wild type background using
RNAi shows short backward swimming in Mg/TEA (2.4 ± 2.9 sec) compared to the control cells
(9.6 ± 4.2 sec), as expected. The XNTA depleted cells also showed long backward swimming in
high K+ and no change in behavior in Na/TEA, which was different than the XntA1 mutant
(Supplement Table 3.I). Figure 3.1A does not contain backward swimming data for the XntA1
mutants because these cells have no reaction in Mg/TEA. When both XNTA and PKD2 were
depleted at the same time, no additional decrease in backward swimming compared to the XNTA
depleted cells in Mg/TEA was observed. The PKD2 + XNTA depleted cells swam backward in
the Mg/TEA solution for 2.6 ± 3.9 seconds compared to 2.4 ± 2.9 seconds in the XNTA depleted
cells, but significantly shorter than the PKD2 depleted cells (4.8 ± 4.1 sec).
A second XntA1 mutant phenotype we investigated was the resistance of the mutant cells
to heavy metals. Exposure to heavy metals can cause a decrease in and paralysis of ciliary
motion (Naitoh, 1966). In mammalian cells, concentrations of 100 µM NiCl2 cause reduced
metabolism and ciliostasis of rat, guinea pig, and hamster tracheal explants with no obvious
changes in cell or ciliary morphology (Gabridge et al., 1982). Previous work on the Paramecium
XntA1 mutant demonstrated these mutants have some resistance to heavy metals. In the case of
NiCl2, XntA1 mutants are 10 times more resistant than the wild type cells to ciliary paralysis and
death (Preston and Kung, 1994b). Therefore, we compared the resistance to NiCl2 paralysis and
death of wild type cells, PKD2 and XNTA depleted wild type cells, and XntA1 mutants. The
results are shown in Figure 3.1B. Although other concentrations were tested (25, 50, and 250 µM
NiCl2), only 100 µM is shown here. Lower concentrations had little effect on the cells during the
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time tested (25 and 50 µM) and the highest concentration (250 µM) was too strong, leading to cell
death even in the XntA1 mutant. In Figure 3.1B, all data points at and after 90 minutes were
significantly different from the control cells fed the empty RNAi vector (L4440) (asterisk:
ANOVA, multiple comparison test, at least P<0.05). All samples at and after 150 minutes were
significantly different (P<0.001) compared to the control cells. There was no significant difference
between the survival rates of the PKD2 or XNTA depleted cells and the XntA1 mutants in 100 µM
NiCl2.
Over-expression phenotype
Voltage clamp experiments on wild type Paramecium have demonstrated that applying
physiological changes to the membrane in the presence of calcium and magnesium will cause a
robust inward current (1-2 nA) of Mg2+ (Haynes et al., 2002). The XntA1 mutants, under the same
conditions, elicit no inward Mg2+ current (Haynes et al., 2002, Preston and Kung, 1994b, Preston
and Kung, 1994a). If the XntA1 mutants are given the XNTA+/+ gene in a linear plasmid to
express, they show a return of IMg and Mg2+-induced backward swimming (Haynes et al., 2002).
We attempted to replicate these experiments by using the XntA1 mutant and wild type cells to
express epitope-tagged versions of XNTA and PKD2 or the FLAG epitope. We then examined
these expressing cells in a Mg/TEA solution. TEA can be applied externally in the bath to block
the fast-acting K+ conductance which counteracts the influx of calcium ions (Satow, 1978)
resulting in prolonged backward swimming. We are using the measurement of backward
swimming as measure of ion conductance by proxy.
XntA1 mutants expressing the FLAG plasmid show no Mg2+-induced behavior as shown
in Figure 3.2. XntA1 mutants over-expressing PKD2-FLAG show a slight return of backward
swimming in Mg/TEA, 0.7 ± 1.2 sec (N=60) that is significant compared to the XntA1 mutants
expressing FLAG (T-test, asterisk over the bar, P<0.001). XntA1 mutants expressing XNTA-FLAG
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show a strong return of Mg2+-induced behavior, swimming backward for 6.6 ± 4.8 sec (N=60)
which is significantly less than wild type cells expressing FLAG (9.5 ± 5.2 sec, N=165)(T-test,
P<0.001). These data suggest an incomplete curing of the mutant. No difference was observed
between wild type cells expressing FLAG and those expressing PKD2-FLAG (9.9 ± 6.0 sec, N=30).
Wild type cells expressing XNTA-FLAG showed an increase in Mg2+-induced behavior,
swimming backward for longer than the wild type cells expressing FLAG (14.5 ± 5.4 sec, N=78).
When FLAG was expressed on the N-terminus instead of the C-terminus of PKD2 in wild type
cells, Mg2+-induced behavior was inhibited. The expression of FLAG-PKD2 caused the cells to
swim backward for less time than all the other cell types (4.0 ± 3.2 sec, N=127), except the XntA1
mutants expressing FLAG or PKD2-FLAG. Wild type cells expressing FLAG-PKD2 swam
backward significantly longer than the XntA1 mutants expressing FLAG or PKD2-FLAG.
Localization and trafficking of Pkd2-FLAG and XntA-FLAG / XntA-myc
To localize the Pkd2 and XntA proteins, both immunofluorescence and
immunoprecipitation (IP) were used. To determine where Pkd2 and XntA reside, we isolated
and solubilized cell membrane (CM) and whole cilia (WC). The resulting eluate was separated
by SDS-PAGE followed by a transfer to Nitrocellulose paper. The resulting blots were probed
with the appropriate antibodies to recognize Pkd2 (Anti-FLAG) (Figure 3.3A) and XntA (Antimyc) (Figure 3.3B) from test (T) and control (C) samples. The control cells expressed the
appropriate small epitope, either FLAG or myc. Representative loading controls stained with
anti-tubulin demonstrate that the solubilization of the CM or WC began with approximately the
same amount of protein in the test and control samples (Figure 3.3C). The top panel (Figure
3.3A) shows IPs from cells expressing PKD2-FLAG or FLAG. The center panel (Figure 3.3B)
shows IPs from cells that were expressing XntA-myc or myc. Cell membrane IP’s are on the left
(CM IP) and whole cilia IP’s are shown on the right (WC IP).
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The Anti-FLAG antibody identified bands for Pkd2-FLAG on the CM IP blot at 98, 70,
and 55 kD in the test lane only (Figure 3.3A, upper left, black arrows). On the WC IP blot, AntiFLAG identified Pkd2-FLAG bands at 120, 98 and 70 kD (Figure 3.3A, upper right, black arrows).
While the expected size of Pkd2-FLAG is 100 kD, all of the bands have been identified as Pkd2
via LC-MS/MS analysis.
Anti-myc identified multiple XntA-myc bands on both the CM and WC IP blots (Figure
3.3B, grey arrows). The uppermost band in both the CM and WC IP was at 62 kD, which is the
expected size of XntA-myc. On the CM IP blot, there was a band present at 46 kD and both the
CM and WC IPs show bands at 37-38 kD (Figure 3.3B, grey arrows). Multiple bands are often
observed when IP’ing for XntA-myc. The same bands were observed when we IP’d from cells
expressing XNTA-FLAG (data not shown). The multiple bands for XntA-myc have not been
identified through LC-MS/MS analysis, but their identification with two different epitope tags
suggests they are XntA. No bands were present in the IP lanes from control cells except in the
XntA-myc IP blot from WC. This blot and the IP were both performed using rabbit anti-myc
antibodies which showed the heavy chain of the antibody at approximately 55 kD and a few
other non-specific bands in both the test and control lanes. These bands should be ignored.
For immunofluorescence, wild type or XntA1 mutant cells expressing FLAG or PKD2FLAG or XNTA-FLAG were isolated and stained for the basal bodies (Anti-centrin, gift of Dr.
Mark Winey, University of Colorado, Boulder, CO) and the FLAG epitope (Sigma). Figure 3.4
shows the results of the immunofluorescence in wild type cells (Figure 3.4A) or XntA1 mutants
(Figure 3.4B). The anti-centrin staining for the basal bodies serves as a sub-cellular reference
point. No FLAG staining was seen in the FLAG expressing control cells, which was expected.
There was no observable difference between the staining of Pkd2-FLAG and XntA-FLAG in the
wild type cells and the XntA1 mutants. In both cases, the XntA-FLAG and Pkd2-FLAG proteins
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(red staining) was clearly seen in the cilia and at the cell surface. The cells shown are
representative of the populations observed.
Pkd2 has been shown to require other proteins, or signals from those proteins, for its
trafficking to the cilia (Nauli et al., 2003) or the cell membrane (Hanaoka et al., 2000). The XntA1
mutants did not appear to have any differences in the localization of Pkd2-FLAG when
expressing this protein compared to wild type cells (see Figure 3.4). These data suggest that Pkd2
does not require XntA for ciliary or cell membrane localization. To confirm these findings, we
used immunofluorescence to examine wild type cells expressing PKD2-FLAG or XNTA-FLAG
depleted in XNTA or PKD2, respectively, using RNAi. The immunostained images are shown in
Figure 3.5. Included are negative control cells which are wild type cells expressing FLAG. They
show very little background staining (red). For a positive control, wild type cells expressing
PKD2-FLAG or XNTA-FLAG fed the empty RNAi vector L4440 (control) show red staining at the
cell surface and in the cilia indicating that Pkd2-FLAG and XntA-FLAG locate to those areas of
the cell. Cells expressing PKD2-FLAG or XNTA-FLAG depleted in XNTA or PKD2, respectively,
showed no change in the localization of the FLAG-tagged proteins compared to the respective
positive control cells. The efficacy of the depletion of XNTA or PKD2 using RNAi was tested
using Mg2+-induced behavior (backward swimming) of the depleted cells compared to both the
negative and positive control cells in Mg/TEA. In both PKD2 or XNTA depleted cells, Mg2+induced behavior was reduced compared to the positive and negative control cells, as indicated
by an asterisk (T-test, P<0.01) (Figure 3.5), indicating the RNAi was successful.
We have demonstrated here that Pkd2 and XntA do not require each other for trafficking
to the cell membrane or the cilia (Figure 3.4 and 3.5). We have demonstrated previously
(Valentine et al., 2012) and it has been shown in other studies that Pkd2 requires components of
the BBSome, a coat-complex of proteins, to traffic to the cilia but not to the cell surface
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(Hoffmeister et al., 2011, Valentine et al., 2012). The BBSome complex transports select proteins
from the Golgi to the cilia, such as the G-protein coupled Somatostatin receptor 3 (SSTR3) (Jin et
al., 2010, Klinger et al., 2014) and the potassium channel SK1a (Valentine et al., 2012). In order to
confirm that Pkd2 was reaching the cell membrane in Paramecium depleted of BBS components
and that Pkd2 was depleted from the cilia, Paramecium cells expressing PKD2-FLAG were
depleted in BBS8 using RNAi. We chose to deplete BBS8 because we did not expect ciliary
shortening or loss as observed in BBS7 or BBS9 depleted Paramecium (Valentine et al., 2012).
The cell membrane and cilia of paramecia expressing PKD2-FLAG or FLAG and treated
for RNAi were collected and solubilized for IP. The eluates were separated by SDS-PAGE,
transblotted, and developed using Anti-FLAG to compare the amount of Pkd2-FLAG in the cell
and ciliary membranes with control-fed cells expressing PKD2-FLAG and with negative control
cells expressing FLAG. We clearly show that Pkd2-FLAG is almost completely absent from the
cilia (Figure 3.6B) and is found in the cell membrane when BBS8 is depleted from the cells (Figure
3.6, black arrows).
To determine if there was an increase in band intensity in the test lanes (PKD2-FLAG
cells depleted in BBS8) compared to the positive control lanes, band intensities were normalized
to their respective tubulin loading controls. The normalized intensities were then compared
between the test lanes (cells expressing PKD2-FLAG depleted in BBS8) and the positive control
lanes (PKD2-FLAG fed empty vector RNAi). This was done for two separate experiments and the
data were pooled. There was a slight, but not significant, increase in the intensity of the Pkd2FLAG bands (120% ± 38%, n=6) in the test lane from the cell membrane IPs. In contrast and in
agreement with our previous work (Valentine et al., 2012), the IPs from whole cilia show that the
Pkd2-FLAG bands are decreased by 80% in the test lanes compared to the positive control cilia.
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These data confirm that Pkd2 requires BBS8, a component of the BBSome, to traffic to the cilia.
Pkd2 must rely on a different trafficking mechanism to reach the cell membrane.
A phenotype which we observe in paramecia depleted in BBS7, 8, or 9 is long backward
swimming in both Na/TEA and Mg/TEA. We attributed this prolonged backward swimming to
the absence of a rectifying K+ channel, SK1a (Valentine et al., 2012). The BBS8 depleted cells used
in the experiments also displayed this phenotype (Figure 3.6). The IP data demonstrate that Pkd2
was present in the cell membrane and mostly absent from the cilia. The BBS8 depleted cells are
still able to sufficiently depolarize in the presence of Mg2+, as seen by their Mg2+-induced
behavior.
Co-Immunoprecipitation and LC-MS/MS analysis
We asked whether the Pkd2-FLAG and XntA-myc proteins could co-IP, supporting a
direct or indirect interaction of these proteins. Cell membrane and whole cilia from wild type
cells expressing PKD2-FLAG and XNTA-myc alongside control cells expressing FLAG and myc
were solubilized for IP using FLAG affinity agarose followed by myc affinity agarose. Figure 3.7
shows the results of a representative FLAG IP followed by a myc IP from solubilized cell
membrane (Figure 3.7A) and whole cilia (Figure 3.7B). In both experiments, the FLAG affinity
agarose was exposed to the solubilized cell component first, then removed. The myc affinity
agarose was added to the supernatant second. The resulting nitrocellulose blots were probed
using antibodies against FLAG developed with enhanced chemiluminescence (ECL) or myc
developed using alkaline phosphatase to locate the Pkd2-FLAG and XntA-myc epitope-tagged
proteins. In both the IPs from solubilized cell membrane (3.7A) and solubilized whole cilia
(3.7B), the Pkd2-FLAG protein was clearly identified (upper left blots, black arrows). The same
multiple bands were seen in the Pkd2-FLAG IP (120, 98, and 70 kD) as shown in Figure 3.3.
These bands have all been positively identified as Pkd2 using LC-MS/MS analysis. (In a
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previous experiment, these size fragments were sent for LC-MS/MS analysis from a silver
stained gel. The peptide sequences confirmed that the majority of the protein in those lanes was
Pkd2.) From both the cell membrane and the whole cilia, the FLAG IP for Pkd2-FLAG did not coIP the XntA-myc protein (lower left blots in Figure 3.7A and 3.7B). However, the consecutive IP
from the same supernatant using the myc affinity agarose isolated both the XntA-myc protein
(lower blots, right hand side in Figure 3.7A and B) and the Pkd2-FLAG protein (upper blots on
the right in Figure 3.7A and B). These results demonstrate that the XntA-myc protein and the
Pkd2-FLAG protein co-IP, but only when we use the myc affinity agarose to IP XntA-myc.
In an attempt to identify novel candidate interacting partners for Pkd2, we used cell
membrane or whole cilia from wild type cells expressing PKD2-FLAG or FLAG followed by
solubilization, IP, and LC-MS/MS analysis. We used two different buffers for our cilia IPs and
only the IP500 buffer for the cell membrane IP. We used IP500 buffer, a high sodium buffer,
because it was used to demonstrate the association of Pkd2 with TRPC1 (Tsiokas et al., 1999).
The other buffer, Lap200 (a high potassium buffer), had been used previously to solubilize the
Pkd2 protein from whole cilia. Our goal was to successfully solubilize the Pkd2 protein, which
can remain attached to the axoneme as in Chlamydomonas (Huang et al., 2007, Pazour et al., 2005),
while maintaining protein-protein interactions. IP eluates were separated by SDS-PAGE, silver
stained, and the entire lane of resulting proteins from both the test and control samples were
processed with trypsin for analysis. Resulting peptides were run against a database of
Paramecium proteins. Identified proteins found in both the test and control samples were
removed from the analysis. Proteins reported are unique to the test lane.
Shown in Figure 3.8 is a Venn diagram of the distribution of the identified proteins in the
different preparations. Thirty-one proteins were identified in the cell membrane IP and 20 and 50
proteins were identified in the whole cilia Lap200 and IP500 buffer IPs, respectively. Of these,
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the Pkd2 protein was found in all three preparations, five proteins overlapped in the two cilia IPs
and an additional five overlapped between the cell membrane IP and the two cilia IPs (Figure
3.8A). This small number of proteins that co-IP’d from both the cell membrane and the cilia was
expected due to the differences in the composition of the cell membrane and the cilia (Rhoads
and Kaneshiro, 1979, Machemer and Ogura, 1979). In total, 89 unique proteins were identified in
the two membranes. The types of proteins identified in the two membranes are shown in Figure
3.8B and C. In the two types of membranes, almost half the proteins identified (~45%) were
identified as “hypothetical” meaning they have no assigned function. This is not a surprising
find since approximately 40% of the annotated proteins of Paramecium are uncharacterized, most
are species-specific (Zagulski et al., 2004) as in the case of XntA. A complete list of the proteins
identified, including peptide number, accession number and protein descripting, are found in
Supplement Table 3.II. Notable identified proteins include three intraflagellar transport proteins
found in the cilia IPs (IFT 52, 72/74, 81) (GSPATP00006050001, PTETP1200013001, and
GSPATP00033046001). We identified a homologue to the Drosophila protein mutated in lost boys
(lobo) (GSPATP00001683001), also known as CG34110, that is a conserved flagellar protein which
has been shown to interact with Drosophila Pkd2 (Yang et al., 2011). We also identified numerous
dyneins (GSPATP00002701001, GSPATP00038423001, GSPATP00029949001, to name a few)(see
Supplement Table 3.II for a complete list). Note that the XntA protein was not identified in any
of the LC-MS/MS experiments.
Electrophysiology and Membrane Potential (Vm)
To confirm the importance and contribution of the Pkd2 and XntA1 proteins to Mg2+induced behavior in Paramecium, electrophysiology was employed to measure membrane
potential (Vm) changes in ciliated and deciliated cells. The changes in membrane potential (∆Vm)
were calculated by first determining the resting Vm in 1 mM KCl in buffer followed by the newly
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established resting Vm in 0.5 mM MgCl2 with 1 mM KCl in buffer. The difference between these
two Vm’s is the calculated ∆Vm. Previous work has shown that wild type cells depolarize by ~10
mV in the presence of 0.5 mM MgCl2 while XntA1 mutants depolarize by 1 ± 7 mV (N=5) in the
same concentration of Mg2+ (Preston and Kung, 1994a). These previous data prompted us to use
0.5 mM MgCl2 for our recordings. We used cells depleted of XNTA, PKD2, or BBS8 or cells overexpressing the FLAG or PKD2-FLAG plasmid. These data are presented as averages ± standard
deviation (mV) while the histograms (Figure 3.9A and 3.9B) depict averages ± SEM. Table 3.I
includes the average ∆Vm of cells ± standard deviations and the results of Mg2+-induced behavior
for those cells compared to the appropriate controls (backward swimming phenotypes). Table
3.II provides the ∆Vm’s from deciliated cells. We are using ∆Vm as cells were changed between
solutions with and without Mg2+ as a proxy for membrane permeability to Mg2+. We have not
measured membrane permeability or conductance directly. A positive ∆Vm is a depolarization of
the cell, therefore we will refer to these changes as depolarizations. A negative ∆Vm is a
hyperpolarization of the cell, which we did not observe in this study.
We first replicated previous findings of ciliated wild type and XntA1 mutant cells
(Preston and Kung, 1994a). Our data show wild type cells depolarized by 9.8 ± 1.6 mV (N=5) and
the XntA1 mutant cells showed little depolarization in Mg2+ (1.2 ± 2.2 mV, N=7) (Figure 3.9A).
Wild type cells depleted in PKD2 and XNTA showed significantly less depolarization that the
wild type cells, 6.9 ± 3.4 mV (N=9) and 4.7 ± 4.9 mV (N=7), respectively. Wild type cells overexpressing FLAG showed no change in depolarization compared to the wild type cells. Wild
type cells over-expressing PKD2-FLAG depolarized twice as much, 20.9 ± 3.2 mV (N=6),
significantly more than all other cell types presented in Figure 3.9A (ANOVA, individual T-test’s,
P<0.01).
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When we examined the XntA1 mutants, the mutants expressing FLAG, and those
depleted in PKD2 showed almost no depolarization compared to the XntA1 mutants (Table 3.I
and Figure 3.9A). Interestingly, the XntA1 mutants over-expressing PKD2-FLAG showed a
robust depolarization, no different than the depolarization seen in wild type cells (11.9 ± 3.6 mV,
N=6 compared to 9.8 ± 1.6 mV, N=5).
Wild type and XntA1 mutants depleted in BBS8 were then tested for ∆Vm to examine the
contribution of Pkd2 at the cell membrane with and without the XntA protein to Mg2+-induced
depolarization. We have demonstrated that cells depleted in BBS8 have little to no Pkd2 protein
in their cilia and are able to swim backward in Mg2+ solutions, suggesting there is sufficient Pkd2
in the cell membrane for IMg(Ca) by proxy. In both wild type and XntA1 mutants depleted of BBS8,
a larger depolarization was observed compared to their respective controls. Wild type ∆Vm was
increased from 9.8 ± 1.6 mV (N=6) to 12.7 ± 2.4 mV (N=6) when BBS8 was depleted. Surprisingly,
the ∆Vm of the XntA1 mutant was increased from 1.2 ± 2.2 mV (N=7) to 6.5 ± 0.8 mV (N=3) (both
P<0.05, ANOVA, T-tests).
To tease apart the contributions of the cilia and the cell membrane to Vm, we recorded
from deciliated cells. Paramecia are easily deciliated in 5 mM KCl with 5% ethanol with mild
trituration which has no effect on the resting membrane potential of the cells (Machemer and
Ogura, 1979). The amount a deciliated Paramecium cell depolarizes in the presence of 0.5 mM
MgCl2 has not previously been published. Surprisingly, the deciliated wild type cells showed a
depolarization of 17.9 ± 3.8 mV (N=5) and the deciliated XntA1 mutants, 15.7 ± 6.8 (N=8). There
is no statistical difference between these values (See Table 3.II and Figure 3.9B). It should be
noted that the deciliated wild type cells depolarize by the same amount as the ciliated BBS8
depleted wild type cells (12.7 ± 2.4 mV, N=6 compared to 17.9 ± 3.8, N=5, P=0.054, T-test).
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The only changes in depolarization we observed compared to the deciliated wild type
cells and deciliated XntA1 mutants were seen in the wild type cells depleted in PKD2 (10.3 ± 5.3
mV, N=4), the wild type cells over expressing PKD2-FLAG (23.9 ± 4.7 mV, N=4), and the XntA1
mutants depleted in PKD2 (2.9 ± 3.2 mV, N=4) (P<0.05, ANOVA, T-test). The XntA1 mutants
over-expressing PKD2-FLAG showed no change compared to the XntA1 cells expressing FLAG
(See Table 3.II). We did observe that the XntA1 mutants depleted in BBS8 depolarized by 10.1 ±
3.4 mV (N=6) which was less depolarization than the wild type cells (17.9 ± 3.8 mV, N=5) and
wild type cells depleted in BBS8 (20.3 ± 4.2 mV, N=4). However, the deciliated XntA1 mutants
depleted in BBS8 depolarize by the same amount as the deciliated XntA1 mutants (See Table 3.II).
Lastly, deciliated PKD2 depleted XntA1 mutants showed almost no depolarization, 2.9 ±
3.2 mV (N=4), which is significantly less than the other deciliated cells (P<0.01, ANOVA, T-tests)
and is not significantly different than the ciliated XntA1 mutant cells (P=0.455, T-test) or the
ciliated XntA1 cells depleted of PKD2 (P=0.92, T-test).

Discussion
The depletion of PKD2 produces phenotypes that resemble, but do not copy, XntA1
mutant phenotypes. The main XntA1 phenotypes are a lack of IMg(Ca) and resistance to NiCl2
ciliary paralysis (Preston and Kung, 1994b, Preston and Kung, 1994a). These phenotypes were
both demonstrated by PKD2 or XNTA depleted cells, suggesting reduced IMg(Ca). PKD2 depleted
cells showed changes in Mg2+ solutions only, suggesting a Mg2+-specific role for Pkd2. The
mutants and XNTA depleted cells also showed long backward swimming in high K+, presumably
due to a slow deactivation of the Ca2+ current (Preston and Kung, 1994b). This may suggest a role
for XntA in Ca2+-regulation, which IMg relies on, although further investigation is needed.
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Deciliated cells and pawn B mutants, both lacking the voltage-gated calcium channels of the cilia,
do not elicit an IMg(Ca) (Preston, 1990, Preston and Kung, 1994a, Preston, 1998). We have not
measured conductance directly, but used ionic stimuli to prolong the AP of cells causing
prolonged backward swimming which we used as a proxy for ionic conductance. The short
backward swimming in Mg2+ suggests a reduced, but not eliminated, IMg(Ca) in PKD2 and XNTA
depleted cells.
Both Pkd2 and XntA are located in the cell membrane and the cilia, but do not require
each other for trafficking to these membranes. Paramecium Pkd2 does not require XntA or a
signal from XntA to traffic to the cilia or the cell membrane, as Pkd2 does in some other cell types
(Hanaoka et al., 2000, Nauli et al., 2003). These proteins appear more akin to the C. elegans
proteins PKD2 and LOV1 than mammalian Pkd2 and Pkd1. In C. elegans, PKD2 and LOV1 act in
the same pathway for mating behavior, but traffic independently (Barr et al., 2001). In the case of
Paramecium, Pkd2 and XntA contribute to Mg2+-induced behavior and also traffic independently.
When we IP XntA-myc, Pkd2-FLAG co-precipitates but not vice versa. The potential
interaction of XntA-myc and Pkd2-FLAG probably blocks the C-terminal FLAG epitope
preventing the reciprocal IP. We were able to IP Pkd2-FLAG from the same supernatant but
XntA-myc does not co-IP, suggesting a second population of Pkd2 with an unobstructed FLAG
epitope. Our analysis of co-IP proteins from Pkd2-FLAG IPs contained no XntA peptides and
few proteins with transmembrane domains. Human Pkd2 has been shown to interact with other
transmembrane proteins at both its N- and C- terminus (Feng et al., 2011). In an attempt to co-IP
transmembrane proteins and possibly XntA, we expressed Pkd2 with the FLAG tag on the Nterminus but unfortunately, Mg2+-induced behavior was disrupted. We propose two populations
of Pkd2-FLAG, one with a FLAG epitope that is blocked from interactions with other proteins
and one with FLAG available for interactions with other proteins and IP.

154

Our measurements by proxy of membrane permeability to Mg2+ by observing ∆Vm when
cells were changed between solutions with and without Mg2+ helped to tease apart the
contributions of Pkd2 and the cilia to Mg2+ permeability. A summary of our findings can be seen
in Figure 3.10. We found that our depletion of XNTA or PKD2 produced phenocopies of the
mutant, showing less depolarization compared to wild type cells. These data imply a reduced,
but not eliminated, membrane permeability to Mg2+. These data, combined with the short
backward swimming data we presented for these depleted cells as a proxy for studying IMg(Ca),
newly implicate the Pkd2 protein in both Mg2+ permeability and conductance.
Over-expression of PKD2 showed an increase in Mg2+ membrane depolarization and
Mg2+-induced behavior in both the wild type cells and mutants. Expression of PKD2-FLAG in
XntA1 mutants restores the amount the membrane depolarizes in Mg2+ to normal wild type
levels. Therefore, even without the XntA protein present, the Pkd2 expressed protein allows for
Mg2+ depolarization and a return of Mg-induced behavior. These data imply that Pkd2 is
responsible for Mg2+ permeability and that over-expressing Pkd2 in a system without XntA
returns some IMg(Ca).
We became interested in the reaction of deciliated cells when we observed that BBS8
depletion showed no Pkd2 in the cilia and yet retained Mg2+-induced behavior (Valentine et al.,
2012). Our ∆Vm in deciliated cells surprisingly showed that not only did deciliated wild type
cells depolarize more than ciliated cells in Mg2+, but that both deciliated XntA1 mutants and
XNTA depleted cells depolarized as much as deciliated wild type cells. With no functional XntA
protein, our expectation was that, ciliated or not, the XntA1 mutants and the XNTA depleted cells
would not depolarize. Interestingly, ciliated wild type cells depleted of BBS8 demonstrated the
same amount of depolarization as a deciliated wild type cell. These results suggest that Pkd2,
when restricted to the cell membrane, is no longer “repressed” or negatively regulated by XntA
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in the cilia. These data also suggest that XntA is not a Mg2+ channel, that Pkd2 in the cell
membrane, or possibly another protein in the cell membrane, is able to become active when the
cilia are removed.
Our proposal that Pkd2 is the Mg2+ channel in Paramecium is further supported by the
over-expression of PKD2-FLAG in both the wild type and the mutants. In ciliated overexpressing cells we observed larger depolarizations, although we had mixed results for the
deciliated cells. Over-expression in the deciliated XntA1 mutants did not additively increase the
depolarization in Mg2+ solutions over the effects of deciliation alone, which caused unexpectedly
high depolarization by itself. Conversely, the depletion of PKD2 in deciliated wild type cells
reduced the depolarization in Mg2+ as it did in ciliated wild type cells, but the reduction of PKD2
in the mutants significantly decreased the depolarization to almost none.
The outcomes of these studies leads to our proposal that Pkd2 is both necessary and
sufficient for apparent Mg2+ permeability and inferred IMg(Ca) suggesting Pkd2 is the Mg2+
channel. XntA, thought to be the Mg2+ channel or transporter, when mutated or depleted in
ciliated cells, leads to a loss of Mg2+ depolarization and IMg(Ca). These losses can be overcome with
the over-expression of PKD2, restriction of Pkd2 to the cell membrane by BBS8 depletion, or
deciliation. In these cases, Pkd2 is able to act alone and effect larger depolarizations. We have
established that Pkd2 and XntA can interact directly or indirectly in both the cell membrane and
cilia. Although, these interactions are not necessary for Mg2+ depolarization and IMg(Ca). This
story seems straight forward, but it doesn’t end here. There’s a role for cilia in Mg2+ permeability
and conductance. Our model is the following:
•

Pkd2 is in the cilia and the cell membrane and is the channel responsible for the
IMg(Ca).
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•

Pkd2 in intact cells is somehow negatively regulated by ciliary XntA, reducing Pkd2
channel activity.

•

Loss of XntA in ciliated cells leads to a loss of Pkd2 Mg2+ channel activity because
XntA1 positions Pkd2 in microdomains for function or regulates Pkd2 function by
direct or indirect interactions.

•

In XntA1 mutants, the XntA protein is lost from the cell, but Pkd2 is not.
Depolarization and IMg(Ca) are lost as part of the mutant phenotype. Why does Pkd2
not function as a channel in these cells until the cilia are removed?

Deciliation or BBS8 depletion limits the Pkd2 protein to the cell membrane where its activity is
increased in wild type cells due to mass action (concentration inside and outside microdomains.)
Deciliation of the XntA1 mutant suggests that this Pkd2 is free to be active without encumbrance
by XntA1. Deciliated XntA1 mutants with depleted PKD2 show almost no depolarization,
consistent with this model.
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Table 3.I. Changes in membrane potential (∆Vm) for ciliated cells in 0.5 mM MgCl2 + 1 mM
KCl compared to 1 mM KCl and results for Mg2+-induced behavior of the cells in Mg/TEA.
0.5 mM MgCl2 +

Mg2+-induced

1 mM KCl, mV (N)

behavior

∆Vm , wild type

9.8 ± 1.6 (5)^

Normal

∆Vm , XntA1 mutant

1.2 ± 2.2 (7)**

None

∆Vm , wild type XNTA RNAi

4.7 ± 4.9 (7)*

Reduced

∆Vm , wild type PKD2 RNAi

6.9 ± 3.4 (9)*,^

Reduced

∆Vm , wild type expressing FLAG

10.8 ± 2.8 (6)

Normal

∆Vm , wild type expressing PKD2-FLAG

20.9 ± 3.2 (6)†

Normal

∆Vm, XntA1 PKD2 RNAi

3.1 ± 1.8 (4)**

None

∆Vm, XntA1 expressing FLAG

2.0 ± 3.2 (6)**

None

∆Vm, XntA1 expressing PKD2-FLAG

11.9 ± 3.6 (6) ^^

Slight reaction

∆Vm , wild type BBS8 RNAi

12.7 ± 2.4 (6) *, ^^

Increased

∆Vm, XntA1 BBS8 RNAi

6.5 ± 0.8 (3)*,^

Slight reaction

0

Data are averages ± standard deviation (N) in mV. ∆Vm is calculated by subtracting the resting
membrane potential of the cell in 1 mM KCl from the newly established membrane potential in
0.5 mM MgCl2 with 1 mM KCl. Cells were allowed 4 minutes in the solution before Vm was
noted, recordings were continuous. * And ** = significantly different compared to wild type cells,
P<0.05 and P<0.01, respectively. ^ And ^^ = significantly different compared to XntA1 mutant
cells, P<0.05 and P<0.01, respectively. †= significantly different from all other cell types listed,
P<0.01. Mg2+-induced behavior describes the backward swimming phenotype of the cell type in
Mg/TEA compared to the appropriate control cells.
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Table 3.II. Changes in membrane potential (∆Vm) for deciliated cells in 0.5 mM MgCl2 + 1 mM
KCl compared to 1 mM KCl.
0.5 mM MgCl2 +
1 mM KCl (mV, N)
∆Vm , wild type

17.9 ± 3.8 (5)

∆Vm , XntA1 mutant

15.7 ± 6.8 (8)

∆Vm , wild type XNTA RNAi

20.0 ± 7.5 (5)

∆Vm , wild type PKD2 RNAi

10.3 ± 5.3 (4)*

∆Vm , wild type expressing FLAG

17.4 ± 1.7 (5)

∆Vm , wild type expressing PKD2-FLAG

23.9 ± 4.7 (7)*,^

∆Vm, XntA1 PKD2 RNAi

2.9 ± 3.2 (4)**,^^

∆Vm, XntA1 expressing FLAG

14.0 ± 1.5 (4)

∆Vm, XntA1 expressing PKD2-FLAG

16.0 ± 4.0 (4)

0
∆Vm , wild type BBS8 RNAi

20.3 ± 4.2 (4)

∆Vm, XntA1 BBS8 RNAi

10.1 ± 3.4 (6)*

Data are averages ± standard deviation (N) in mV. ∆Vm is calculated by subtracting the resting
membrane potential of the cell in 1 mM KCl from the newly established membrane potential in
0.5 mM MgCl2 with 1 mM KCl. Cells were allowed 4 minutes in the solution before Vm was
noted, recordings were continuous. * And ** = significantly different compared to wild type cells,
P<0.05 and P<0.01, respectively. ^ And ^^ = significantly different compared to XntA1 mutant
cells, P<0.05 and P<0.01, respectively.
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Figure 3.1. Depletion of PKD2 results in a phenotype similar to XntA1 mutant cells.(A)
Backward swimming times of wild type cells fed the control RNAi vector (L4440), depleted in
PKD2, XNTA or both PKD2 and XNTA in Mg/TEA solution. Data are averages ± standard error
of the mean (SEM), N=60 to 77 cells in at least 3 separate experiments. Asterisks indicate
significance compared to the control-fed cells (P<0.001, Mann-Whitney U test) and caret with line
indicates the PKD2 depleted cells showed longer backward swimming compared to the single
depleted XNTA cells and the double depleted PKD2 + XNTA cells (P<0.001, Mann-Whitney U
test). (B) Percent of wild type cells fed L4440 (control) or depleted in PKD2 or XNTA or XntA1
mutants still swimming in 100 µM NiCl2 over time. Data points are average number of cells
swimming compared to the starting number of cells in each depression ± SEM. Data are 3
depressions per experiment, at minimum 3 experiments (9 to 21 counts per time point per cell
type). Significance is seen at and after 90 minutes (asterisk over the line) when compared to the
control cells (ANOVA, multiple comparison test, P<0.05 at minimum). Time points at and after
150 minutes are P<0.001 (ANOVA, multiple comparison test).
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Figure 3.2. Over-expression of FLAG-tagged genes and the effect on Mg2+-induced behavior in
wild type and XntA1 mutant cells. XntA1 mutants and wild type cells over-expressing PKD2FLAG or XNTA-FLAG or the control plasmid (FLAG) were observed for backward swimming in
Mg/TEA. All data seconds ± standard error of the mean, N=30 to 165. An asterisk over a bar
indicates significant differences between samples (ANOVA, multiple T-tests, P<0.001). Caret
indicates the wild type cells expressing FLAG-PKD2 swim backward for significantly less time
compared to all other cell types except the XntA1 mutants expressing PKD2-FLAG or FLAG. No
bar is present for the XntA1 mutants expressing FLAG because these cells do not react to
solutions with Mg2+. Actual backward swimming times (sec) ± SD and sample sizes (N) are
shown in the table on the right.
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Figure 3.3. Immunoprecipitations of Pkd2-FLAG and XntA-myc from cell membrane (CM) and
whole cilia (WC). Proteins were isolated from solubilized cell membrane (CM) or whole cilia
(WC) of test cells (T) expressing (A) PKD2-FLAG or (B) XNTA-myc and the respective controls
cells (C) expressing FLAG or myc. Blots were developed using Anti-FLAG (A, top panel; Pkd2FLAG) or Anti-myc (B, center panel; XntA-myc). A representative set of tubulin loading controls
(C, Anti-tubulin, bottom panel) is included. (A) Anti-FLAG identified bands for Pkd2-FLAG
(black arrows) at 120 kD (WC only), 98 kD and 70 kD (both WC and CM) and 55 kD (CM only).
The expected size of Pkd2-FLAG is 100 kD. (B) Anti-myc identified bands for XntA-myc (center
panel, grey arrows) at 62 kD, which is the expected size of XntA-myc (61.5 kD). Anti-myc
identified smaller fragments of XntA-myc at 46 kD (CM IP) and 37-38 kD (both CM and WC IPs).
The robust bands in the WC IP at ~55 kD which are present in both the C and T lane for XntAmyc are antibody heavy chain; the IP and immunoblot were both done using primary antibodies
produced in rabbit, and therefore should be ignored.
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Figure 3.4. Immunolocalization of Pkd2-FLAG and XntA-FLAG in wild type cells and XntA1
mutants. Wild type (A) or XntA1 mutants (B) expressing FLAG (control cells, top row), PKD2FLAG (center row) or XNTA-FLAG (bottom row). Centrin, shown in green, localizes the basal
bodies and is a sub-cell membrane marker. FLAG staining can be seen in red. Also included is
the merge image. Small amounts of non-specific FLAG staining can be seen in the control cells
expressing FLAG. Scale bars are 15 µm; these cells are representative images of the population.
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Figure 3.5. Immunofluorescence of wild type cells expressing PKD2-FLAG or XNTA-FLAG
depleted in XNTA or PKD2, respectively. Wild type cells expressing FLAG, PKD2-FLAG or
XNTA-FLAG were fed the empty RNAi vector, L4440 (control) or were depleted in XNTA (PKD2FLAG expressing cells) or PKD2 (XNTA-FLAG expressing cells). Anti-FLAG (red) shows
expressed proteins (Pkd2-FLAG or XntA-FLAG); Anti-centrin (green) marks the basal bodies just
below the cell surface. Images are stacks of 20 to 30 Z sections (~ 10 to 15 µm thick), cells shown
are representative of the population. Scale bars are 15 µm. Before immunostaining, cells were
tested for Mg2+-induced behavior in Mg/TEA to examine efficacy of RNAi. Graphs for each cell
type are shown below images. Columns indicate average backward swimming time in seconds ±
SEM, N=45 to 105 cells. Asterisk indicates significantly shorter backward swimming compared to
the control cells (T-test, P<0.01).
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Figure 3.6. Depletion of BBS8 shows Pkd2-FLAG is present at the cell surface in the cell
membrane but is absent from the cilia. Cells expressing FLAG were fed the empty RNAi vector
L4440 (negative control) and cells expressing PKD2-FLAG were fed L4440 (positive control) or
were depleted in BBS8 (test cells). Type of RNAi and plasmid being expressed are shown below
the blots. Cell membranes (A) or whole cilia (B) were isolated, solubilized and used for IP. Blots
were developed with Anti-FLAG using alkaline phosphatase (A) or enhanced
chemiluminescence (B). Black arrows indicate Pkd2-FLAG protein from cell membrane (A) test
cells (~120, 100, and 70 kD) depleted in BBS8. Tubulin loading controls are present below
indicating equal amounts of protein were solubilized before IP. Cells were tested for Mg2+induced behavior to test the efficacy of the RNAi. Cells isolated for the cell membrane or whole
cilia showed longer backward swimming compared to the negative control cells as expected in
Na/TEA and Mg/TEA (asterisk: T-test, P<0.01).
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Figure 3.7. The XntA-myc protein can co-IP Pkd2-FLAG from solubilized cell membrane (A)
and whole cilia (B). Isolated cell membrane (A) or whole cilia (B) were solubilized for IP from
cells expressing PKD2-FLAG and XNTA-myc (TEST) or the FLAG and myc epitopes (control).
The resulting immunoblots were probed for the FLAG epitope (upper blots, Pkd2-FLAG, black
arrows) followed by stripping the blots and probing for the myc epitope (lower blots, XntA-myc,
grey arrows). The myc IP from both cell membrane and cilia show the heavy chain of the
antibody at 50 kD (blots and IP were performed using antibody produced in rabbit.) IP for Pkd2FLAG did not produce XntA-myc (Anti-myc blots, lower blots in A and B, left side.) IP for XntAmyc produced the Pkd2-FLAG protein in both the cell membrane and the cilia (upper right blots
in both A and B.) Below are tubulin loading controls, samples were removed before
solubilization to demonstrate TEST and control samples had approximately equal concentrations
of proteins before solubilization.
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Figure 3.8. Types of proteins identified in IPs for Pkd2-FLAG from cell membrane and cilia
using LC-MS/MS. A total of 89 unique proteins were identified in three separate experiments. A
breakdown of the proteins identified in the three preparations can be seen in the Venn diagram in
(A). The one peptide identified in all three preparations was Pkd2. The types of proteins
identified in the cell membrane IP (B) and whole cilia IPs (C) are included. Two cilia Pkd2-FLAG
IPs using different buffers were combined to create the chart for cilia (C). Including Pkd2, 31
proteins were identified in the cell membrane IP and 69 proteins were identified in the two cilia
IPs. A complete list of the identified proteins can be seen in Supplement Table II.
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Figure 3.9. Changes in membrane potential for ciliated (A) and deciliated (B) cells. Data are
presented as average mV ± SEM (N are between 3 and 7 for each cell type). ∆Vm were obtained
by comparing the resting membrane potential of the cells in the control solution of 1 mM KCl
compared to the newly established membrane potential in the test solution of 0.5 mM MgCl2 with
1 mM KCl. Some data sets are repeated on the graphs for comparison. Wild type is abbreviated
WT and XntA1 mutant is XntA1. RNAi depletion (PKD2, XNTA, BBS8) follows the cell type or
the gene being over-expressed (PKD2-FLAG or FLAG). Asterisk with bars indicates statistical
significance (at least P<0.05, T-test). Caret indicates statistically different compared to all other
cell types, P<0.01, T-test, except in the case of the deciliated cells. (The deciliated WT cells
expressing PKD2-FLAG do not depolarize more than the WT cells depleted in BBS8.) All ∆Vm’s
for these cell types, both ciliated and deciliated, are shown in Table I and Table II, respectively.
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Figure 3.10. Summary of findings from electrophysiology. A summary of our findings from
membrane potential recordings of ciliated and deciliated cells in 1 mM KCl solution with and
without 0.5 mM MgCl2. The cell type is described and depicted with proteins present, absent, or
depleted. Deciliated cell results are summarized in the boxed out area. Changes in
depolarization can be seen to the right of each image showing increases or decreases in
membrane permeability to Mg2+. Ciliated XntA1 mutants and deciliated XntA1 mutants depleted
in PKD2 show almost no membrane permeability to Mg2+, shown by a straight line. Our
conclusions (blue box) are that the concentration of the Pkd2 channel in the cell membrane and
ciliary membrane and the presence or absence of the cilia and XntA protein impact the
permeability of the Pkd2 channel. These data summarize our findings and support our proposal
of the Paramecium Pkd2 channel being responsible for membrane Mg2+ permeability.
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Supplement Table 3.I. Normalized backward swimming in ionic stimuli of different depleted
cells.
30 mM KCl

25 mM TEA / 10 mM

25 mM TEA / 5 mM

NaCl

MgCl2

Control

100% ± 20.99% (107)

100% ± 35.52% (103)

100% ± 57.63% (102)

PKD2

86.18% ± 31.35% (61)

92.25% ± 32.21% (63)

46.42% ± 36.42% (68) *

XNTA

120.13% ± 33.72% (62)*

81.74% ± 37.03% (62)

25.05% ± 30.0% (66)*

XntA1 mutant

284.24% ± 51.48% (60)*

33.35% ± 11.68% (40)*

0 ± 0% (65)*

Asterisk indicates statistically significant, Students T-Test (P<0.001) compared to the control cells.
Bold red indicates shorter than the control cells and bold blue indicates longer than the control
cells.
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Supplement Table 3.II. Pkd2-FLAG co-IP proteins from two whole cilia IP’s and one cell
membrane IP
Cell Membrane IP500 Buffer

Protein ID*

Protein Description

G_00005599001
G_00004235001

PKD2
Hypothetical Protein - huge
extracellular domain
Hypothetical Protein - cell
adhesion
Hypothetical Protein concanavalin-A like lectin
Hypothetical Protein
Hypothetical Protein
Hypothetical Protein - ER to
Golgi transport Kinesin
Dynein heavy chain
2-oxoglutarate
dehydrogenase
2-oxoglutarate
dehydrogenase
Alanyl aminopeptidase
Hsp70Pt08
Hsp70Pt07
Hsp70Pt01
PCM2 (Paramecium CaMbinding membrane-bound
protein 2)
Hsp70
Succinate dehydrogenase
Hypothetical Protein Nucleotide binding
Hypothetical Protein possible protein peptidase
M16 family
PCM1 (Paramecium CaMbinding membrane-bound
protein 1)
Hypothetical Protein
Glyceraldehyde 3phosphate dehydrogenase
Hypothetical Protein
Isocitrate dehydrogenase

G_00002466001
G_00002468001
G_00006905001
G_00032017001
G_00029381001
G_00029949001
G_00020020001
G_00006583001
G_00019968001
G_00027959001
P_4000011001
P_3300001001
P_14200002001

G_00021676001
G_00035998001
G_00006368001
G_00012178001

G_00029566001

G_00006971001
G_00013616001
G_00012836001
G_00023050001

Mol.
Mass
99 kD
436 kD

Predicted
TM
domains
6
1

110 kD

# Peptides Found
Control
TEST

0
0

14
14

0

0

3

530 kD

0

0

3

136 kD
143 kD
116 kD

1
0
0

0
0
0

3
4
3

215 kD
113 kD

0
0

0
0

2
2

115 kD

0

0

2

112 kD
72 kD
72 kD
72 kD
70 kD

1
0
0
0
0

0
0
0
0
0

2
30
14
15
2

72 kD
70 kD
56.8 kD

0
0
0

0
0
0

2
2
2

52.5 kD

0

0

2

70.5 kD

0

0

2

42.7 kD
39.8 kD

1
0

0
0

2
2

43.5 kD
37.6 kD

1
0

0
0

2
2
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G_00036831001
G_00012123001
G_00030389001
G_00032183001
G_00032072001
G_00030301001
G_00032993001

Tubulin beta-1 chain
49.5 kD
0
0
Hypothetical Protein
31.4 kD
0
0
Hypothetical Protein
23.5 kD
0
0
Hypothetical Protein
21.7 kD
1
0
Hypothetical Protein
22.5 kD
2
0
Hypothetical Protein
27.5 kD
0
0
ADP/ATP translocase
58.8 kD
3
0
*Protein ID G_ = ID begins with GSPATP, Protein ID P_ = ID begins with PTETP.

3
2
3
2
2
2
2

Whole Cilia IP500 Buffer

Accession #*

Protein Description

G_00005599001
G_00012627001
G_00002701001

PKD2
Hypothetical Protein
Dynein Heavy chain
protein (Tetrahymena)
Hypothetical Protein
Dynein heavy chain
Dynein Heavy chain
protein (Tetrahymena)
Dynein Heavy chain
protein family
(Tetrahymena)
Ubiquitin Family protein
Hypothetical Protein ATPase/transposase
Dynein heavy chain
family protein
Hypothetical Protein
Ubiquitin Family protein
Hypothetical Protein conserved : coiled-coil
domain (possible
CG34110)
Hypothetical Protein TPR domain containing
protein
Hypothetical Protein WD-40 repeats
Hypothetical Protein ATPase/transposase
Radial spoke protein
Hypothetical Protein

G_00017360001
G_00038423001
G_00038424001
G_00002700001

P_700012001
G_00020971001
G_00029949001
G_00008392001
P_1100012001
G_00001683001

G_00032013001

G_00022879001
G_00020972001
G_00023151001
G_00002137001

Mol.
Mass
99 kD
437.6 kD
231.5 kD

Predicted
TM domains
6
8
0

380.3 kD
307.5 kD
50.8 kD

# Peptides Found
Control
TEST
0
0
0

8
6
5

0
0
0

0
0
0

4
3
3

203.5 kD

0

0

3

92 kD
10 kD

0
0

0
0

3
3

214 kD

0

0

3

177 kD
97.8 kD
99 kD

0
0
0

0
0
0

2
2
4

102 kD

0

0

3

101 kD

0

0

3

10 kD

0

0

2

80 kD
102.5 kD

0
0

0
0

2
3
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G_00018639001
G_00029488001
G_00030739001
G_00028934001

G_00006874001

G_00006050001
G_00007851001
G_00027959001
P_3300001001
G_00022952001

P_1200013001
G_00011724001
G_00014332001
G_00023143001
G_00001529001

G_00003044001

G_00010841001
G_00004375001

G_00003522001
P_10600002001
G_00010730001

G_00005132001

P_10700002001
G_00033046001
G_00020334001
P_13700002001

Hypothetical Protein
Hypothetical Protein
Hypothetical Protein
Hypothetical Protein Dynein intermediate
chain WD-40 repeats
Hypothetical Protein Adenylate kinase family
protein (Tetrahymena)
IFT 81
Hypothetical Protein oxidoreductase
HSP 70 pt8
HSP 70
Hypothetical Protein Dynein Intermediate
chain
IFT 72/74
Hypothetical Protein
Hypothetical Protein
Hypothetical Protein
Hypothetical Protein contains Leucine rich
repeats
Hypothetical Protein outer dynein arm
docking protein
Hypothetical Protein
Hypothetical Protein flagellar associated
protein
Fork head domain
protein
Hypothetical Protein
Hypothetical Protein contains conserved Fbox and Leucine rich
domain
Hypothetical Protein cation channel family
protein in Tetrahymena
Hypothetical Protein
IFT52
Hypothetical Protein
Hsp 40

183.8 kD
75 kD
75 kD
77 kD

0
0
0
0

0
0
0
0

3
3
3
2

88.6 kD

0

0

2

81 kD
84.8 kD

0
0

0
0

2
2

72 kD
70 kD
75.8 kD

0
0
0

0
0
0

8
6
3

67.5 kD
70.1 kD
68.4 kD
69.1 kD
59.4 kD

0
0
0
0
0

0
0
0
0
0

6
6
4
4
4

65.6 kD

0

0

2

11.4 kD
60.2 kD

0
0

0
0

2
2

60.7 kD

0

0

6

75.8 kD
60.5 kD

0
0

0
0

3
4

61 kD

0

0

2

76 kD
49.5 kD
36.6 kD
37.8 kD

0
0
0
0

0
0
0
0

2
2
4
3
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P_2700002001

Hypothetical Protein 37.3 kD
0
0
Hsp40/DnaJ family of
proteins
G_00008057001
Hypothetical Protein 31 kD
0
0
calmodulin or troponin
protein
G_00033919001
Hypothetical Protein 49.1 kD
0
0
STOP conserved domain
- stabilizes microtubules
in neurons
G_00036831001
Beta tubulin
49.5 kD
0
0
G_00008057001
Calmodulin-like protein;
31 kD
0
0
EF hand
G_00004620001
Hypothetical Protein
26.5 kD
0
0
*Protein ID G_ = ID begins with GSPATP, Protein ID P_ = ID begins with PTETP.

2

2

4

2
2
2

Whole Cilia Lap200 Buffer

Protein ID*

Protein Description

G_00005599001
P_4000011001
P_10700002001
P_3300001001
P_11000002001
G_00029765001

PKD2
HSP70, isoform 7
Hypothetical Protein
Hsp 70
Hsp 70 isoform 9
cytoplasmic dynein, WD40 domain containing
HSP 70 protein, ER-type
cytoplasmic dynein, WD40 domain containing
protein
Hypothetical Protein TPR-1 protein
Hypothetical Protein

G_00024719001
P_1900003001

G_00022677001
G_00034717001
G_00026329001
G_00029566001

G_00033610001
G_00012627001

Hypothetical Protein HSP mitochondrial-like
PCM1 (Paramecium CaMbinding membrane-bound
protein 1)
Ribosomal protein L4
Hypothetical Protein ABC-transporter

Mol.
Mass
99 kD
72.2 kD
76 kD
72 kD
72 kD
81.6 kD

Predicted
TM domains
6
0
0
0
0
0

30.3 kD
81.5 kD

# Peptides Found
Control
TEST
0
0
0
0
0
0

13
14
9
10
8
6

0
0

0
0

5
3

51.8 kD

0

0

3

168.1
kD
72.2 kD

0

0

2

0

0

2

70.5 kD

0

0

2

44.8 kD
437.5
kD

0
6 or 8

0
0

2
4
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G_00034716001

Hypothetical Protein 128.3
2
0
adhesion/cell membrane
kD
(wall) protein
G_00007851001 Hypothetical Protein 84.8 kD
0
0
reductase
G_00021916001 PKAr3-1
43 kD
0
0
G_00008057001 Calmodulin-like protein
31 kD
0
0
G_00004584001 60s ribosomal protein L7
28.6 kD
0
0
G_00017494001 ATP synthase
44 kD
0
0
*Protein ID G_ = ID begins with GSPATP, Protein ID P_ = ID begins with PTETP.
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2

2
2
1
2
2
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Summary
The data presented in this work highlight the important contributions of our versatile
model organism, Paramecium tetraurelia in the understanding of ciliopathy proteins, namely
Polycystin-2 (Pkd2) and Meckelin (MKS3). Many of our findings would not have been possible
using mammalian cells. Using techniques such as RNAi and electrophysiology, we have
uncovered novel and intriguing roles for the proteins MKS3 and Pkd2. We also have a
broadened knowledge of the XntA protein, suggesting a role other than a Mg2+ channel.
The distorted basal body rows and misshapen cortical units of the MKS3 depleted cells
would not have been visible or easily observed without the highly organized and patterned cell
surface of Paramecium. Nor would we have been able to observe the misaligned basal bodies and
propose the possible second pool of MKS3, important for guiding the daughter basal body along
the kinetodesmal fiber. The novel contribution of this second pool of MKS3, important for the
attachment and guidance of the basal body along the kinetodesmal fiber, must be investigated
further. The involvement of MKS3 and its attachment points must be determined to better
understand how the MKS3 protein is contributing in this guidance role.
Our use of electrophysiology and membrane potential recordings of Paramecium has shed
new light on potential roles for the Pkd2 channel. Our observations of the Pkd2 protein acting as
a Mg2+ channel are both novel and highlight the importance of a non-canonical research model to
elucidate new functions of proteins. The Pkd2 channel is both promiscuous and versatile in
mammalian cells, demonstrating that its interactions, function, and location are cell-type specific.
Our findings here are no different. We show that the Pkd2 channel behaves and is most likely
regulated differently in the cell and ciliary membranes. Also, Pkd2 utilizes different trafficking
pathways to reach each membrane. The original findings we contribute from this study may
prompt new avenues of investigations of the Pkd2 channel in other cell types. Our study may
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also motivate new thinking concerning the contributions of Pkd2 to ciliopathies and human
diseases. It is feasible that the Pkd2 channel passes Mg2+ in mammalian cells, but because of its
established background as a non-selective calcium channel, the potential conductance of Mg2+
ions by the mammalian channel may be overlooked.
Our hypothesis that the XntA protein is not the Mg2+ channel, but instead is important
for stabilizing or regulating Pkd2 in membrane microdomains is supported by other findings in
our lab. Recent LC-MS/MS analyses of immunoprecipitations (IPs) of the voltage-gated calcium
channels (VGCCs) from the cilia have co-IP’d the XntA protein. If XntA is stabilizing Pkd2 in or
recruiting Pkd2 to membrane microdomains, XntA may also be stabilizing or recruiting other
channels and proteins in the same domains. In addition, PMCAs 18 and 19 co-IP with the VGCC
(Yano, unpublished data). PMCAs are crucial for the removal of calcium from the ciliary space
(Saidu et al., 2009) and are expected to help sustain membrane hyperpolarization during
chemoattraction (Wright and van Houten, 1990, Wright et al., 1993). The XntA1 mutants are
unable to maintain their membrane hyperpolarization in the presence of certain attractants (see
Appendix II). Together, these data suggest the possibility that the VGCCs and the PMCAs of the
cilia are in membrane microdomains together with the XntA protein. Possibly, XntA is not only
stabilizing or regulating Pkd2 in ciliary membrane domains, but also the PMCAs and VGCCs.
The cooperation of the PMCAs, XntA, and the VGCCs could be vital to the stabilization and
function of these proteins in the control and regulation of membrane potential.
To follow are proposed experiments which would be beneficial to further our knowledge
and understanding of the proteins discussed in this study. Up to this point, our findings on
XntA, Pkd2 and MKS3 have greatly expanded upon the understanding of the location and
function of these proteins in Paramecium. The use of our model organism has provided intriguing
new roles for MKS3 and Pkd2 which are applicable to mammalian cells. XntA, which is specific
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to Paramecium and Tetrahymena, may have a distant relative with similar functions in mammalian
cells, but this potential distant homolog has not yet been identified.

Further expansion on all of the projects presented in this work are either already
underway or should be considered for further investigation. A complete understanding of the
roles of their proteins, Mks3, Pkd2, and XntA, in Paramecium is not nearly complete. Further
experiments to uncover the interacting partners and functions would help us to better
understand the roles of MKS3, Pkd2, and XntA in human ciliopathies, as well as in our model
organism Paramecium.
I.

Further exploration of MKS3 in Paramecium
The work presented on Meckelin (MKS3) in Paramecium has been a long and on-going

research focus of our lab. My Master’s work was focused on this project, as well as other
collaborative efforts continuing over the years since. One re-appearing question which needs
further investigation is the second proposed location of the MKS3 protein in Paramecium.
Although we have published MKS3’s first location (Picariello et al., 2014), the second transient
pool of MKS3p has not yet been confirmed.
We have demonstrated that the N-terminal FLAG tagged MKS3 protein is located just
above the plane of almost every basal body in the cell (Picariello et al., 2014). This location of
FLAG-MKS3p above the basal body places it in the transition zone for Paramecium, which is in
agreement with the localization of MKS3 in mammalian cells (Dawe et al., 2007, Williams et al.,
2011, Chih et al., 2012). The transition zone is the area between where the triplet microtubules of
the basal body become doublets to where the plate with the central pair of microtubules of the
axoneme begins (Dute and Kung, 1978, Aubusson-Fleury et al., 2012, Garcia-Gonzalo et al., 2011).
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However, we have not been successful as of yet in the identification of the MKS3 protein in the
second proposed location: a transient pool of the protein, which is at or near the attachment point
of the daughter basal body to the kinetodesmal fiber (Picariello et al., 2014). There could be many
reasons for the difficulty and our lack of success in localizing MKS3p at the transient location
near the kinetodesmal fiber.
For starters, we expect the transient pool of MKS3 to be just that; temporary or shortlived. The movement of the daughter basal body away from the mother basal body is not a
prolonged event, taking perhaps only a few minutes. A Paramecium cell divides approximately
every six hours. Of that six hours, the last 30 minutes encompasses the process of binary fission
(Ruiz et al., 1987). Before division can begin, all dikinetids (two basal body units) must convert to
monokinetids (single basal body units) (Iftode and Fleury-Aubusson, 2003). That is to say that all
daughter basal bodies, which are anterior to the mother basal bodies in the anterior-posterior axis
of the cell, must move anteriorly, away from their mother basal bodies. Connection points that
exist during this migration include the bone node and the foot of the bone node (Iftode and
Fleury-Aubusson, 2003). One might expect the location of the proposed transient pool of MKS3p
to be located near the foot of the bone node of daughter basal body. The bone node connection
point to the striated rootlet is also transient; once the daughter basal body has migrated anteriorly
from the mother basal body, the bone node will disappear and the connection to the
kinetodesmal fiber will appear (Iftode and Fleury-Aubusson, 2003). The expeditious migration of
the daughter basal bodies as well as the short-lived nature of the bone node and foot connections
to the kinetodesmal fiber may hamper the identification of the MKS3 protein at this location.
It would be helpful to attempt to “stop time” to capture the cells at just the right time
point in their life cycle to obtain images of the transient pool of MKS3p. For starters, our current
use of immunofluorescence using the DeltaVision microscopy system would not give appropriate
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resolution to detect such a finite and precise location of a protein. One approach to tackle this
problem would be to utilize immunogold labeling of thin sections using transmission electron
microscopy of cells expressing the FLAG-MKS3 protein. Although the expression of FLAGMKS3 has proven difficult and also short-lived, without an antibody to specifically recognize
Paramecium MKS3, this may be the best approach. To begin, the Paramecium cells would need to
be in the correct stage of growth in an attempt to isolate the temporary attachment point of the
bone node and the foot to the kinetodesmal fiber. Cells can be synchronized by isolating cells at a
specific point in division after control autogamy (Ruiz et al., 1987) or by incubating the cells at
37°C for approximately 30 minutes to an hour. Synchronizing the cells would place them at
approximately the same point in their growth stage. Although the cells would be in the right
stage of growth, there would be great difficulty in obtaining the correct section of the cell using
TEM fixation techniques to visualize the bone node and the foot. I would expect many sections
would need to be examined cut from a single block of fixed cells. The sections could first be
screened to see 1) if cells are in the correct orientation and 2) if the bone node can be visualized
and identified. Only then should consecutive sections be isolated and immune-gold labelled to
possibly identify the presence of FLAG-MKS3. This approach would take a great deal of time
and patience.
Another approach would be to use super resolution microscopy to obtain a more detailed
image of the location of FLAG-MKS3p or the endogenous protein using an antibody to recognize
Paramecium’s MKS3 protein. Super resolution microscopy allows for the detection of particles
with a resolution of 50 to 20 nm (Huang et al., 2009). An antibody was developed against the
Paramecium MKS3 protein, but has not yet been optimized for use on Western blots or
immunofluorescence. Regardless, the use of super resolution could more closely pinpoint the
endogenous or FLAG-MKS3p in Paramecium. Subcellular markers to help with this localization
could be to stain the basal body with ID5 (Synaptic systems, Goettingen, Germany) or the Anti-
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centrin antibody which was made against Tetrahymena centrin 1 and recognizes Paramecium
centrin 2 (Gift of Dr. Mark Winey, University of Colorado, Boulder, CO). We also have
kinetodesmal fiber antibody (Gift of Dr. Janine Beisson, Gif-Sur-Yvette, France). Therefore, we
have numerous markers for the subcellular structures and could again synchronize the cells in
their growth, maximizing our chances of obtaining cells in the process of division to obtain
images of the transient pool of MKS3p.
In Chapter 2, we showed results from a glutathione sepharose transferase (GST) pull
down using the coiled coil domain of Paramecium MKS3. In this pull-down, kinetodesmal fiber
(Kd) proteins were included, specifically KdB2. Work continues on these findings of a potential
interaction of the MKS3 protein with the Kd elements. Numerous sequences within the
Paramecium genome were identified as being members of the Kd family, many of which were
subsequently tagged with N-FLAG and expressed Paramecium. Immunoprecipitations of these
proteins from whole cell extracts of paramecia expressing the tagged Kd genes did not yield, as of
yet, the MKS3 protein. Although, the IPs for the tagged Kd fiber proteins have produced other
Kd proteins. This work is on-going and will hopefully yield more information concerning the
interaction of the Kd proteins with other intracellular proteins and possibly MKS3.
An important contribution to the study of MKS3 and Paramecium would be the
investigation of the identification of the Paramecium transition zone complex proteins. Some of
the proteins found within the transition zone form a filter to selectively allow passage of certain
proteins in and out of the cilium. The filter complex includes the tectonic proteins (Tctn), MKS1,
Tmem267, Cep290, B9d1, and others (Garcia-Gonzalo et al., 2011). The MKS1 protein has been
researched in Paramecium. Depletion of MKS1 leads to a separation of the cell membrane from
the underlying cytoskeleton, leaving the depleted cells without defined cortical units and a
membrane that is easily aspirated from the underlying cytoskeleton compared to wild type cells
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(Campillo et al., 2012). The MKS1 protein has not yet been localized in the cells. MKS1 has no
predicted transmembrane domains, so one might expect it to be found in many locations within
the cell. When expressed in HEK293 cells, mammalian MKS1 is localized at the basal bodies
(Dawe et al., 2007). Other proposed complex proteins, including MKS5, or RIPGRIP1L, has a
homolog in Paramecium (GSPATG00016244001). Some groups have localized MKS5 to the
transition zone as a component of the NPHP complex (Sang et al., 2011, Williams et al., 2011).
Others have characterized MKS5/RPGRIP1L as a component of the basal body (Garcia-Gonzalo
et al., 2011). The location of the MKS5 protein in Paramecium using epitope-tagging and overexpression may help to collaborate our findings of MKS3p. It may also facilitate the co-IP of the
MKS3 protein from isolated membranes, which may contain the transition zone or transition
zone components. Currently, work is undergoing to further study Paramecium MKS5 in our lab
while researchers in France are currently attempting to identify and characterize the transition
zone proteins in Paramecium.
We are currently able to perform membrane potential recordings in our lab which could
shed light on the impacted channels that reside in the remaining cilia on MKS3 depleted cells.
Appendix I discusses the changes in swimming behavior of MKS3 and IFT88 depleted cells
compared to control cells. IFT88 depleted cells provide an important comparison because we
expect a global shortening and loss of cilia from the depleted cells. This differs from the MKS3
depleted cells, where we expect a change in their channel proteins because we have disturbed the
transition zone. The change in channel composition is apparent from the altered backward
swimming of the MKS3 depleted cells from both the control cells and the IFT88 depleted cells.
We are able to use membrane potential measurements and backward swimming assays as an
indirect measurement of membrane permeability to an ion and ion conductance, respectively. It
would be very interesting to examine the membrane potential of MKS3 depleted cells and the
ability of these cells to depolarize or hyperpolarize under certain ionic conditions. Again, the
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IFT88 depleted cells provide a valuable control for this study. The IFT88 depleted cells
demonstrate long backward swimming in depolarizing solutions containing TEA, suggesting an
ineffective IK(Ca), while the MKS3 depleted cells showed backward swimming that was sodiumspecific. The MKS3 depleted cells displayed backward swimming consistent with an overly
active INa(Ca). Measuring the membrane potential of these cells in varying ionic solutions may
shed more light on the defective or over-active channels that exist in these cells.
Clearly further investigation into the MKS3 protein as well as other possible interacting
partners, such as MKS5 and the kinetodesmal fiber proteins in Paramecium are needed. Many of
these projects are already underway. Hopefully the current Paramecium MKS3 antibody can be
further cleaned to become useful for immunostaining or immunoprecipitation studies. This
would greatly increase the chances of teasing apart the Paramecium transition zone component
proteins as well as clearly identifying both proposed populations of MKS3p. We have begun to
explore the proteins important for anchoring the basal bodies below the cell surface, namely the
kinetodesmal fiber proteins. Work on the Paramecium MKS5 gene and protein are also underway,
starting with an RNAi construct to deplete the cells of MKS5 and observe for phenotypes. Our
continued work on MKS3p and proteins that may complex with it will surely yield new insights
into the importance and function of these proteins.

II.

Further exploration of PKD2 in Paramecium

Our investigation of the Pkd2 protein in Paramecium began with a curiosity about the
presence and function of transient receptor potential (TRP) family proteins in Paramecium. We
were initially looking to identify the possible mechanoreceptor channel in Paramecium. Because
of the interactions of Pkd2 with Pkd1 for mechanosensation in mammalian systems, Pkd2 seemed
to be a promising channel to investigate. Our search for TRP channels in general within the
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Paramecium database turned up very few homologs. The three candidate PKD2 genes named in
Chapter 3, PKD2a (GSPATG00005599001), PKD2b (GSPATG00024265001), and what we refer to as
PKD2L (GSPATG0001264001), were some of the only genes we were able to suggest were
potential TRP channels.
When we depleted PKD2 from Paramecium using RNAi and observed short backward
swimming specific to Mg2+ solutions, it was apparent that we had found a protein with some
involvement in the Mg2+-induced behavior. Our further investigation into Pkd2 and its functions
in Paramecium provided novel roles for the Pkd2 protein. Our studies have identified candidate
interacting partners that are worth investigating further. Our persistence has also provided the
opportunity to revive to use of electrophysiology in the lab, providing us with invaluable
information on the Paramecium Pkd2 channel. The continued use of electrophysiology in the lab
will allow further study of other Paramecium channels and receptors we have investigated in the
past as well as those being investigated currently. That includes the glutamate receptor (See
Appendix II), the cAMP receptor for chemoattraction, and the voltage-gated calcium channels.
Based on our findings in Chapter 3, we have proposed that Pkd2 is both necessary and
sufficient for Mg2+-induced behavior in Paramecium contributing to both membrane potential
changes and IMg(Ca). In the cilia, we propose the Pkd2 protein is regulated by the XntA protein
probably in microdomains, although more research is needed to determine how this occurs.
Previous work (Preston and Kung, 1994, Haynes et al., 2002) combined with our findings show
that in cilia, XntA is sufficient for apparent Mg2+ permeability. We suggest that XntA in cilia
interacts with the Pkd2 protein, directly or indirectly. Pkd2 in the cell membrane is negatively
regulated by XntA in the cilia or another protein in the cilia which has yet to be identified.
Although XntA has been proposed to be a Mg2+ channel, we suggest that Pkd2 is the Mg2+
channel while XntA is a regulator of that channel.
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Our proposal that the Pkd2 protein is present in microdomains where it may be
regulated by the XntA protein is an important avenue to explore. The microdomains, sometimes
referred to as lipid rafts or detergent-resistant membranes (DRMs), are small microdomains that
are tightly packed with sphingolipids and cholesterol. The term “lipid rafts” is still a highly
debated topic as to whether or not they exist. Recent evidence, as reviewed by Kraft (2013),
discussed that although there is an existence of membrane microdomains where areas in the
membrane are enriched in sphingolipids, that cholesterols are evenly distributed in the
membrane and not concentrated in these microdomains (Kraft, 2013). However, the author then
goes on to mention that the size of the cholesterol microdomains could be less than 85 nm and
undetectable by current detection techniques.
Regardless, microdomains that are detergent-resistant appear to be important for cell
signaling processes. Interference with or removal of cholesterol or the sphingolipids from the cell
membrane hampers signaling pathways and the proteins involved (Radeva and Sharom, 2004,
Foster et al., 2003). These microdomains are expected to be tightly packed with signaling
proteins, including glycosylphosphatidyl inositol (GPI)-anchored proteins and tyrosine kinases.
These membrane microdomains are typically detergent resistant, meaning that they are not easily
solubilized in cold non-ionic detergents, such as Triton X-100 or Brij-96, hence the name
detergent-resistant membranes (DRMs). However, because of their light buoyant density, these
microdomains will float up on sucrose or OptiPrep™ gradients when spun at very high speeds
(Radeva and Sharom, 2004, Pike, 2003).
To begin to answer the question of whether XntA recruits or stabilizes Pkd2 in
microdomains, we would first need to establish that Pkd2 is present in the membrane
microdomains. We would begin with cell membrane and cilia isolated from Pkd2-FLAG
expressing cells. These different membranes would then be disrupted by incubating with cold
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Triton X-100 along with heavy vortexing to disrupt the membranes. The use of OptiPrep™ or
sucrose gradients and centrifugation would then allow us to separate the microdomains from the
triton soluble portions of the membrane and dense cytoskeletal elements. Once the isolated
fractions are concentrated, separated by SDS-PAGE and transblotted to nitrocellulose, the blots
can be probed for the Pkd2-FLAG protein using anti-FLAG. We also have antibodies available to
mark for GPI-anchored proteins in Paramecium such as the surface A and B i-antigens (Kind Gift
of Dr. J. Forney, Perdue University, West Lafayette, Indiana) and the GPI-anchored Folate
receptor (Weeraratne, 2007). Higher fractions, toward the top of the gradient, would contain light
fractions where we would expect to find GPI-anchored proteins. Fractions toward the bottom of
the gradient, would indicate heavy or more dense fractions. These experiments would allow us
to determine if Pkd2 is present in the microdomains as well as if Pkd2 is associated with light or
heavy fractions from the sucrose or OptiPrep™ density gradients
To determine if XntA is important for the positioning of Pkd2-FLAG in these
microdomains, we could do two experiments. Both experiments would be similar to the one
described above. Instead of wild type cells, we would express PKD2-FLAG in XntA1 mutant cells
or we could deplete wild type cells expressing the Pkd2-FLAG protein of XNTA using RNAi. We
could then observe changes in the location of the Pkd2-FLAG protein in the OptiPrep™ or
sucrose gradients from what we observed without disturbing the XntA protein. If the XntA
protein is important for positioning Pkd2 in the microdomains, the Pkd2 protein may not be
found in or its distribution may change in the gradients when the XntA protein is missing or
depleted.
Another approach is to disrupt the lipid rafts or microdomains in Paramecium using
Methyl-β-cyclodextrin (MβCD). Incubation with MβCD will selectively remove cholesterol from
the membrane (Rodal et al., 1999). MβCD is very effective at removing the cholesterol without
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harming the cells (Foster et al., 2003). Incubation of Paramecium cells in a buffer containing
MβCD can be compared to cells that have been incubated in the same buffer, but without the
MβCD. The cilia and cell membranes can be isolated and separated on the density gradients and
the distribution of the Pkd2-FLAG protein can be observed on GPI-anchored folate receptor
(Weeraratne, 2007). With the depletion of cholesterol from the membranes using MβCD, we
expect many of the microdomain-associated proteins to collapse into the more-dense fractions of
the density gradient. Previous work in our lab has shown that MβCD incubation will easily
deplete the cell membrane of sterols, but not the cilia. The removal of cholesterol from the ciliary
membrane and disruption of ciliary microdomains has proven far more difficult (Ray, 2008). This
may make it more difficult to determine if Pkd2 is acting in microdomains in the cilia.
Cholesterol assays can also be performed on the gradient fractions to determine the effectiveness
of the cholesterol depletion, such as the Amplex Red Cholesterol Assay kit (Life Technologies) or
the Cholesterol Quantitation Kit (Sigma).
To accompany the immunoblots of cells depleted in MβCD, it would also be important to
examine the membrane potential of the cells treated with and without methyl-β-cyclodextrin. To
my knowledge, this has not been done before in Paramecium. It would be important to examine
the cells not only in solutions with and without magnesium, but to also examine the cells in
solutions containing known attractants for Paramecium that typically cause the membrane to
hyperpolarize (See Appendix II). Work in our lab has been done to examine the chemoattraction
of cells treated and mock-treated with MβCD using T-maze assays. To data, attraction to cAMP
and glutamate have been shown to be diminished with MβCD treatment while attraction to
folate, ammonia, and acetate appear unaffected (Pan, 2008). We now have an antibody against
one of the cAMP receptors in Paramecium, pCAR3 (GSPATG00017916001). The protein is
approximately 31 kD in size (Czapla, 2012). It is possible that the pCAR3 membrane receptor
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would be useful in the microdomain studies. The attractant cAMP would also important to
examine in T-maze assays using cells treated and mock-treated with MβCD.
Another important investigation that should take place is to look more closely at the
multiple bands that are observed for the Pkd2 protein on Western blots. We have shown
(Chapter 3) that multiple bands are observed for the Pkd2 protein and that using LC-MS/MS, the
Pkd2 protein is present in these bands (See Appendix II). One of the bands is larger than the
expected size of the Pkd2 protein (~120 kD). This higher band is most often found from the IPs
obtained from solubilized whole cilia. In mammalian cells, Pkd2 has been shown to be Nglycosylated both when it is expressed in cell lines as well as endogenously in human kidney
cells (Cai et al., 1999). To test for N-glycosylation, we can treat Pkd2 IP eluates with
endoglycosidase H (EndoH). We would expect the larger band (120 kD) observed in the Western
blots to collapse into the expected molecular mass (100 kD) or smaller. EndoH cleaves highmannose oligosaccharides from proteins. To test the isolated proteins for EndoH-sensitivity, IP’s
from whole cilia of cells expressing PKD2-FLAG, and cilia from cells expressing FLAG as a
control, would be collected and separated. One half would be mock-treated for EndoH, receiving
the same treatment as the test cells but without receiving the EndoH enzyme. The other half of
the IPs would be treated with EndoH. The treated and mock-treated IP eluates would then be
separated by SDS-PAGE and probed with anti-FLAG. If the upper band observed in whole cilia
IPs is indeed Pkd2 that has been N-glycosylated, we would expect the upper band, or perhaps
even other bands, to collapse and blend with bands lower on the gel. The mock-treated sample
should show no change in the distribution of Pkd2-FLAG from what we typically observe. The
highest band at 120 kD should remain. N-glycosylation may explain the larger size we observe in
blots of the Pkd2-FLAG protein, although other modifications are also possible.
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We have presented data that suggest the Pkd2 protein is the Mg2+ channel. We have
used backward swimming assays and membrane potential measurements to indirectly measure
ion conductance and membrane ion permeability, respectively. It would be appropriate to use
two electrode voltage clamp on Pkd2 depleted cells to measure Mg2+ ion conductance. Our lab is
not currently able to perform these experiments, we do not have the necessary equipment.
However, that is not to say we cannot obtain the equipment or use equipment from another lab.
It is important to note that these experiments are not trivial. The successful impalement of a
ciliated Paramecium cell which would be moving with not one, but two glass electrodes, is a
technically challenging task.
To further test the function of the Pkd2 channel in Paramecium, it could be prudent to
treat cells with known Pkd2 inhibitors while recording the membrane potential of cells in
solutions with and without Mg2+. Compounds such as lanthanum (La3+) or gadolinium (Gd3+)
have been shown to inhibit Pkd2 activity as well as amiloride. By adding these compounds to the
bath solution, Mg2+-induced membrane depolarization may be inhibited if Pkd2 is acting as a
Mg2+ channel. Both La3+ and Gd3+ are heavy metals, shown to inhibit Pkd2 channel activity in
reconstituted human term syncytiotrophoblast (hST) membranes (Gonzalez-Perrett et al., 2001).
Gadolinium inhibits Pkd2 at a concentration of 400 µM (Giamarchi et al., 2010) and lanthanum at
a concentration of 500 µM (Kottgen et al., 2005). Amiloride can be used to inhibit Pkd2 channel
activity at a concentration of 100 µM (Giamarchi et al., 2010). In mammalian cells, amiloride
appears to be an inhibitor of Pkd2 activity. The other compounds, La3+ and Gd3+ are better
blocking compounds of Pkd2 activity. Lanthanum is a better blocking compound than amiloride
(Giamarchi and Delmas, 2007).
Lanthanum has been used on Paramecium for a study of calcium-dependent exocytosis.
The external application of 1 mM lanthanum caused the “explosive” release of trichocysts as well
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as local cortical increases in intracellular calcium concentrations. The site of application of the
La3+ also became deformed (Klauke et al., 2000). The concentration used in the exocytosis study
was twice that of what has been published to be successful in blocking Pkd2 channel activity.
Lower concentrations would most likely work to inhibit Pkd2 channel activity and not cause
trichocyst discharge at the same time.
The application of these potential Paramecium Pkd2 channel inhibitors does pose a few
issues. First, we are not sure if La3+, Gd3+, or amiloride will work to block Pkd2 channel activity.
Second, it would be difficult to determine if these chemicals were blocking Pkd2 and not another
protein or channel because we do not have a knock out available for Pkd2. The best approach we
currently have is the ability to deplete cells of PKD2 mRNA using RNAi. We would expect that if
one of these chemicals were blocking Pkd2 channel activity, that membrane potential recordings
would be similar to that of a PKD2 depleted cell. We now know that a ciliated XntA1 mutant
shows almost no change in resting membrane potential in a bath solution containing 0.5 mM
MgCl2, but that if that XntA1 mutant cell is expressing PKD2-FLAG, there is a depolarization of
the membrane indistinguishable from that of a wild type cell (Chapter 3). If these Pkd2 channel
blockers were working to inhibit Pkd2 channel activity, we would expect that their application to
an XntA1 mutant cell expressing PKD2-FLAG would remove any depolarization of that cell in
the presence of Mg2+, making it appear like an XntA1 mutant again. If successful, these channel
blockers could also help to determine if the Pkd2 protein is a channel and if it is contributing to
Mg2+ conductance.
The application of these blockers to deciliated cells may help to demonstrate that Pkd2 is
the channel protein in the cell membrane that is causing the large membrane depolarizations.
Both wild type and XntA1 mutant cells show membrane depolarizations in the presence of Mg2+
when these cells are deciliated (Chapter 3). These findings were unexpected; we had no
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indication that the membrane of a deciliated XntA1 mutant would depolarize at all in the
presence of Mg2+. To our surprise the deciliated XntA1 mutant depolarized by the same amount
as the deciliated wild type cells in the presence of Mg2+. Only when PKD2 was depleted from the
deciliated XntA1 mutants did we see the membrane depolarize as we expected, which was
hardly at all. Application of La3+ or Gd3+, assuming these compounds block Pkd2 channel
activity in Paramecium, may prevent the membrane depolarization in Mg2+ solutions of the
deciliated wild type and XntA1 mutant cells. The results may support, or refute, our notion that
Pkd2 is acting as the Mg2+ channel in the cell membrane.
The Paramecium sequence for Pkd2 is different than that of mammals. The Paramecium
amino acid sequence for Pkd2 is shorter than that of mammals, including humans (Accession
number Q13563). The Paramecium sequence is 849 amino acids compared to the human sequence
which is 968 amino acids. Similar to the mammalian Pkd2 sequences, Pkd2 in Paramecium does
have two proposed coiled coil domains. One at the N-terminus (amino acids 1 to 56) and one at
the C-terminus (amino acids 811 to 832) (PCOILS: http://toolkit.tuebingen.mpg.de/pcoils).
These regions may be important for protein-protein interactions. Expression of truncated Pkd2
proteins in Paramecium using the pPXV plasmid could provide insight into these regions of the
protein. Two truncated versions could be created for the study. The first where the first 56 amino
acids of Pkd2 are removed and the second where the last 37 amino acids are removed. These
truncated versions could be inserted into the pPXV plasmid and injected into the macronucleus
of paramecia. The expression of the truncated versions of Pkd2 could shed light on whether the
coiled coil regions are important for protein-protein interactions. If the coiled coil domains are
important for interactions, their removal may interfere with the function of the endogenous Pkd2
protein. The interference with the endogenous protein function would most likely manifest as
reduced backward swimming in Mg2+ solutions or a reduced amount of membrane
depolarization in solutions containing Mg2+. The pPXV-C-FLAG plasmid could also be used in
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place of the pPXV plasmid to use immunofluorescence to determine if the trafficking of the
truncated versions of the Pkd2 protein are altered.
Expressing mutated versions of the Pkd2 protein may also help to determine the pore
region of the protein. The fifth and sixth transmembrane spanning regions for Paramecium Pkd2
are expected to be amino acids A655 to D678 and L759 to F781. The region between these two
predicted transmembrane regions (D678 to L759) should contain the pore region. Within the
mammalian sequene of the pore region, there are four amino acids that are conserved with the
human PKD2 and PKD2L sequences, position F626, F637, I640 and G657. These amino acids are
spaced 0F, +11F, +14I, +31G. Amino acids with a similar spacing, but not exact, appear in the
predicted pore region of Paramecium Pkd2. Amino acids F702, F712, I714 and I715 are found in
the predicted Paramecium pore region that are similar to the mammalian sequences and may be
important for the pore formation (Tsiokas et al., 1999, Nomura et al., 1998). The pore region
could be mutated and expressed using the pPXV plasmid in Paramecium followed by backward
swimming assays and membrane potential measurements. The results could help decipher
whether these amino acids are important for channel function, ion permeability, or ion
selectivity.
It could be highly beneficial to develop an antibody against the Pkd2 sequence in
Paramecium. Although the C-terminal epitope tagging has been relatively successful, N-terminal
tagging of the Pkd2 protein was not. We have proposed that the Pkd2-FLAG protein may be
interacting with XntA at the C-terminus which may occlude the C-terminal FLAG tag preventing
the co-immunoprecipitation of the Pkd2 and XntA proteins. Developing an antibody to
recognize a region in the large extracellular loop between the first and second predicted
transmembrane domains could be beneficial. An antibody to recognize this region could yield a
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successful IP of the Pkd2 protein and would allow for co-immunoprecipitation of proteins that
may interact with both the N- or C-terminus of Pkd2.
Although not discussed here, our lab has glutathione sepharose transferase (GST)-fusion
proteins of the N- and C-terminus of Pkd2. The N-terminus GST-fusion includes M1 to S198
without any predicted transmembrane domains. The C-terminus GST-fusion protein is the final
215 amino acids, N638 to N849. The C-terminal Pkd2 sequence includes the putative fifth and
sixth transmembrane spanning domains and the pore loop. These proteins have been expressed
before in bacteria, although they are not easy to extract and purify. The GST-fusion proteins for
Pkd2 require a special protocol to isolate and extract the expressed proteins from inclusion
bodies. Special bacteria must also be used that are efficient at expressing sequences rich in
adenines and thymines (BL21-CodonPlus (DE3)-RIL bacteria, Agilent Technologies, Santa Clara,
CA). It is possible that these short GST-fusion proteins could be expressed and be used for GST
pull-down assays, although those assays can be difficult. Precautions must be taken to prevent or
remove bacterial proteins from binding to and occupying the expressed proteins.
A more fruitful and informative approach might be to use these purified expressed
proteins for Far Western development. This could be performed on IPs from whole cells or IPs
from whole cilia that are expressing the XntA-FLAG protein. An important control would be the
successful IP and identification of the XntA-FLAG protein from these cells. Another IP separated
by SDS-PAGE, transblotted and then re-natured would then be probed using the expressed GSTfusion N- or C-terminal Pkd2 purified proteins. The blot would then be probed with anti-GST to
recognize the GST-fusion proteins which would hopefully correspond with the XntA-FLAG band
on the corresponding blot. If N- or C-terminal Pkd2 interacted with the re-natured XntA or
XntA-FLAG on the blot, it should bind to the XntA protein. Cells expressing FLAG would need
to be used as a control as well as a blot that was developed by incubating it with expressed GST
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to ensure it was the terminal end of Pkd2 interacting with XntA, not the GST. These experiments
would provide very useful information concerning direct interaction of the Pkd2 protein and
XntA. It would also provide information as to which termini of Pkd2 interacts with XntA. Based
on our proposed model in Chapter 3, we would expect the C-terminal Pkd2-GST fusion protein
would bind to the XntA protein.
We have clearly shown in our data that Pkd2 requires the BBSome to traffic to the cilia.
However, what method is Pkd2 using to reach the cell membrane? This is a question I would like
to investigate further and would contribute to the overall understanding of the movement of this
protein within the cell. Other groups have also shown that Pkd2 requires the BBSome or
components therein to reach the cilia (Hoffmeister et al., 2011, Valentine et al., 2012). It would be
beneficial for our work to determine how Pkd2 reaches the cell membrane. Knowing how the
protein reaches the cell membrane may allow for the interruption of membrane Pkd2 trafficking
while leaving Pkd2 in the cilia undisrupted.
In mammalian cells, there are instances where Pkd2 requires a signal, typically from
Pkd1, to traffic to the cilia or the cell membrane (Hanaoka et al., 2000, Nauli et al., 2003).
However, our work suggests Pkd2 does not require XntA to traffic to the cilia or the cell
membrane. That is not to say there is not another protein in the cilia or in the cell membrane that
may need to signal for Pkd2 to be trafficked to these membranes. It is possible this signaling
protein exists and we have not identified it as of yet. Hoffmeister and colleagues did describe
two amino acids that were necessary for the movement of human Pkd2 from the trans-Golgi to
the cell membrane in the fourth transmembrane spanning region of the protein, K572 and F576.
When these amino acids were mutated to alanines, the mutated Pkd2 protein no longer trafficked
to the cell membrane in non-ciliated COS-7 and LLC-PK cells (Hoffmeister et al., 2011). If we
were able to somehow prevent Pkd2 from reaching the cell membrane of Paramecium, but allow it
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to reach the cilia, this would be a very useful model to study the activity of Pkd2 and its
contribution to Mg2+-induced behavior in only the ciliary membrane. So far, we are unsure of
what this membrane trafficking protein might be.
Our research on the Pkd2 protein in Paramecium has provided a great deal of information
on the Pkd2 protein, its potential interacting partners (see Appendix III), and what its role might
be in our ciliated model organism. We have shown the importance of the BBSome for the
trafficking of the Pkd2 protein to the cilia (Valentine et al., 2012). Also, that when BBS8 is
depleted, Pkd2 is able to reach the cell membrane where it is able to contribute to Mg2+-induced
behavior. We have presented novel findings on the involvement of Pkd2 in Mg2+-induced
behavior and that Pkd2 interacts with the XntA protein, either directly or indirectly. Our indirect
evidence that suggests Pkd2 is involved in Mg2+ conductance is novel and may not be unique to
Paramecium. Our lab plans to continue research on Pkd2 in Paramecium to further understand the
role of this protein in Mg2+-induced behavior, involvement with XntA, and Pkd2 presence in
membrane microdomains.

III.

Further exploration of XntA in Paramecium
Magnesium conductance and regulation have been of interest for almost 25 years in

Paramecium. Investigations into Mg2+ membrane permeability started in the 1990’s when
Paramecium was discovered to have a calcium-dependent magnesium conductance (Preston,
1990). The XntA protein is a small protein, 550 amino acids. Its name lends true to its moniker of
eccentric, being quite unconventional in many ways. What the XntA protein is doing in
Paramecium is still undecided but numerous other experiments could help to better understand
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the roles and function of XntA. Some of the proposed experiments to follow are relevant to the
work presented in Chapter 3, as well as the work shown in Appendix II.
One of the first areas of investigation to conclude would be to have a complete
understanding of the expression of the mutated and truncated versions of the XntA protein in the
XntA1 mutant (see Appendix II). It would be important to repeat these experiments and include
electrophysiology to recorded the changes in membrane potential in solutions with and without
Mg2+ to compare to the backward swimming assays. We were unable to perform membrane
potential measurements when the expression experiments were being done. The outcomes may
shed more light on the ability of the XntA protein to function in its role and contribute to Mg2+
conductance and membrane permeability by proxy.
An additional version of the XNTA gene to express in the XntA1 mutants would be one
where the PEST sequence has been removed. The PEST sequence is brief (Haynes et al., 2002),
characterized by a richness in prolines (P), glutamic acids (E), serines (S), and threonines (T).
PEST sequences are common in proteins that are targeted for early or rapid degradation (Rogers
et al., 1986, Rechsteiner and Rogers, 1996). If the PEST sequence targets the XntA protein for
early degradation, its removal may allow for a longer life-span of the XntA protein. If the XntA
protein is able function in the cells for a longer time and not be broken down or degraded
rapidly, the cells may display longer backward swimming or more membrane depolarization in
solutions containing Mg2+. We have other instances that suggest when there is an excess of XntA,
there is prolonged Mg2+-induced behavior or increased membrane depolarization. We observed
that over-expression of the XNTA-FLAG gene in the XntA1 mutants led to partial curing of the
mutants. The XntA1 mutants expressing XNTA-FLAG showed significantly longer backward
swimming in Mg2+ solutions compared to the XntA1 mutants expressing FLAG, but not as much
as the control wild type cells. Also, wild type cells expressing XNTA-FLAG showed significantly

213

longer backward swimming in Mg2+ solutions than the wild type control cells, indirectly
suggesting that the over-expression of the XntA protein increases the Mg2+ conductance.
It would also be on interest to examine the expression of both the N- and the C- term of
XNTA to cure the XntA1 mutants. Individually, the N-term and C-term of XntA showed no
curing or very little curing of the XntA1 mutant, respectively (See Appendix II). However, if they
are expressed together within the cells, it is possible that the two fragments may be able to act
together to rescue the mutant. Although we hypothesize that the protein must be full-length to
properly function, the expression of the two separate fragments would help to confirm this
hypothesis. If the expression of both fragments did not show any increase in backward
swimming, we would have more support of our hypothesis that the XntA protein must be fulllength to properly function.
We did not have the capabilities to record membrane potential when many of the injected
cells were available. Although voltage clamp studies have been done previously on XntA1
mutants expressing the wild type XNTA gene (Haynes et al., 2002), it would be useful to use
electrophysiology to record the membrane potential changes in Mg2+ solutions of XntA1 mutants
expressing XNTA-FLAG and FLAG-XNTA, as well as FLAG-PKD2. We have membrane
potential recordings of wild type cells and XntA1 mutants expressing the PKD2-FLAG gene, but
not of the wild type cells or XntA1 mutants expressing XNTA-FLAG. Now that were able to
perform these membrane potential recordings, it would help complete the study of the XntA1
mutant if these recordings were performed.
As of yet, we have not identified any peptides from the XntA protein in any of our LCMS/MS analyses. We are able to consistently visualize bands when using IP to precipitate XntAFLAG or XntA-myc with antibodies against the epitope tags. We expect that because the same
bands are identified on Western blots from the eluates of both the XntA-FLAG IP and the XntA-
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myc IP that those bands are fragments of the expressed XntA protein with the C-terminal epitope
tag intact. Additional attempts to IP the XntA-FLAG or XntA-myc protein are suggested where
the entire silver stained gel from the IP eluates is sent for LC-MS/MS analysis, not just certain gel
fragments. Dr. Junji Yano has identified two peptides belonging to XntA in his analysis of
TritonX-114 phase separation of the ciliary membrane (Yano et al., 2013). These data, combined
with our IPs and immunostaining data presented in Chapter 3, clearly demonstrate the XntA
protein is in the cilia. Because the XntA protein has eleven predicted transmembrane domains, it
is possible that Triton X-114 phase separation of the cell or ciliary membrane is needed to
solubilize enough of the protein for LC-MS/MS analysis. Another possibility is that XntA is
present in detergent resistant membranes (DRNs) and is not easily solubilized using cold nonionic detergents. The presence of XntA in DNRs would be consistent with our proposed model
that XntA may interact with Pkd2 in membrane microdomains. If XntA is found in the
membrane microdomains of the cell and cilia membrane, then it should float up in our density
gradients after the membrane is disrupted with Triton X-100 as described for Pkd2. It would be
wise then to perform the same membrane microdomain studies using cells expressing XntAFLAG or –myc to see if the XntA protein is found in the same fraction of the density gradient at
Pkd2. If both proteins are found in the same fraction, it is possible they are interacting in the
microdomains. Very similar experiments for XntA could be performed as what was described for
the microdomain studies for the Pkd2 protein.
We have had a lot of difficulty in obtaining successful IPs with the full-length of XntA
(~61 kD). The varied success in IP’ing the full length XntA has hampered our ability to do the
reciprocal IP of Pkd2-FLAG and XntA-myc (Chapter 3), where we instead IP XntA-myc first to
co-IP Pkd2-FLAG. We were unsuccessful in our last attempts to complete this experiment. An
antibody to recognize the XntA protein in Paramecium may help facilitate these experiments. An
antibody specific for the XntA protein might allow us to identify and IP the endogenous protein.
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We could both visualize the protein on Western blots and perhaps even visualize the protein
within the cells using immunofluorescence. There are no commercial antibodies for the XntA
protein since the sequence is very unique to Paramecium and Tetrahymena. We don’t believe the
epitope tags are interfering with the function of the XntA protein, either endogenous or
exogenous. We have shown some curing of the mutant when XNTA-FLAG is expressed. Wild
type cells have shown an increase in Mg2+-induced behavior with XNTA-FLAG is expressed. A
section of the XntA protein to target for antibody development, however, would be a challenge.
As mentioned, XntA has 11 predicted transmembrane spanning regions with an extraordinarily
short N- and C- terminal tail, 15 and 1 amino acids, respectively (Haynes et al., 2002). There is
one loop between the first and second predicted transmembrane spanning regions that is 26
amino acids in length which contains five acidic amino acids. Although the loop is short, a
keyhole limpet hemocyanin (KLH)-conjugated antibody with these 26 amino acids could prove to
be useful. Otherwise, the large intracellular loop could be used to develop a GST-fusion peptide
for antibody development.
There is some indication that the XntA1 mutants are unable to hyperpolarize their
membrane in response to attractants (See Appendix II). The same attractants cause a 5 to 10 mV
hyperpolarization of the membrane potential in wild type cells (See Appendix II and (Van
Houten, 1979, Preston and Van Houten, 1987)). It would be beneficial for the XntA1 mutants to
be tested in T-maze assays to assess their attraction to typical attractants such as folate,
glutamate, cAMP, ammonium, and acetate. These attractants cause the activation of different
pathways to hyperpolarize the membrane of Paramecium. Two of the pathways, the glutamate
pathway and the pathway that includes cAMP and folate, cause the hyperpolarization of the
membrane by eventually activating the plasma membrane Ca2+-ATPase pumps that remove
calcium from the cells. Ammonium chloride crosses the membrane as ammonia and causes a
hyperpolarization of the membrane (Van Houten, 1998). There is also evidence that the presence
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of Mg2+ in the bath may alter the response of Paramecium to some of their attractants, specifically
biotin, which paramecia are attracted to (Bell et al., 2007, Bell et al., 1998).
The XntA1 mutant cells can be tested for their reaction to these attractants using the Tmaze assay which is a three-armed apparatus with a two-way stop cock. The cells are loaded
into the center arm which is shorter and perpendicular to the other two horizontal arms. A
control solution is loaded into one of the arms and the test solution containing the attractant is
placed in the other arm. Importantly, the ions are balanced between the two arms so the cells do
not swim in one direction or the other based on ionic concentrations, but on the
presence/absence of the attractant. Cells are given 30 minutes to swim into either arm after being
loaded, then the arms are emptied and the cells in each arm are counted. The cells in the average
number of cells found in the test arm are divided by the total number of cells in the control and
test arms to determine the index of chemoattraction (IChe). An IChe above 0.5 indicates attraction,
below 0.5 indicates repulsion and an IChe at 0.5 indicates neutrality (Van Houten et al., 1982).
The T-maze assays as well as more membrane potential recordings would be quite
informative as to whether the XntA1 mutants are able to respond to the attractants the same way
wild type cells are. T-maze assays would assess the ability of the XntA1 mutants to swim toward
and attractant and maintain themselves within the T-maze arm containing the attractant.
Measuring the membrane potential changes of these cells in solutions with and without the
attractants has already hinted at the fact that these cells may not be able to maintain their
membrane potentials in these solutions. Meaning, the XntA1 mutants may not be able to
maintain a hyperpolarized membrane potential in solutions containing the attractants compared
to solutions without the attractants (see Appendix II). This could be due to XntA stabilizing or
recruiting proteins to the membrane microdomains. The plasma membrane calcium ATPases
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(PMCAs), necessary for many of these maintained hyperpolarizations of the membrane, could
also be stabilized in the microdomains by XntA, especially in the cilia.
It would also be interesting to test some of these attractants with and without the
presence of Mg2+ in the T-maze solutions or the membrane potential solutions to see if there is
any effect of Mg2+ on the reactivity of cells to attractants, both wild type and XntA1 mutants. The
results could be informative concerning an influence of extracellular Mg2+ on the
chemoresponsiveness of cells to chemoattractants and on the membrane potential changes that
might occur. Although extracellular Mg2+ is an effective blocker of N-methyl D-aspartic acid
(NMDA) ionotropic glutamate receptors (Nikolaev et al., 2012), previous work in our lab has
shown that there was no effect of extracellular Mg2+ on glutamate chemoresponse (Jacobs, 2007).
The results could yield insights into the function of the XntA protein being responsible for
stabilizing other proteins in membrane microdomains other than the Pkd2 protein, such as the
receptors or channels necessary for chemoattration processes. Also, if Mg2+ has any influence on
the chemoresponse of the cells.
We do have evidence that the XntA protein co-immunoprecipitates with the voltagegated calcium channels (VGCCs) of the cilia (Dr. Junji Yano, unpublished results). Our lab is
currently investigating the presence of the VGCCs in membrane microdomains of the cilia. It is
possible that the XntA protein is an important stabilizer of proteins in these membrane
microdomains, not just the Pkd2 protein, maybe including the VGCCs and the PMCAs. The
“eccentric” behavior of the XntA1 mutant cells could be explained by the instability of signaling
pathways in membrane microdomains, both in the cell membrane and in the cilia, leading to an
inability of the cell to regulate and control signaling pathways and swimming patterns. Eccentric
received its moniker because of random bouts of backward swimming and odd behaviors in ionic
solutions, not just those solutions with Mg2+. Perhaps we have stumbled into the true nature of
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the XntA protein as a stabilizer of signaling proteins in membrane microdomains. Continued
research on this project using the approaches discussed here will continue to shed light on this
unique protein and lead to a better understanding of these membrane microdomains.
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Appendix I: Depletion of Meckelin (MKS3) Leads to Short Cilia, Changes in
Ciliary Ion Channels over Time, and a Loss of Trichocyst Discharge
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Abstract
Meckelin (MKS3), a highly conserved integral membrane protein linked to MeckelGruber syndrome (MKS), assists in the migration of centrioles to the cell surface and ciliogenesis.
In Paramecium, the MKS3 protein is located at the base of cilia, consistent with a role as a
transition zone protein. In addition to its proposed role at the transition zone in Paramecium, we
have also speculated that MKS3 is important for the guidance of daughter basal bodies along the
striated rootlet before cell division. We have demonstrated previously that the reduction of
MKS3 leads to basal body rotation out of the anterior-posterior axis of the cell, a disruption of
cortical rows and a disruption of the cell and ciliary surface, as well as a global loss of cilia. We
present here additional and more detailed findings in Paramecium upon depletion of MKS3.
Time-course studies of the RNAi treated cells, as well as the IFT88 depleted cells, show short and
missing cilia as soon as 24 hours after the start of the RNAi treatment. The ion channels of the
ciliary membrane become unbalanced showing changes in the behavior of the MKS3 depleted
cells that are different from the IFT88 depleted cells, suggesting further that MKS3 is important
for regulating the proteins of the cilia. Lastly, trichocyst expulsion is inhibited in the MKS3
depleted cells, presumably due to the disrupted cell surface. These results further highlight the
importance of the MKS3 protein in proper ciliary maintenance and content and that depletion of
MKS3 has global effects on the cell surface and the cilia which worsen over time.
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Introduction
Abnormalities in the assembly, maintenance or function of cilia are collectively called
ciliopathies. Ciliopathies can lead to defects in development, cysts in the kidneys and/or
pancreas, fertility problems, and many other complications in mammals (reviewed in (D'Angelo
and Franco, 2009)). In an effort to better understand the broad distribution of disorders and
complications that arise from ciliopathies, research is needed to understand the function and
involvement of the dysfunctional genes that contribute to the complications (Pazour et al., 2000,
Pedersen and Rosenbaum, 2008, Sharma et al., 2008). One such ciliopathic gene, Meckelin (MKS3
or TMEM67), is linked to numerous ciliopathies. Presented here are additional results of the
depletion of MKS3 in the model organism Paramecium tetraurelia.
Cilia are highly conserved organelles that are vital for development and signal
transduction in cells (Pedersen and Rosenbaum, 2008). These organelles are generally anchored
by the basal body, which is positioned just below the cell surface. The basal body, as well as a
closely related organelle, the centriole, are comprised of nine triplets of microtubules arranged in
a circle to form a cartwheel pattern. The basal body is approximately 220 nm wide and 400 nm
tall (Ringo, 1967). The cilia that emanate from the basal body are generally described as motile or
non-motile, but all appear to have sensory functions. In general, non-motile or primary cilia lack
the central pair of microtubules while motile cilia generally have a central pair of microtubules.
However, there are examples of cilia that are motile and lack the central pair of microtubules, or
have other configurations (Basu and Brueckner, 2008).
The cilium develops from the basal body using cargo that is transported via intraflagellar
transport (IFT) complexes. These complexes were first described in Chlamydomonas reinhardtii
(Kozminski et al., 1993, Rosenbaum et al., 1999). This transportation mechanism is bi-directional,
using a kinesin-2 motor protein to carry cargo and proteins toward the tip (Kozminski et al.,
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1995) and a dynein 2 motor protein to return cargo from the tip to the base (Pazour et al., 1999,
Porter et al., 1999). Anterograde transport from base to tip relies on the IFT B complex while
retrograde transport from the tip to base relies on the IFT A complex (Kozminski et al., 1995,
Pazour et al., 1999). Complex B is comprised of at least eleven proteins, and complex A is made
of at least six proteins (Cole et al., 1998, Piperno and Mead, 1997). IFT88, a component of
complex B, leads to missing cilia or severely truncated ones when it is non-functional or missing
(Nonaka et al., 1998). Defects in the IFT complexes are linked to ciliopathies (Pazour et al., 2000).
Previously, we demonstrated that the MKS3 protein is located above the plane of the
basal body and is present at almost every basal body. Depletion of MKS3 in Paramecium leads to
missing cilia, disrupted basal body rows, and unorganized cortical units (Picariello et al., 2014).
The thousands of cilia and organized cell surface of Paramecium has made it an ideal model
organism for the study of MKS3. The surface of these cells is organized into a pattern of
hexagonal polarized units arranged in rows that run longitudinally along the cell (Allen, 1971,
Sonneborn, 1970). Each of these cortical units is outlined by a ridge and contains one or two basal
bodies (Allen and Fok, 1980) with associated rootlets. The basal body in single basal body units,
or the posterior (mother) basal body in two basal body units has three associated rootlets. The
striated rootlet, or kinetodesmal fiber, projects toward the anterior of the cell and may pass
through numerous cortical units. The other two associated rootlets are at 7 o’clock and 5 o’clock,
as if looking down upon the basal body as if it were a clock face. The post ciliary rootlet is at 7
o’clock and the transverse microtubule is at 5 o’clock (Iftode, 1996). During division, all these
components undergo a highly complex and organized process to create two daughter cells.
Disruptions or arrest at certain stages in this process can cause the cells to stop their growth or to
die (Iftode et al., 1989, Ruiz et al., 2005, Ruiz, 1999).
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Also present just below the cell surface at the apex of the ridges that delineate the
cortical units are secretory vesicles named trichocysts (Sonneborn, 1970, Allen, 1971, Iftode et al.,
1989). The trichocysts are expected to be a defense mechanism (Buonanno et al., 2013). When a
Paramecium cell comes into contact with a predatory, the trichocysts are rapidly expelled in a Cadependent manner (Buonanno et al., 2013, Hardt and Plattner, 2000). When the trichocysts are
expelled, it also causes the cilia to reverse, propelling the cell backwards and away from the
predator (Hardt and Plattner, 2000, Husser et al., 2004). There are Paramecium mutants that are
unable to expel their trichocysts, called ND mutants for “non-discharge” (Gogendeau et al., 2005).
Ciliopathies can also arise from defects in the sensory function of cilia. Paramecia rely on
their cilia not only for locomotion, but also for sensory perception of their environment. Defects
in sensory perception can be monitored by the swimming behavior of these cells. The cilia of
Paramecium are under the electrical control of the membrane which is dependent on the ion
channels of the cell membrane and of the cilia (Eckert, 1972, Eckert and Brehm, 1979, Machemer
and Ogura, 1979). The majority of the ion channels that are important for this behavior reside in
the cilia (Machemer and Ogura, 1979). Changes to the channel content can easily be observed
through changes in swimming behaviors of paramecia cells. Longer or shorter backward
swimming in certain ionic stimuli can infer an overactive or underactive channel. This allows for
the study of ionic conductances by proxy of swimming behavior in Paramecium (Machemer and
Ogura, 1979, Brehm et al., 1978).
We present here additional studies of MKS3 using RNAi beyond our previously
published works (Picariello et al., 2014). Included are additional studies on IFT88 RNAi that
accompany the MKS3 RNAi studies for comparison. Reduction of IFT88 using RNAi is used as a
positive control because the functions of IFT88 in ciliogenesis are well understood. We expect the
observations of these depleted cells are from the global shortening and loss of cilia due to a loss
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of IFT. This additional work examines the rate of loss of the cilia on MKS3 and IFT88 depleted
cells as well as changes to the backward swimming behavior of these cells over time. Lastly, an
analysis of trichocyst discharge of the cells is included, focusing on the central midline where we
most commonly see disruptions of the basal bodies and cortical units (Picariello et al., 2014). This
work supports Paramecium Mks3p having a role in the gating or passage of proteins into the cilia
as well as in the organization of the cell surface.

Materials and Methods
Stocks, Cultures and Chemicals
Cells were grown in wheat grass medium inoculated with Klebsiella pneumoniae or
Aerobacter aerogenes (adapted from (Sasner and Vanhouten, 1989)).

Cell lines used were

Paramecium tetraurelia (51-s, sensitive to killer) or Paramecium tetraurelia (ND6) non-discharge
mutant (Gogendeau et al., 2005). All chemicals were from Sigma-Aldrich unless otherwise noted.
In all experiments, cells were filtered and collected by low-speed centrifugation and washed two
times in Dryl’s solution (1 mM Na2HPO4, 1 mM NaH2PO4, 1.5 mM CaCl2, 2 mM Na-citrate, pH
6.8).
Data Mining and Construct Design
Constructs were created as previously described (Picariello et al., 2014). Constructs were
created from genomic DNA isolated using organic extraction and isopropanol precipitation.
Sequence GSPATG00015939001 was used to create the RNAi construct to target MKS3 mRNA,
from positions +1100 to +2019, which is 31.9% of the gene. Primers were: 5’GAAAACCCAAGCCAATCAATAC-3’ and 5’-GGTCGACAATCTGAAGGATAAG-3’. The
construct to target IFT88 mRNA was designed from GSPATG00038505001 and is 91.9% of the
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gene, including positions +48 to +2201. Primers were: 5’- CAATTAAGGAAAACCACCTG-3’
and 5’-AAAACTAACAGGATTGTCATCT-3’. The sequences used to create the RNAi constructs
were analyzed by the ParameciumDB off-target tool (http://paramecium.cgm.cnrsgif.fr/cgi/tool/alignment/off_target.cgi). The sequence used for the MKS3 construct will only
target GSPATG00015939001 while the construct designed for IFT88 will target all five of the
potential orthologs (Li and Durbin, 2009).
Samples were analyzed on a 0.75 or 1.0 % agarose gel and visualized with ethidium
bromide. Bands were then cloned into pCR®2.1-TOPO® vector (Invitrogen), transformed into
OneShot® cells (Invitrogen), and sequenced at the Vermont Cancer Center DNA Analysis Facility
(University of Vermont, Burlington, VT). Sequences were cut from the plasmid and ligated into
the double-T7 promoter vector L4440 (AddGene) using the Ligate-IT™ Kit (USB), as per the kit
instructions. Escherichia coli strain Ht115 (DE3) which lacks RNase-III, were transformed with 50
ng of plasmid DNA for either MKS3 or IFT88. As a control, Ht115 cells were transformed with
empty L4440. Bacterial cultures were maintained with tetracycline (12.5 µg/mL) and ampicillin
(AMP) (100 µg/mL).
RNAi by Feeding
Cultures were prepared as previously described (Nowacki et al., 2005) except bacteria
were prepared in LB with 0.1 mg/mL AMP and were induced for three hours using a final
concentration of IPTG of 0.125 mg/mL. Bacteria were then collected by centrifugation and
resuspended in wheat grass medium. Paramecia were collected by centrifugation and
resuspended in 10 mL of Dryl’s solution for at least one hour before being added to the culture.
The paramecia were added to each culture: 50 to 100 paramecia to the control culture, 4000 cells
to the MKS3 culture and 8000 cells to the IFT88 culture. At 24 and 48 hours, an additional 0.125
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mg/mL of IPTG, 0.1 mg/mL AMP, and 800 µg of stigmasterol were added. Growth rates of
cultures were determined by counting cells at 24, 48, and 72 hours of growth.
Immunofluorescence and Scanning Electron Micrographs
Cells were collected, washed and reduced to 100 µL. Cells were permeabilized for 2
minutes in 1 mL of PHEM buffer [60 mM PIPES, 25 mM HEPES, 2 mM MgCl2, 10 mM EGTA, and
0.1% Triton X-100] and fixed for one hour in 4% paraformaldehyde [Electron Microscopy Sciences
(EMS)] in PBS (phosphate buffered saline). Cells were washed three times in PBS with 1% BSA
and 0.1% Tween-20. Primary antibody for ciliary measurements, mouse anti-alpha-acetylatedtubulin 1:200 (Sigma). Cells were incubated in primary antibodies in 100 µL PBS for one hour,
washed three times in PBS with 0.1% Tween-20, and incubated one hour with 1:200 dilution of
secondary antibody AlexaFluor® goat anti-mouse 555 in PBS with 0.1% Tween-20. Cells were
washed five times in PBS with 0.1% Tween-20 and mixed 1:1 with VectaShield® (Vector Labs),
stored in aluminum foil at 4oC until use.
The DeltaVision® Restoration Microscopy System (inverted Olympus IX70 microscope
and a Kodak CH350E camera) at the Neuroscience COBRE Program (University of Vermont,
Burlington, VT) was used at 20-22oC using PlanApo 60x/1.40 oil-immersion objective. Images
were deconvolved and analyzed using SoftWoRx® Pro software. Cilia length measurements
were completed using ImageJ (Rasband, 1997-2009). Only straight cilia within the same z-section
were used, the oral grove and caudal cilia were not used for measurements. Colocalization
analysis was completed using SoftWoRx® Pro. All Statistical tests (unpaired T-tests) were
completed using GraphPad Prism®, Excel, or R. Sample sizes were between 3 to 9 cells for each
time point and between 191 and 482 cilia were measured.
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To obtain cells for the scanning electron micrographs, RNAi cell cultures of 100 mL were
staggered in order to collect cells of different times points (22, 46, and 70 hours) in the RNAi
bacteria on the same day. Control cells fed the empty RNAi vector, L4440, were only collected at
the longest time point, ~70 hours. RNAi bacteria were prepared as above and cells were imaged
as previously described (Picariello et al., 2014).
Behavioral Assays
Each testing solution contained 1 mM calcium citrate, and ~1.3 mM Tris Base. Additional
salts were added and pH adjusted using Tris Base to 7.05. Testing solutions included: 20 mM
NaCl; 25 mM TEA with 10 mM NaCl; and 25 mM TEA with 5 mM MgCl2; or 30 mM KCl. Cells
were transferred to Resting Buffer (4 mM KCl in base buffer above) for 30 minutes then to a
testing solution individually. The length of time the cell immediately swam backward or jerked
in repetition upon a change in solution was measured using a stop-watch. Timing was stopped
when the cell returned to a forward swimming direction. In each solution at each time point,
between 48 and 96 cells were observed.
For presentation, the backward swimming data were normalized. Control cells’ values
were set to 100% and the mRNA reduced cells’ time spent swimming backward were compared
to this value. Data are presented as ± standard error of the mean (SEM). All statistical tests were
performed on original non-normalized data. Because backward swimming in 20 mM NaCl is
typically a fast turn, these data could not be normalized and therefore are presented as text
within the results.
Secretion Assay
To elicit trichocyst secretion, we added a drop (~60 µL) of saturated picric acid solution
to approximately 20 µL of each cell type which we observed for secreted trichocysts using an
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Olympus CK2 microscope with an (LWD)CDPlan40FPL 0.55 NA 160/1 objective. Each cell was
scored as S (secretion), PS (partial secretion), or NS (no secretion). Partial secretion was defined
as showing trichocysts discharged outside but not completely around the periphery of the cell.
The DIC images presented in Figure I.3 were taken using a BioRad Multiphoton Confocal system
with an Olympus BX51W1 microscope using an XLumPlanFl 20x/0,95w dipping lens. The ND6
paramecia are non-discharge mutants unable to secrete their trichocysts (Gogendeau et al., 2005).
Therefore, no secretion was expected in 100% of these cells. Cells from seven different
experiments were examined with the totals of 426 control cells, 450 MKS3 depleted cells, 416
IFT88 depleted cells, and 249 ND6 cells.
Transmission Electron Microscopy (TEM)
100 mL cultures of RNAi treated cells were collected and washed twice in 100 mL Dryl’s
solution. Cells were then transferred to 1.5 mL Eppendorf tubes and fixed in 1% gluteraldehyde
(EMS) in 0.05 M sodium cacodylate, pH 7.2 for 30 minutes on ice. Cells were washed three times
in the same buffer and resuspended in 1% gluteraldehyde (EMS) in 0.05 M sodium cacodylate
buffer, 1% osmium tetroxide, pH 7.2 on ice for 30 minutes. Cells were washed three times in the
same buffer, 10 minutes each, and pre-embedded in 2% agarose (Invitrogen) in 0.05 M sodium
cacodylate buffer. Samples were sliced into 1 mm x 1 mm blocks and placed in 50% ethanol and
rocked for 30 minutes. Blocks were rinsed for 30 minutes in a series of ethanol concentrations
(50%, 70%, 90%, two times with 100%) and two washes in propylene oxide. Cells were left
overnight on specimen rotator in 1:1 of propylene oxide and Spurr’s solution (EMS). Samples
were washed in fresh Spurr’s (EMS) for 6 hours, and placed in flat embedding molds with fresh
Spurr’s (EMS) at 60oC for 48 hours. Thin sections (90 nm) were placed on copper 200 mesh grids,
contrasted with 2% Uranyl acetate in 50% ethanol for 6 minutes, and then lead citrate for 4
minutes. Sections were imaged using a JEOL JEM-1210 Electron microscope.
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Results
Ciliary Lengths
Scanning electron micrographs are shown to visualize this ciliary loss from the MKS3
depleted cells at different time points in the RNAi bacteria. Figure I.1 shows the MKS3 depleted
cells after 22, 46, and 70 hours (Figure I.1B-D) in the RNAi bacteria compared to the control cells
which were fed the L4440 bacteria for 70 hours (Figure I.1A). Cilia loss is observed by 22 hours
and is very evident at the 70 hour mark. Cilia loss and shortening occurs globally and the oral
grove cilia appear to be the last cilia lost from the MKS3 depleted cells.
To quantify the lengths of the remaining cilia, the MKS3 and IFT88 mRNA depleted and
control cells were permeabilized, fixed, and stained with anti-tubulin at 24-hour intervals. Our
quantitative analysis of cilia length included only those cilia present on the cells and does not
account for missing cilia. Many of the depleted cells had large bald patches and by 72 hours, the
depleted cells were mostly bald, especially the IFT88 depleted cells.
By 24 hours, both the MKS3 and IFT88 depleted cells had significantly shorter cilia than
the controls (P<0.0001, multiple T-tests) and by 48 hours, the IFT88 depleted cells showed shorter
cilia than both the controls (P <0.0001, multiple T-tests) and the MKS3 depleted cells (P <0.001,
multiple T-tests) (Figure I.2A). At 72 hours, both depleted cell lines had significantly shorter cilia
than the controls (P <0.0001, multiple T-tests), but no difference between each other. The
measurements from these different time points are shown in Table I.I.
Swimming Assays of Ion Channel Function
There is a large body of research on Paramecium ion channels and the importance of those
channels on swimming behavior (Eckert, 1972, Brehm et al., 1978, Eckert and Brehm, 1979, Kung
and Saimi, 1982, Ling and Kung, 1980). By changing the ionic environment and monitoring
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swimming behavior, we are able to decipher changes in ciliary ion channel function.
Depolarizing solutions, such as high Na+ (20 mM) or high K+ (30 mM), will open the voltage
gated calcium channels (CaV), which are found exclusively in the cilia (Dunlap, 1977), causing an
action potential and backward swimming as long as Ca2+ remains high in the cilia. Repolarization
of the cell by the activation of the voltage- and Ca2+- activated K+ channels (KV and KCa,
respectively) ends the action potential (Brehm et al., 1978). If Na+ or Mg2+ is present in the
surrounding solution, the action potential can be prolonged through the Ca2+-activated Na+
(INa(Ca)) (Saimi and Kung, 1980) or Ca2+-activated Mg2+ (IMg(Ca)) (Preston and Kung, 1994b, Preston
and Kung, 1994a) conductance.
MKS3 and IFT88 depleted wild type cells were tested in 24-hour increments to account
for changes over time. While the MKS3 and IFT88 depleted cells swam more slowly than control
cells, they were able to reverse their cilia and respond to the different test solutions. Some of
their responses to depolarizing stimuli were normal with the exceptions presented below.
20 mM NaCl: High Na+ usually elicits a quick reversal of the power stroke that causes a turn in
the swimming path, called an avoidance reaction. This solution tests the activity of Na+ channels
to cause backward swimming as well as K+ channels to repolarize the cell. It does not distinguish
between the KV and KCa channels. Because the length of time of backward swimming by the
control cells was shorter than can be timed by the stop-watch, the backward swimming durations
for these cells are presented in Table I.II. However, at each time point, both the MKS3 and IFT88
depleted cells show easily measureable long backward swimming compared to the controls
(P<0.0001, T-tests).
TEA solutions: Tetraethylammonium chloride (TEA) blocks the voltage-activated K+ current
(IK(V)) when applied to the cells externally (Satow and Kung, 1976). When TEA solution is
combined with a depolarizing stimulus, such as high Na+ (10 mM) or high Mg2+ (5 mM), cells will
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display long backward swimming and rely mostly on the KCa channels to repolarize the action
potential.
When depolarized with 10 mM NaCl in 25 mM TEA, both depleted cell types
demonstrated longer than normal backward swimming (Figure I.2B). The backward swimming
of the IFT88 depleted cells at 24 hours was significantly longer than both the control and MKS3
depleted cells (P<0.0001, T-tests). Both the MKS3 and IFT88 depleted cells showed longer than
normal backward swimming at 48 and 72 hours (P<0.0001, T-test). At 48 hours, the IFT88
depleted cells swam backward even longer than the MKS3 depleted cells (P <0.0001, T-test).
When the cells were depolarized with 5 mM MgCl2 in 25 mM TEA, the only difference
observed was by the IFT88 depleted cells (Figure I.2C). These depleted cells showed significantly
longer backward swimming at 24, 48, and 72 hours compared to both the controls and MKS3
depleted cells (P <0.0001, T-tests).
30 mM KCl: In high K+, paramecia depolarize beyond threshold and fire an action potential
resulting in transient backward swimming due to the activity of the CaV channel. After 24 hours
of feeding, the IFT88 depleted cells showed significantly shorter backward swimming (P <0.0001,
T-tests) (Figure I.2D). By 48 hours, both the MKS3 and IFT88 depleted cells showed shorter
backward swimming (P<0.0001, T-tests) with no further decrease at 72 hours.
Secretion Assay
Cells were exposed to picric acid to stimulate the secretion of the trichocysts, small (3-4
µm) organelles that are part of a regulated calcium-controlled secretion system in Paramecium
(Vayssie et al., 2001). Cells were scored as S (secretion), PS (partial secretion) or NS (no secretion).
We included the ND6 mutant of Paramecium, which lacks a membrane associated protein vital for
the last step of membrane fusion and exocytosis of trichocysts (Gogendeau et al., 2005). As
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expected, one hundred percent of these cells showed no secretion (Figure I.3A). The MKS3
depleted cells were statistically less likely to secrete their trichocysts and more likely to
demonstrate NS or PS when compared to the control and IFT88 depleted cells (ANOVA, post-hoc
unpaired T-test, P<0.05; bar with asterisk, Figure I.3A). Differential Interference Contrast images
(DIC) images show trichocyst secretion from the different cell types (Figure I.3B). The
representative control cell and IFT88 depleted cell both display secretions of the trichocysts
(arrow heads) while the ND6 cell shows only cilia (arrow) around its edge (NS). The DIC image
of the MKS3 depleted cell shows there are secreted trichocysts only at the posterior end of the cell
(arrow head). Of importance, of the MKS3 depleted cells scored as PS, over 70% failed to secrete
their trichocysts at the midline of the cell while none of the PS control cells shows such localized
failure to secrete.
Ultrastructure Analysis
Transmission electron microscopy (TEM) and ImageJ analysis (Rasband, 1997-2009),
showed no observable differences between the observed basal bodies of the control (Figure I.4A)
and MKS3 depleted cells (Figure I.4D). Cross sections of the control cilia, both transverse (Figure
I.4B) and longitudinal (Figure I.4C), showed that the structures were the same compared to the
MKS3 depleted cells (Figure I.4E and F, respectively). The basal bodies were comparable in size
and position: control basal bodies 379.6 ± 42.4 nm in length and 202.9 ± 22.8 nm wide (± SD,
N=13) and MKS3 depleted cell’s basal bodies 367.7 ± 35.5 nm long and 191.8 ± 21.9 nm wide (±
SD, N=14). However, a tangential section through the MKS3 depleted cell shows cilia missing
from cortical units (Figure I.4G, arrows).
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Discussion
We used feeding RNAi to further examine cellular functions that were interrupted in P.
tetraurelia upon depletion of the MKS3 protein. We used IFT88 as a positive control for our
approach because it is a well characterized ciliopathy gene and reduction of its mRNA should
result in short and missing cilia with no disruptions to the cell surface. While both depleted cell
types have short and missing cilia, the phenotype of MKS3 depleted cells differs from that of
IFT88 depleted cells. The differences cannot be explained simply by a reduction of ciliary length
or IFT function alone.
Depletion of MKS3 and IFT88 quickly lead to short and missing cilia
Our study clearly shows that cells reduced in MKS3 or IFT88 mRNA have short and
missing cilia. This phenotype for MKS3 depletion have been previously reported by ourselves
and others (Picariello et al., 2014, Dawe et al., 2007). Work by Dawe and colleagues (2007)
suggests the migration of centrioles to the cell surface for cilium formation requires both MKS3
and MKS1, another MKS ciliopathy protein. Paramecium has a homologue for the mammalian
MKS1 protein. The depletion of MKS1 in Paramecium leads to a separation of the cytoskeleton
from the cell membrane, essentially flattening the surface of the cells (Campillo et al., 2012).
MKS1 is another component of the transition zone MKS complex in mammalian cells, which
includes MKS3, to form a filter barrier between the cell and the cilia (Garcia-Gonzalo et al., 2011,
Williams et al., 2011, Czarnecki and Shah, 2012, Chih et al., 2012).
The depletion of MKS3 has been shown to create numerous cilia or centrioles when there
should only be one cilium or centriole, which is in contrast to our findings. One group identified
longer cilia when the MKS3 gene was missing in the bpck/bpck mouse model for kidney disease
(Cook et al., 2009). Another study by Tammachote et al. (2009) found that the MKS kidney cells
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from patients and IMCD3 cultured cells had multiple centrosomes, multiple cilia per cell, or cilia
of varying lengths on wpk rat kidney cells (Tammachote et al., 2009). In contrast, the confluent
mutant-MKS3 transfected HEK293 cells used by Dawe and colleagues (2007), while showing
multiple centrioles, had short or missing cilia. At no point in our study did we see longer or
more numerous cilia on the MKS3 depleted cells. Cook et al. (2009) speculated that if the RNAi
were allowed to run longer, that perhaps longer cilia would develop as seen in their MKS3 knock
out mouse model. However, in our experience, longer application of the MKS3 RNAi in
Paramecium by re-feeding is lethal. In Paramecium, it appears that depletion of MKS3 leads to a
shortening of cilia over time, which eventually disappear. Our study of P. tetraurelia, like that of
Dawe and colleagues (2007), found that MKS3 depletion causes short and missing cilia, but
unlike Dawe and colleagues (2007), we have found no evidence of altered centrosome number, or
in this case basal body number. There appears to be variations in reports of MKS3 depletion
perhaps due to cell types, state of confluence of cultured cells, and the methods used to disrupt
MKS3 by using RNAi or knock out.
MKS3 depleted cells show a deficiency in ciliary ion channel function
In depolarizing stimuli, the MKS3 and IFT88 depleted cells displayed different
phenotypes, even though both types have short and missing cilia. The IFT88 depleted cells’
behavior was consistent with the reduction of the Ca2+-activated K+ conductance (IK(Ca)). Because
there is abnormally longer backward swimming by the IFT88 depleted cells both in solutions of
TEA with Mg2+ and with Na+, we interpret the longer backward swimming to be due to an
ineffective IK(Ca) conductance rather than prolonged Na+ or Mg2+ inward conductance. In contrast
with IFT88 depleted cells, the MKS3 depleted cells’ prolonged backward swimming was specific
to Na+ solutions. The cells’ behavior was consistent with an overly long activation of the INa(Ca) as

258

evidenced by prolonged backward swimming in solutions with NaCl with or without TEA, but
not Mg2+ with TEA, which eliminates the IK(Ca) as the altered conductance.
Both depleted cell types have extremely short backward swimming in high K+ solution.
The short backward swimming could be from a reduced voltage-activated Ca2+ conductance
(ICa(V)) of the CaV channels that are exclusively in the cilia (Dunlap, 1977) or an increased IK(V).
Because our sodium data showed prolonged backward swimming, we expect IK(V) to be either
normal or decreased, consistent with the observed prolonged backward swimming. Therefore, a
decreased ICa(V) is the most likely reason for the altered behavior in depolarizing K+ solutions for
both cell types.
The voltage dependent Ca2+ channels, other than being exclusively in the cilia membrane,
are more concentrated at the distal end (Dunlap, 1977, Machemer and Ogura, 1979). Perhaps
shortening the cilia in both depleted cell types contributed to short backward swimming in
depolarizing K+ solutions, but shortening alone cannot account for the differences between the
depleted cell types in other solutions.
Interestingly, despite the decrease in ICa(V) as the cilia shorten in both depleted cell types,
there must be sufficient ICa(V) to cause the reversal of the ciliary power stroke and to activate the
KCa channels in the MKS3 depleted cells. KCa channels must reside in the cilia in order to be
activated (Husser et al., 2004). There is no spill-over of Ca2+ from action potentials from the cilia
to the cell body (Husser et al., 2004), and the Ca2+ for activating this KCa channel comes from the
ciliary CaV channels (Brehm et al., 1978, Satow and Kung, 1980).
These observations lead us to postulate that the P. tetraurelia IFT88 protein functions in
transport of both structural ciliary proteins and membrane channels, and reduction of IFT88p
leads to loss of the ciliary membrane proteins evenly as the cilia become shorter. The MKS3
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protein, on the other hand, appears to be critical for positioning the components of the cortical
units, including the basal bodies and ciliary cargo finding its way to the cell surface, including the
ciliary membrane.
MKS3, but not IFT88, depleted cells have decreased secretion
When exposed to picric acid to induce trichocyst secretion, the MKS3 depleted cells
demonstrated variable amounts of secretion while over 80% of the control and IFT88 depleted
cells showed full secretion of their trichocysts. The trichocysts dock at the plasma membrane at
specific sites (rosettes) on the ridges between the basal bodies that outline each cortical unit
(Allen and Hausmann, 1976). The majority of Ca2+ for this secretion is supplied by the alveolar
sacs (Hardt and Plattner, 2000). The reduced secretion of trichocysts at the midline is most likely
a secondary effect of the heavily disrupted membrane that does not allow for proper release of
the trichocyst vesicles.
The IFT88 depleted cells showed no disruption in their cell surface or secretion. Another
IFT protein, IFT20 in a complex with IFT88 and IFT57, was linked to secretion in non-ciliated
human lymphocytes (Finetti et al., 2009). We might have expected, based on these data, that the
IFT88 reduced paramecia would show reduced secretion compared to the controls, but this was
not the case.
MKS3 depleted cells have seemingly undisrupted basal bodies
Our ultrastructure analysis of the MKS3 depleted cells using TEM compared to the
control cells showed no glaring abnormalities with the observed basal bodies or cilia. Although
we did observe an instance where a tangential section of a MKS3 depleted cell showed missing
cilia (Figure I.4G), there were no other obvious abnormalities observed. The measurements of the
observed basal bodies in the control cells and the MKS3 depleted cells also showed no statistical
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differences in height or width or positioning. We would suggest for any future analysis, that the
population of cells used for ultrastructure studies be heavily hit with RNAi, possibly by refeeding the cells. More sections of cells and if possible, consecutive sections, should be used for
analysis to help to ensure what we were examining with TEM were highly depleted MKS3 RNAi
cells. Lastly, the concentration or cleaning of our Paramecium MKS3 antibody could be used to
label the MKS3 protein for TEM immunogold labeling. The antibody is not currently up for this
task, but in the future, the cleaning and concentration of the antibody using an ammonium
sulfate purification could produce a more useful antibody against Paramecium MKS3.
Conclusions
The data presented here demonstrate that feeding RNAi to deplete the mRNA for MKS3
and IFT88 interferes with ciliary channels and secretion of membrane organelles, namely the
trichocysts. IFT88 and MKS3 depleted cells share the phenotype of deficiencies in CaV channel
function, most likely due to the global shortening of the cilia. However, the two depleted cell
types differ in other apparent ciliary ion channel defects. The IFT88 depleted cells showed
defects in IK(Ca) while MKS3 depleted cells showed prolonged activation of INa(Ca). The reduced
secretion of the MKS3 depleted cells is most likely due to the disruption of their cell surface,
interfering with the docking of the trichocysts. The hallmark of the MKS3 depleted cells is
disrupted basal body rows and cortical units, and short and missing cilia. Our structural analysis
of the basal bodies demonstrates they are normal in their length and width. More information is
needed concerning basal body orientation along the anterior-posterior axis of the cell. Current
work is underway to investigate the interactions with the rootlet system of Paramecium.
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Table I.I: Cilia length measurements over time for MKS3 and IFT88 depleted cells compared to
the control cells.
Control (µm)

MKS3 (µm)

IFT88 (µm)

24 hours

9.7 ± 0.1 (293; 8)

7.4 ± 0.1 (400; 9)*

7.0 ± 0.2 (377; 8)*

48 hours

9.6 ± 0.1 (339; 8)

4.5 ± 0.1 (482; 6)*

3.7 ± 0.1 (347; 9)*^

72 hours

9.6 ± 0.1 (191; 3)

3.7 ± 0.1 (412; 3)*

3.7 ± 0.2 (279; 3)*

All values are µm ± standard error of the mean. Values in parentheses are the number of cilia
measured and the number of cells used to obtain those measurements, respectively. Bald patches
and missing cilia were not quantified and are not reflected in these data. (*= P<0.0001 compared
to the controls, unpaired T-test; ^=P<0.001 compared to MKS3 depleted cells, unpaired T-test).
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Table I.II: Backward swimming time for control and MKS3 or IFT88 depleted cells in 20 mM
NaCl.

24 hours

48 hours

72 hours

Control

0.65 ± 0.23 (85)

0.55 ± 0.23 (91)

0.02 ±0.02 (75)

MKS3

12.39 ± 1.39 (90)*

32.55 ± 3.00 (91)*

30.64 ± 3.28 (61)*

IFT88

22.43 ± 1.79 (93)*^

50.02 ± 3.10 (93)*^

34.70 ± 3.75 (48)*

Data are seconds ± standard error of the mean, (number of cells). *=P<0.0001, unpaired T-tests
compared to the controls; ^=P<0.0001, unpaired T-tests, compared to MKS3 depleted cells.

268

Figure I.1: Time course study of MKS3 depleted cells compared to a control cell. Control cells
were fed the bacteria for 70 hours (A) and MKS3 depleted cells were fed the RNAi bacteria for 22
hours (B), 46 hours (C) and 70 hours (D). MKS3 depleted cells show short and missing cilia at 22
hours and by 70 hours there are few cilia remaining and the surface is disrupted. Cells shown are
representative of the population. Scale bars are 10 µm.
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Figure I.2: Changes in cilia length and backward swimming over time in MKS3 and IFT88
depleted cells compared to control cells. (A) RNAi depleted cells were observed in 24 hour
increments for shortening of the cilia using immunofluorescence. Short cilia on MKS3 and IFT88
depleted cells seen by 24 hours became shorter over time. Data are average µm ± standard error
of the mean; tabulated data can be seen in Table I.I.

(B, C, D) Normalized backward swimming

(see Materials and Methods), averages are ± standard error of the mean in NaCl with TEA (B),
MgCl2 with TEA (C) and KCl (D). In all graphs, asterisk indicates statistical significance
compared to the control (P<0.0001, unpaired T-test) or between the indicated data sets MKS3 and
IFT88 (P<0.001, unpaired T-test). Statistical tests were performed on the raw data, not the
normalized data.
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Figure I.3: Secretion of trichocysts induced by picric acid. Cells of each type (non-discharge 6
(ND6), control fed RNAi and MKS3 or IFT88 depleted) were concentrated, washed, and exposed
to picric acid. Trichocyst secretion was classified as S (secretion), PS (partial secretion), or NS (no
secretion). (A) Histogram shows the percentage of S, PS and NS of each cell type ± standard error
of the mean, asterisk=P<0.05, ANOVA, post hoc unpaired T-tests). (B) DIC images show
trichocyst secretion; scale bars: 20 µm. Arrows indicate cilia, arrow heads indicate discharged
trichocysts. Cilia appear as a ring around the control and ND6 cells.
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Figure I.4: Transmission Electron Micrographs of control fed and MKS3 depleted RNAi cells.
Control (A, B and C) and MKS3 depleted cells (D-G). Of the basal bodies observed, there were no
obvious ultrastructure differences between the control and MKS3 depleted cells. However, a
tangential section of an MKS3 depleted cell demonstrates missing cilia (arrows). a=alveolar sac,
bb= basal body, ax= axoneme. Scale bars: 100 nm except G, scale bar: 1 µm.
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Appendix II: The eccentric gene (XNTA) in Paramecium
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Abstract
The XntA protein is a small protein of somewhat unknown function in P. tetraurelia.
Although XntA has been described as a channel-like protein partially based on its predicted
structure, it appears to be involved in numerous signaling pathways other than the Ca2+dependent Mg2+ conductance for which it is known. We have suggested previously (Chapter 3)
that the XntA protein may be involved in stabilizing proteins, namely Pkd2, in membrane
microdomains. In this work, we use expression of XNTA and truncated and mutated versions of
XNTA in the XntA1 mutants, immunofluorescence, co-immunoprecipitations, and
electrophysiology in an attempt to better understand the XntA protein and its function in P.
tetraurelia. We demonstrate that the XntA protein must be full length to cure the mutant. We also
show that XntA-myc and Pkd2-FLAG co-IP from whole cell extract but that although we observe
epitope-tagged proteins on Western blots, we only identified peptides from Pkd2-FLAG when
FLAG was the IP target using LC-MS/MS analysis. Lastly, we show that ciliated XntA1 mutant
cells do not hyperpolarize their membrane in the presence of folate. When deciliated, the XntA1
cells do not hyperpolarize in the presence of acetate. Both of these actions were different than
that of wild type cells. Hyperpolarization of the membrane in the presence of L-glutamate
remains unchanged between the wild type cells and the XntA1 mutants but when these cells
were deciliated, no hyperpolarization of the membrane was observed in the presence of Lglutamate. These data support the localization of the L-glutamate receptor in the cilia. The data
presented here continue to suggest that the XntA protein is not a channel, but instead may be
important in stabilizing proteins in membrane microdomains for important signaling pathways.
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Introduction
Magnesium ions are important for numerous enzymatic reactions, including ATP and
ADP synthesis, protein synthesis, and neurotransmitter release, to name a few (Maguire and
Cowan, 2002). Magnesium is also required for the bending of cilia and is needed for the beating
of the cilia in the model organism Paramecium. Previous research had also shown that extracted
models of this cell, permeabilized with the non-ionic detergent Triton X-100, would reverse the
orientation of the cilia on the cell surface toward the anterior of the cell in the presence of ATP
and Mg2+ (Kung and Naito, 1973). In the ‘90’s, researchers demonstrated that Paramecium has a
robust inward Mg2+ current that is calcium dependent. When activated, it causes a
depolarization of the cell (Preston, 1990). The membrane of Paramecium will depolarize in the
presence of Mg2+ and Ca2+, causing an influx of both ions, a prolonged action potential, and a
reversal in the ciliary beat (Preston, 1990). The intracellular free Mg2+ concentration of
Paramecium, shown to be ~0.4 mM (Preston, 1998, Preston, 1990) is not much different than that of
other excitable cells, ~0.3 to 0.7 mM (Alvarez-Leefmans et al., 1987). Paramecium also has a
second uncharacterized intracellular store of Mg2+ that is close to 8 mM (Preston, 1998, Preston,
1990).
In an attempt to better understand the regulation of Mg2+ across the membrane of
Paramecium, Preston and colleagues (1994a,i) created mutants deficient in their Mg2+ conductance.
Site-directed mutagenesis in Paramecium is essentially impossible due to the multiple nuclei of
these cells. Therefore, a population of cells was mutated using a general mutagen, N-methyl-N’nitro-N-nitrosoguanidine (MNNG) which causes the methylation of guanine residues, creating 7methylguanines (Craddock, 1968). Those cells that survived the mutagen were then allowed to
go through autogamy (Preston and Kung, 1994h, Preston and Kung, 1994a). The process of
autogamy causes the breakdown of the somatic macronucleus followed by the meiotic division of
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the germ line micronuclei. The four meiotic products are reduced to one which then divides
mitotically to create a diploid cell that is homozygous for all genes (reviewed in (Kung et al.,
1975)). The paramecia that survived the mutagen and autogamy were briefly cultured and then
screened for cells deficient in their response to Mg2+.
Two types of single-gene mutations were identified in the created mutants that were
deficient in their response to Mg2+. The recessive mutations were unlinked occurring in two
separate genes, XNTA and XNTB. The XntA and XntB mutants showed no or reduced inward
Mg2+ current (IMg), respectively (Preston and Kung, 1994h, Preston and Kung, 1994a). The XntA
mutants showed a resistance to heavy metal paralysis of their cilia, a reduced ability to deactivate
their depolarization activated Ca conductance (ICa(d)), and a rapidly deactivating Na+-dependent
Ca2+ current (INa(Ca)) (Preston and Kung, 1994h, Preston and Kung, 1994a). How the mutation in
the XNTA gene leads to the slow deactivation of the Ca2+ conductance and the rapid deactivation
of the INa(Ca) is unknown. In 2002, when the gene XNTA gene was sequenced and identified, the
authors speculated that perhaps XntA was an accessory protein that can affect the activity of
other channels, such as a kinase or a regulatory protein. The authors concluded, based on the
amino acid sequence analysis and their rescue studies, that XntA was a channel-like exchanger
protein (Preston and Kung, 1994h, Preston and Kung, 1994a, Haynes et al., 2002). However, none
of the rescue studies that were done addressed the two conductances other than the Ca2+dependent Mg2+-conductance nor did they address the heavy metal resistance of the mutant. A
complete understanding of the XntA protein and its function was incomplete.
The XNTA gene (PTETG4300006001) was identified through multiple injections into the
XntA1 mutant of plasmids containing fragments of the wild type genomic library (Haynes et al.,
2002). XNTA is 1707 nucleic acids long, with two introns located near the 5’ end. The mRNA is
1653 nucleic acids, coding for 550 amino acids. The sequence can be broken into two regions, an
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α1 and an α2 region, with five and six predicted transmembrane spanning segments,
respectively. These two regions have very low levels of homology to the K+-dependent Na+/Ca2+
exchangers. These two regions are connected by a large intracellular loop which contains a
potential PEST sequence (Haynes et al., 2002) and a potential ubiquitination site at lysine (K)
position 300. A PEST sequence is an amino acid sequence rich in proline, glutamic acid, serine,
and threonine. These sequences serve as proteolytic signals, targeting proteins for rapid
degradation (Rechsteiner and Rogers, 1996). Expression of wild type XNTA in the XntA1 mutant
returns the IMg(Ca) to these cells. The expression of the XNTA gene in the XntB mutant, however,
does not show curing of the XntB mutant and vice versa (Haynes et al., 2002). The sequence of
XNTB remains unknown.
The return of the IMg(Ca) in the XntA1 mutant by expressing the XNTA gene has been
demonstrated by both voltage clamp experiments as well as by measuring the backward
swimming times of cells in solutions that contain Mg2+ (Haynes et al., 2002). The backward
swimming of Paramecium can be used as a measurement of ion conductance by proxy. Paramecia
cells typically swim forward, but if stimulated by a repellent or physical interaction at the
anterior end of the cell, the membrane may depolarize beyond threshold causing an action
potential. The increase in membrane potential causes the activation of the voltage-dependent
calcium channels of the cilia and calcium to enter the cilia. The transient increase in the ciliary
calcium concentration causes the cilia to reverse their power stroke from one towards the
posterior of the cell to one that is toward the anterior. The cilia will remain beating strong
toward the anterior of the cell as long as calcium remains high. The depolarization of the
membrane is countered by the efflux of K+ ions through the voltage-dependent and Ca2+dependent K+ channels, also presumably in the cilia (Brehm et al., 1978, Satow and Kung, 1980).
The duration of the action potential and therefore the length of time a cell swims backward can
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be prolonged by the presence of other ions in the bath, such as Na+ and Mg2+ which activate the
Ca2+-dependent Na+ and Mg2+ conductances, respectively.
In this work, we examine the expression of the XNTA gene in the XntA1 mutants by
expressing fragments of the gene in order to determine whether the entire gene is necessary for
the return of IMg(Ca) in the XntA1 mutant. We have also used immunofluorescence to look for the
localization of some of the truncated versions of the XntA protein within the cell. Whole cell
extracts of cells expressing XNTA-myc and PKD2-FLAG or control cells expressing FLAG and
myc were used for immunoprecipitation (IP) in an attempt to co-IP the PKD2-FLAG and XntAmyc proteins. Gels were used for both silver staining and LC-MS/MS analysis of select bands
while others were transferred to nitrocellulose and developed using antibodies against the
epitope tags. Although these proteins appear to co-IP from whole cell lysate, only the Pkd2
protein was identified using LC-MS/MS analysis. Finally, we used electrophysiology to examine
membrane potential changes in the wild type and XntA1 mutant cells. We determined that there
is no difference between the wild type and XntA1 mutants in 5 mM and 1 mM KCl solutions.
Examining both ciliated and deciliated cells in typical attractants for Paramecium such as folate,
glutamate and acetate provided novel findings that deciliated cells did not show a significant
hyperpolarization in glutamate solutions and also, that the XntA1 mutants were not as receptive
to the attractants as the wild type cells. Our data suggest the XntA protein may have roles within
the cell and ciliary membrane that are separate from XntA being a Mg2+ channel but instead
perhaps as a stabilizer of proteins in membrane microdomains.
Materials and Methods:
All research was done using Paramecium tetraurelia, 51-s (sensitive to killer) or the
mutant XntA1. Cells were cultured as previously described (Sasner and Vanhouten, 1989,
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Valentine et al., 2012). Injected cells were maintained at 15°C and cultured at 22°C. Culture
medium was inoculated with Klebsiella pneumoniae or Aerobacter aerogenes.
Plasmid Creation
The plasmids used for microinjection are a modified version of the pPXV-GFP plasmid
(gift of Dr. W. John Haynes). The creation of this plasmid has been previously described
(Valentine et al., 2012). Briefly, a GFP sequence was removed and a triple-FLAG sequence was
inserted (DYKDDDDK)x3. The Kpn I cut site at the 3’-end of the 3×FLAG sequence was mutated
to create a stop codon. The existing restriction enzymes on the 5’-end of the 3×FLAG sequence
were utilized to insert a linking sequence with the following order of restriction enzyme cut sites:
SpeI – Apa I – Sac I – Nhe I. These restriction enzyme cut sites allowed for the cloning of the
fragments of the XNTA gene to be inserted into the pPXV plasmid after primers were used to
amplify the sequences and create the necessary restriction enzyme cut sites using Platinum®Pfx
Taq polymerase (Life Technologies, Grand Island, NY). The primer sequences used for DNA
sequencing and for the creation of the different XNTA constructs are shown in Table II.I. The
different combinations of the primers used to create the constructs and the positions in the XNTA
sequence that the constructs consist of are shown in Table II.II. The PCR conditions used to
create the inserts of XNTA were all the same (shown below). Template for the PCR was the
previously made and sequenced XntA-FLAG plasmid DNA at 50 to 100 pg per PCR reaction.
The N-terminus of XntA (N-term XntA) included the first five transmembrane spanning regions
and the intracellular loop with the PEST sequence. The C-terminus of XntA (C-term XntA)
included the entire 3’end of the DNA sequence starting just after the first five transmembrane
spanning regions. The C-terminus plus two the last two transmembrane domains from the Nterminus (C+2N XntA) starts from position +390. The K300R plasmid contains a mutated lysine
(K) to an arginine (R) at position 300. The lysine at position 300 was predicted to be a
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ubiquitination site targeting the protein for degradation. The creation of the K300R version of the
gene is described below. A diagram of each insert is shown in Figure II.1.
The following PCR cycles were used to create the constructs: 94°C for 5 minutes; then 5
cycles of 94°C for 1 min, 52°C for 1 min, 68°C for 2 min; 5 cycles of 94°C for 1 min, 58°C for 1 min,
68°C for 2 min; and twenty cycles of 94°C for 1 min, 61°C for 1 min, 68°C for 2 min. PCR reactions
were checked on a 1% agarose gel stained with ethidium bromide and visualized using UV light.
Resulting bands of expected sizes were removed using a razor blade and cleaned using the
PrepEase® Gel Extraction kit (Affymetrix) as per the kit’s instructions. Extracted and cleaned
DNA was ligated into the prepared pPXV-C-FLAG plasmid using the restriction enzymes Spe I
and Nhe I (New England BioLabs). Ligated plasmids were cloned into chemically competent
DH5α bacteria as previously described (Valentine et al., 2012).
K300R was made by mutating the potential ubiquitination site at position 300 from a
lysine (K) to an arginine (R). This was done using two primers to change an adenine to a guanine
(bold), forward primer: 5’-CCTCAAAGTGCAATAAGATAAAGAAATGATT-3’, and reverse
primer: 5’-TTATTCATCATTTAGTTATTATCTTTACTTCTATTTTGG-3’. The mutation was done
using the Finnzymes Phusion® Site-Directed Mutagenesis Kit (Finnzymes/Thermo Fisher) as per
the kit instructions. The primers were phosphorylated separately using 1 U (0.3 µL) T4 PNK (Life
Technologies) in the appropriate buffer with 5 µL of 10 mM ATP in a 50 µL reaction at 37°C for 30
minutes. The T4 kinase was then deactivated by heating the reaction at 65°C for 20 minutes. 0.5
µM (2.5 µL) of each phosphorylated primer was mixed in a 50 µL reaction with 0.5 mM dNTPs,
700 pg of XntA-FLAG plasmid, 10 µL of 10x Phusion buffer, water and 0.5 µL HSII DNA
Polymerase. The reaction was heated to 98°C for 30 seconds, followed by 98°C for 30 sec, 67°C
for 30 sec, and 72°C for 3 minutes. A final extension of 72°C for 10 minutes was then completed
and the reaction cooled to 4°C. 5 µL of this reaction was added to 100 µL of competent DH5α E.
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coli bacteria and incubated on ice for 20 minutes. The bacteria were then heat-shocked at 42°C for
one minute then plunged on ice. 250 µL of SOC media was added to the bacteria which were
then shaken at 37°C for 1 hour. The bacteria were then spread on two LB-AMP plates for growth
overnight at 37°C. The resulting bacteria colonies (10) were screened by isolating plasmid from
three of the colonies and sending the plasmid for sequencing. All three colonies were positive for
the mutation K300R.
We used previously described plasmids in this work, including XNTA-FLAG and XNTAmyc (Chapter 3). Also, the PKD2-FLAG plasmid was previously published (Valentine et al.,
2012). A double-tagged XntA construct was also created for study, although it was not used. The
C-FLAG plasmid that was digested with Spe I and ligated the 3×myc sequence into the plasmid.
The 5’-end of the primer contained a start codon sequence (bold) followed directly by the 3xmyc
sequence. The 3×myc sequence was created by fusing two complementary primers together as
previously described (Valentine et al., 2012). The upper sequence primer: 5’CTAGTATG[GAACAAAAATTGATTTCAGAAGAAGATTT]×3A-3’ was fused to the lower
sequence primer: 5’- CTAGT[CAAATCTTCTTCTGAAATCAATTTTTGTTC]×3CATA. The
double-stranded DNA was then ligated into the open pPXV-C-FLAG plasmid using LigateIT®
(Affymetrix) as per the kits instructions.
Cracking Gel
To screen bacterial colonies, 30 overnight shaking cultures were started from the
resulting bacterial colonies in 50 µL LB containing 100 µg/mL AMP. Five µL of the overnight
shaking culture was mixed with 6 µL Lysis buffer [0.1 N NaOH, 10 mM EDTA, 1% sodium
dodecyl sulfate (Life technologies), 10% glycerol (Affymetrix, Santa Clara, CA)] and 2 µL Loading
buffer [0.25% bromophenol blue, 0.25% Xylene Cyanol FF, 30% glycerol (Affymetrix)]. Samples
were loaded into a 0.75% Agarose (Affymetrix) gel and 2 µL of Supercoiled DNA ladder (Life
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Technologies) was added in one lane as a standard. After being run at 100 mA for approximately
45 minutes, the gel was visualized by soaking in ethidium bromide for 40 minutes and visualized
with UV light. Colonies producing bands of the appropriate size were used to start overnight
cultures with 6 mL LB containing 100 µg/mL AMP.
Plasmid Extraction
Plasmids were extracted using the Wizard® Plasmid extraction kit (Promega, Madison,
WI). Briefly, 5 mL of the overnight culture was centrifuged in a 15 mL sterile centrifuge tube at
1875 × g (3400 rpm) for 15 minutes. The resulting pellet was resuspended in 400 µL Cell
Resuspension Buffer (50 mM Tris, 10 mM Na2EDTA, and 0.1 mg/mL RNase I). The sample was
moved to a 1.5 mL Eppendorf tube and mixed with 400 µL Cell Lysis Buffer [0.2 M NaOH and
1% sodium dodecyl sulfate (Life technologies)]. Samples were lysed at room temperature for 5
minutes, then the pH was neutralized using 400 µL of Neutralization buffer (0.13 M potassium
acetate, pH 4.8). The tube was spun at 18,407 × g for 8 minutes (Eppendorf 5424 Centrifuge,
Hauppauge, NY). A 3 mL Luer-lock syringe was prepared by placing a Wizard® Column
(Promega) on the syringe and adding 1 mL of Resin Solution (Promega). The supernatant from
the spun sample was then added to the resin and forced into the column using the plunger. The
column was washed using 2 mL of Column Wash (80 mM potassium acetate, 8.3 mM Tris, 40 µM
Na2EDTA and 55% Ethanol). The column was dried by placing it on a 1.5 mL Eppendorf tube
and spinning for 2 minutes at 18,407 × g. The column was then moved to a new tube and 25 µL
of MilliQ water was added to the column to dissolve the plasmid. The sample was spun for 2
minutes at 18,407 × g. The collected water was passed through the column again to increase the
yield. The concentration of the eluted plasmid was checked using the Agilent spectrophotometer
(Agilent, Santa Clara, CA) (O.D. of 260 and 280 nm) and stored at -20oC for later use. Twenty µg
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of the plasmid at a concentration of 50 ng/µL was sent for sequencing at the Vermont Genetics
Center DNA Facility (University of Vermont, Burlington, VT).
All plasmids were prepped for microinjection as previously described (Valentine et al.,
2012). Approximately 5 pL were injected into the macronucleus of XntA1 mutants which were
checked for Mg2+-induced behavior before injection to ensure they had no reaction in that
solution. Control cells were injected with the FLAG plasmid as all constructs contained a Cterminal FLAG tag. If cells were to receive a second plasmid for injection, they were first
screened using genomic DNA extraction and PCR to ensure they contained the exogenous
plasmid. Only then would some cells receive the second plasmid. After all injections, cells were
maintained as individual clones at 15°C. All injected cells were tested for the exogenous plasmid
by extracting genomic DNA and performing PCR using XNTA primers as well as primers specific
to the exogenous pPXV plasmid. All primers can be found in Tables II.I and II.II. The PCR
conditions were as follows: 94°C for 5 minutes, then 30 cycles of 94°C for 1 min, 42°C for 1 min,
68°C for 2 min, followed by a final extension of 68°C for 10 minutes. PCR products were
visualized on a 1% agarose gel using ethidium bromide. Positive cell lines were maintained for
no more than 4 weeks at 15°C with regular feeding to prevent autogamy.
Behavior Assays
We used different ionic stimuli to examine paramecia for ion channel defects. The
swimming behavior of these cells are governed by their membrane potential. By exposing
paramecia to different ionic solutions and observing their swimming behavior (i.e., backward
swimming assays), we are able to infer ion conductances across the membrane. All the solutions
contain the base buffer of 1 mM calcium citrate and ~1.3 mM Tris Base
([Tris(hydroxymethyl)aminomethane]). Additional salts were then added and the pH adjusted to
7.02 to 7.05 using 100 mM Tris Base. The following salts were added to the base buffer: 25 mM
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TEA (tetraethylammonium chloride) with 5 mM MgCl2 (Mg/TEA) and a resting buffer that
contained 4 mM KCl.
After screening the cells for the injected plasmid, the cells were subjected to backward
swimming assays in the MgCl2 with TEA solution. The main phenotype of the XntA1 mutant is
the inability to swim backward in Mg2+ solutions because of the missing IMg(Ca) (Preston and
Kung, 1994h, Preston and Kung, 1994a). We wanted to observe the ability of the small fragments
of XntA to cure the XntA1 phenotype. Cells were transferred, approximately 20 at a time, to 500
µL of resting buffer (4 mM KCl in base buffer) and allowed to acclimate for at least 15 minutes.
Cells were then transferred one at a time using specially made Pasteur pipettes to 100 µL of the
test solutions and the time the cells spent swimming backward was timed using a stop watch.
Once the cells returned to a forward swimming pattern, the stop watch was stopped and the time
recorded. Test solutions were changed after ~5 cells had been tested in it. All tests were done in
glass depression slides using dissecting microscopes.
Immunostaining
Immunostaining was done as previously described (Valentine et al., 2012). Merged
images are shown. Primary antibodies used were 1:1000 rabbit anti-centrin (Gift from Dr. Mark
Winey, University of Colorado, Boulder, CO) to highlight the basal bodies just below the cell
surface and 1:500 mouse Anti-FLAG (Sigma M2 clone). Secondary antibodies were Alexa Fluor®
donkey anti-mouse 488 and donkey Anti-rabbit 568, 1:250 dilution. Images were taken using the
DeltaVision Microscope system using an Olympus IX70 microscope PlanApo 60x/1.4 oil lens.
Images presented are stacks of Z-sections and are approximately 10 to 20 µM thick. Images are
representative of the population.
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Whole Cell Extract IP
Whole cell extract was adapted and completed as published in previous works (Nachury
et al., 2007, Valentine et al., 2012). Briefly, cells were washed twice in 200 mL cold Lap200 Buffer
(50 mM HEPES, 200 mM KCl, 1 mM EGTA, 1 mM MgCl2, pH 7.8) and then in 100 mL cold
Lap200 with protease inhibitors: 1 mM Phenylmethylsulfonyl fluoride (PMSF) (Sigma), 1 µg/mL
Leupeptin (Research Products International) and 1 µg/mL Pepstatin A (Research Products
International). Cells were then homogenized in less than 8 mL of Lap200 with protease
inhibitors. The protein concentration of the homogenate was determined using a BCA protein
assay (ThermoFisher) and the volumes and concentrations equalized between the two samples,
test and control. Five µL of sample was removed from each for a loading control and enough
Triton X-100 was added to each sample for the final concentration to be 1%. Proteins were
solubilized while rocking for one hour on ice. Insoluble protein was removed by centrifugation
at 31,000 × g for 20 minutes and then 100,000 × g for one hour, both at 4oC. The final supernatant
was then used for immunoprecipitation (IP) using FLAG or myc affinity agarose (Sigma) as
previously described (Valentine et al., 2012).
SDS-PAGE, Western Blots, Silver Staining, and LC-MS/MS
To examine proteins present in the IPs from whole cell extracts, the agarose affinity beads
were mixed with 30-35 µL of sample buffer and 2 µL β-mercaptoethanol then boiled for 5
minutes. Samples were plunged into ice and then spun at 4°C for 5 minutes to pellet the beads.
Samples were separated on 7-15% acrylamide gels using 10 µL of Thermo Scientific™
PageRuler™ prestained protein ladder or 30 µL of diluted Benchmark™ protein ladder (Life
Technologies) as a molecular mass standard. For Western blots, proteins were transferred to
Nitrocellulose paper (Pall Gelman, Port Washington, NY). For mass spectrometry, gels were
silver stained. Transfers to nitrocellulose paper was done using a wet tank transfer in transfer
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buffer (40 mM glycine, 50 mM Tris Base, and 20% methanol). Gels were transblotted at 390 mA
for an hour and 20 minutes, then 250 mA for an hour and 20 minutes at 4°C.
Blots were developed using either Enhanced Chemiluminescence (ECL) or alkaline
phosphatase (AP). For ECL, blots were blocked in 10 to 20 mL 5% Non-fat Dry milk in TBS-T (15
mM Tris-HCl, 140 mM NaCl, 0.1% w/v TWEEN®-20 (Sigma), pH 7.5). For AP blots, 2% w/v
Telost gelatin from fish (Sigma) and 3% Normal Goat Serum (Vector Labs, Burlingame, CA) was
added to the milk and TBS-T mixture. Blots were blocked for one hour at room temperature
before primary antibodies were added. ECL blots were rinsed three times, 1× 15 minutes, 2× 5
minutes, with approximately 20 mL of TBS-T before the primary antibodies were added in TBS-T.
AP blots were given the primary antibody in the blocking buffer. Primary antibodies and their
dilutions included: rabbit or mouse Anti-FLAG M2 clone (Sigma) 1:2500; rabbit or mouse Anti-Cmyc (GenScript, Piscataway, NJ), 1:2000; mouse Anti-Tubulin, acetylated (Sigma), 1:10,000. Blots
were incubated in primary antibody overnight at room temperature (TBS-T) or 4°C (milk
blocking buffer). The following day, the blots were rinsed three times with ~20 mL TBS-T before
the addition of the secondary antibodies in TBS-T, 1:10,000 dilution. Secondary antibodies
included donkey Anti-rabbit IgG HRP conjugate (GE Healthcare), goat Anti-rabbit IgG AP
conjugate (Sigma), goat Anti-mouse IgG HRP conjugate (Thermo Scientific), and goat Anti-mouse
AP conjugate (Sigma). After one hour, blots were washed 4× with ~20 mL TBS-T and then
developed using 15 mL BCIP/NBT substrate (Moss, Inc., Pasadena, MD) or SuperSignal West
Pico Chemiluminescence Substrate (Thermo Scientific) as per the kit’s instructions.
Silver staining was completed as previously described (Valentine et al., 2012) using the
FASTSilver™ staining kit (G-Biosciences, St. Louis, MO). After stopping the reaction with 2%
acetic acid, gels were stored at 4°C in fresh 2% acetic acid until they were processed. Gels were
processed for LC-MS/MS analysis as soon as possible after silver staining. The gels were cut,
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destained, and processed for LC-MS/MS as previously described in Chapter 2 and 3 and in other
reports (Valentine et al., 2012, Yano et al., 2013, Picariello et al., 2014).
Electrophysiology
Cells used for electrophysiology were in early logarithmic growth phase. Glass
electrodes for recording membrane potential were pulled using 1 mm borosilicate glass capillary
tubes (with filament) (World Precision Instruments, Sarasota, FL) by a Narishige pipet puller
(Japan). The pulled electrodes were back filled with 500 mM KCl, showing a resistance in the
starting bath of between 40 and 110 MΩ. The resting membrane potential of the cells was
continuously recorded using a Warner Intracellular Electrometer IE-251A (Warner Instruments,
Hamden, CT) processed through AD Instruments PowerLab 4/35 and analyzed using LabChart
Pro (AD Instruments, Colorado Springs, CO). The main chamber bath was filled with 5 mM KCl
in base buffer (See Behavior Assays). The main chamber was grounded to a 3M KCl reference
bath connected by a 3% agar in 3 M KCl bridge sealed with Vaseline. The main chamber bath
was under a constant controlled flow of buffer using a Buchler polystaltic pump (Buchler, Fort
Lee, NJ) set to a flow rate of ~3 mL/min. The membrane potential recordings began in 5 mM KCl
and cells were allowed to acclimate for 4 to 6 minutes before the chamber bath was changed to an
attractant solution. The cells was given four minutes in the test solution then returned to 5 mM
KCl for another 4 minutes before the next attractant solution was applied. Membrane potentials
were noted down after the four minutes. Attractant solutions were prepared in the base buffer
previously described (Behavior Assays). The K+ ion concentration was maintained between the
resting solution and the attractant solution. Solutions included 5 mM K-acetate, 5 mM K-DGlutamate, 5 mM K-L-Glutamate, and 2.5 mM K2-Folate.
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Results
The swimming speed and direction of ciliary beat in Paramecium is governed by its
membrane potential (Naitoh, 1968, Van Houten, 1979). These cells will depolarize in strong ionic
solutions, such as Mg2+ concentrations above 0.5 mM, which will activate the ciliary voltagegated calcium channels (Preston, 1990, Preston, 1998). When these channels open, calcium enters
the cilia causing them to reverse their power stroke, propelling the cell backward. As long as
calcium remains high, the cell will continue to swim backward. The presence of Mg2+ in the bath
allows for activation of the IMg(Ca) which prolongs the depolarization (Preston, 1990) and
therefore, the backward swimming duration. The addition of TEA further prolongs the
backward swimming as this chemical blocks the fast-acting repolarizing K+ conductance (Satow
and Kung, 1976, Satow and Kung, 1980). The XntA1 mutant, which does not swim backward in
Mg2+ solutions, lacks the IMg(Ca) and does not depolarize in the presence of Mg2+ (Preston and
Kung, 1994h, Preston and Kung, 1994a, Haynes et al., 2002).
The injection of the wild type XNTA gene into the macronucleus of this mutant has been
shown previously to recover the IMg(Ca) and backward swimming in the XntA1 mutant (Haynes et
al., 2002). Our data also suggest that we were able to cure the mutant by expressing XNTAFLAG, but not to the level of wild type cells (Figure II.1 and II.2). Our previous findings
suggested this protein is cleaved into smaller fragments and could be degraded very quickly (See
Chapter 3). A single potential ubiquitination site was identified at K300 using UbPred
(www.ubpred.org) with a high confidence rating. XntA also has a predicted PEST sequence (302
RNDQQDNDQDDNPLIDSNPMESVH 325). The predicted PEST sequence was found using
Emboss epestfind (http://emboss.bioinformatics.nl/cgi-bin/emboss/epestfind) and the
sequence was published previously (Haynes et al., 2002). These two sites, the PEST sequence and
the potential ubiquitination site, may target the XntA protein for early degradation which could

290

explain the smaller fragments that we find. In an effort to prevent ubiquitination, we mutated
the lysine to an arginine. Arginine was chosen because it is similar to lysine, but ubiquitination
cannot occur. After creating the truncated and mutated versions of the XNTA gene, we
expressed these genes in the XntA1 mutant and examined the cells for a return Mg2+-induced
behavior. Depictions and backward swimming times of the different XNTA genes expressed in
the XntA1 mutant as well as the wild type control data are shown in Figures II.1 and II.2. All
backward swimming times were analyzed using unpaired T-tests.
Expression of the N-terminus of XntA (N-term, amino acids 1-357) showed no rescue of
the mutant, essentially no backward swimming in Mg/TEA solution was observed (Figure II.1
and II.2). The expression of the C-terminus of XntA (C-term, amino acids 177 to 550, 353 amino
acids in length) and the expression of the C-terminus plus the last two transmembrane spanning
regions of the N-terminus (C+2N, amino acids 112-550, 438 amino acids in length) showed a
small, but significant, amount of backward swimming in Mg/TEA solutions. These data suggest
a small amount of functionality of the protein. However, none of the truncated versions of the
protein showed the level of curing as the full length of the XntA protein as shown here or in
previous work (Haynes et al., 2002).
There was no difference in the backward swimming times in Mg/TEA observed by
XntA1 mutants expressing XNTA-FLAG or the mutated XntA, K300R (P=0.7). However, XntA1
mutants expressing FLAG-XNTA showed significantly longer backward swimming compared to
the XntA1 mutants expressing XNTA-FLAG, K300R, and myc-XNTA-FLAG (P<0.001). The
XntA1 mutants expressing K300R and XNTA-FLAG swim backward for significantly longer in
Mg/TEA than the XntA1 mutants expressing myc-XNTA-FLAG cells. Regardless, none of these
XntA1 expressing cells were able to swim backward as long as wild type cells expressing FLAG
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in Mg/TEA solutions (P<0.001). All backward swimming times are shown in Figures II.1 and
II.2.
To visualize the location of the different XntA epitope-tagged proteins in the XntA1
mutants, most of the different XntA1 expressing mutants were immunostained (Figure II.3).
XntA1 mutants expressing the FLAG plasmid were used as the control. Anti-centrin, a stain for
the basal bodies found just below the cell surface was also used as an intracellular marker (Anticentrin was a kind gift from Dr. Mark Winey, University of Colorado, Boulder, CO). We saw no
difference in the localization of the different truncated versions of the XntA protein in the XntA1
mutant. FLAG-XNTA, XNTA-FLAG, K300R-FLAG, and C+2N-FLAG all appear to be localized at
the cell surface and in the cilia. Figure II.3 shows representative cells within the population that
were immunostained for each of these expressing mutant cell types. These were the injected
XntA1 mutants that demonstrated the best curing, meaning a return of Mg2+-induced behavior.
The N-term and C-term expressing XntA1 mutants showed so little curing at the time of testing,
and were not immunostained.
To determine possible interacting partners for the XntA1 protein we expressed XNTAmyc in wild type cells as well as PKD2-FLAG. Our previous work suggests these two proteins
are involved in Mg2+-induced behavior and could be potential interacting partners. Control cells
were expressing FLAG and myc. We performed a whole cell extract and solubilized the samples
with 1% Triton X-100. Proteins were immunoprecipitated (IP’d) using myc affinity agarose. The
resulting eluate was divided and separated by SDS-PAGE. One-tenth of the test and control IP
eluates were run on a separate gel and used for Western blot. The remaining eluate was silver
stained and used for LC-MS/MS analysis. The Western blot was first probed with Anti-myc
antibody (Figure II.4A), the blot was then stripped and re-probed using ant-FLAG antibody to
determine if the Pkd2-FLAG protein co-IP’d with XntA-myc (Figure II.4B, blue arrows). Figure
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II.4C shows the resulting silver stained gel with blue and purple arrowheads and brackets with
numbers to indicate the approximate regions of the gel that were cut and sent for LC-MS/MS
corresponding to the bands on the Western blots. A tubulin loading control was also included to
demonstrate that the solubilization of the test and control whole cell extracts started with
approximately the same amount of protein.
Bands of the approximate sizes for the XntA-myc protein were observed by Western blot
at approximately 61 kD (full length XntA-myc), as well as smaller fragments at 41 kD, 35 kD and
33 kD (Figure II.4A, purple arrow heads). The re-probed Western blot to identify the Pkd2-FLAG
protein showed faint bands at 110 kD, 100 kD, 90-88 kD, and 65-63 kD (Figure II.4B, blue arrow
heads). The expected full length of Pkd2-FLAG is 100 kD. The approximate areas of the silver
stained gel that corresponded to the anti-myc and anti-FLAG bands were excised and processed
for LC-MS/MS analysis. Although these bands appeared on the Western blot, no peptides from
XntA or Pkd2 were identified in the LC-MS/MS analysis of the gel slices. A list of the proteins
identified with the XntA-myc IP Are shown in Table II.III. These proteins were identified in the
test lane only. Proteins that were identified in both the control and test lane were removed from
the analysis.
The same IP experiment was done in the reverse orientation, where FLAG affinity
agarose was incubated in the solubilized whole cell extract from cell expressing PKD2-FLAG and
XNTA-myc. Control cells were expressing FLAG and myc. One-tenth of the resulting eluate was
again used for Western blot while the remaining sample was separated by SDS-PAGE and silver
stained. The blot was first probed with Anti-FLAG, then stripped and re-probed with Anti-myc.
Similar to the results shown in Figure II.4B, Figure II.5A shows bands for Pkd2-FLAG at
approximately 100 kD, 90-88 kD, 70-68 kD (Figure II.5A, blue arrow heads). This blot was
stripped and re-probed using Anti-myc which identified bands at 61 kD, 41 kD and 35 kD (Figure
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II.5B, purple arrow heads). A tubulin loading control is shown, demonstrating the protein used
for the solubilization between the test and control samples was approximately equal (Figure
II.5D). As before, the approximate areas of the silver stained gel that corresponded to the bands
identified for XntA-myc and Pkd2-FLAG on the Western blots were excised and processed for
LC-MS/MS (Figure II.5C). These areas are designated again by brackets and numbers as well as
colored arrowheads that approximately match with bands on the Western blots. Note the grey
arrows near brackets 1, 2, and 3. These bands were visually different between the two gels and
therefore were excised and processed for LC-MS/MS. Because of the darkness of the ladder, the
approximate mass of these bands is unknown, but we expect them to be at or above 100 kD. The
LC-MS/MS analysis identified the Pkd2 protein in all of the upper excised bands (1 through 6).
Disappointingly, no XntA peptides were identified in this analysis. A complete list of the proteins
unique to the test lane are shown in Table II.IV which correspond to the gel slice, or band, they
were identified in. Proteins that were identified in both the control and test lane were removed
from the analysis; only proteins unique to the test lane are shown.
An important experiment was to ensure that the XntA-myc IP results we were observing
were not due to the myc affinity agarose IP’ing the FLAG protein. This control experiment can
also accompany the results from Chapter 3. To ensure the myc affinity agarose was not IP’ing the
FLAG epitope of Pkd2-FLAG, whole cilia from cells expressing FLAG (control) and whole cilia
from cells expressing PKD2-FLAG were solubilized and used for two IPs, one using FLAG
affinity agarose and the other using myc affinity agarose. The results are shown in Figure II.6.
The immunoblot for this developed using rabbit anti-FLAG. Because the myc affinity agarose
beads use a rabbit polyclonal antibody and the primary antibody used to develop the blot was
produced in rabbit, the heavy and light chain of the antibody are very robust, at ~50 and ~25 kD.
While clear bands are observed in the FLAG affinity agarose IP lane for Pkd2-FLAG (Figure II.6,
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white arrows), there are no Pkd2-FLAG bands observed in the lane using the myc affinity agarose
on the whole cilia from cells expressing Pkd2-FLAG.
During the process of training on the electrophysiology equipment, we decided to
measure the resting membrane potential of wild type cells and XntA1 mutants in multiple ionic
solutions. Prior publications demonstrated that there was no difference between the resting
membrane potentials of wild type cells and an XntA1 mutant cells in 1 mM KCl in buffer, -38 ± 1
mV and -39 mV ± 1 mV, respectively. However, when the bath solution was changed to 1 mM
KCl with 0.5 mM MgCl2, the wild type cells depolarized by 10 ± 1 mV while the XntA1 mutants
depolarized only by 1 ± 7 mV (Preston and Kung, 1994a). To further investigate the
depolarization ability of the XntA1 mutants’ membrane, we measured the membrane potential of
these mutant cells and of wild type cells in various attractant solutions and potassium solutions.
All statistical comparisons were done using un-paired T-tests.
We first established the resting membrane potential of these cells in 5 mM KCl in buffer
as well as how much the cells hyperpolarize when changed to 1 mM KCl in buffer. The wild type
cells had a resting membrane potential in 5 mM KCl in buffer of -28 ± 5.6 mV (N=22). The XntA1
mutants had a resting membrane potential in 5 mM KCl in buffer of -27.2 ± 5.7 mV (N=9), not
statistically different than the wild type cells (P=0.75). When these cells were changed to a bath
containing 1 mM KCl in buffer from 5 mM KCl, the wild type cells hyperpolarized (become more
negative) by -13.2 ± 7 mV (N=14) and the XntA1 mutants hyperpolarized by -14.3 ± 5.2 mV (N=9).
There was no statistical difference between the membrane potential of the wild type and XntA1
mutants in 1 mM KCl (P=0.68). When the wild type and XntA1 mutant cells were deciliated,
there was no difference observed in their resting membrane potential in 5 mM KCl. The
deciliated wild type cells had a resting membrane potential of -29 ± 7.2 mV (N=8) and the
deciliated XntA1 mutant cells -31.5 ± 6.5 mV (N=8) (P=0.52). These values are also not
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statistically different from the resting membrane potential of the ciliated cells, as expected from
previous published data (Machemer and Ogura, 1979).
Previous studies have shown that when exposed to attractants, such as glutamate or
folate, the membrane of Paramecium will hyperpolarize (become more negative) (Van Houten,
1979, Preston and Van Houten, 1987). Bacteria are thought to expel these attractants into the
environment which the paramecia then use as a food cue, swimming into the area where bacteria
are inhabiting to ingest them (Preston and Usherwood, 1988). The hyperpolarization of the
membrane would lead to fast, smooth forward swimming of the cell (Van Houten, 1979, Eckert,
1972). In the presence of 5 mM acetate, the membrane should hyperpolarize by ~7.5 mV and in
the presence of 2.5 mM folate, there should be a hyperpolarization of ~11 mV. These values do
not change if the cells are deciliated (Van Houten, 1979, Preston and Van Houten, 1987).
Although the hyperpolarizations of the wild type cells we observed was not as large as in
previously published work (Preston and Van Houten, 1987), the wild type cells did
hyperpolarized by -5.3 ± 2.1 mV (N=13) in 5 mM K-acetate, and by -5.8 ± 3 mV (N=17) in 2.5 mM
K2-folate. The XntA1 mutants do not hyperpolarize as much in 5 mM K-acetate, -0.9 ± 3.5 mV
(N=5), although the values are not significantly different. However, in 2.5 mM K2-folate, the
XntA1 mutants hyperpolarize significantly less than the wild type cells, -1.9 ± 1.3 mV (N=6)
(P<0.001). All values for the change in membrane potential are shown in Table II.V.
An intriguing find was in the deciliated cells, both wild type and XntA1 mutants. First,
the deciliated wild type cells hardly hyperpolarize at all in 5 mM K-L-Glutamate, a significantly
smaller hyperpolarization that in the ciliated wild type cells (P<0.01). There were no difference in
the amount of hyperpolarization by the ciliated and deciliated wild type cells in 5 mM acetate,
which was expected (Preston and Van Houten, 1987). However, the deciliated XntA1 mutants
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depolarized in 5 mM K-acetate, which was significantly different than the deciliated wild type
cells (P<0.01). All values for the change in membrane potential are shown in Table II.VI.

Discussion
We have shown here that we were capable of partially curing the XntA1 mutant by
expressing various full-length fragments of the XNTA gene. The expression of small truncated
fragments of XNTA were able to return some Mg2+-induced behavior to the mutant, but not to the
degree of expressing the full length gene. Expressing the 5’- or 3’- end of the XNTA gene (Nterm, C-term, or C+2N term) did not show a dramatic curing of the mutant, suggesting the fulllength protein is required. The majority of the XntA mutants (seven out of eight) that were
initially studied were shown to have mutations creating premature truncations in the first half of
the gene or protein. These XntA mutants were completely devoid of IMg(Ca), even with some of
the N-terminus of the protein in some cases (Haynes et al., 2002). Therefore, we were not
surprised by the lack of backward swimming in Mg2+ solutions by the XntA1 mutants expressing
the N-term of XNTA. The expression of the C-term or the C+2N did show a significant increase
in the backward swimming of the mutant, but not to the degree of full-length XntA. Further
studies should be done to determine if the protein must be whole to be functional. For example,
expression of the N-term and the C-term in the XntA1 mutant may show significantly more
curing which might suggest the protein does not have to be whole to be functional. Also,
removal of the PEST sequence may change the activity of the expressed protein. If the PEST
sequence does indeed target XntA for rapid degradation, its removal from the sequence may
allow the XntA protein to be over-active. The over-activity of the protein could be measured by
swimming assays and by electrophysiology in solutions containing Mg2+.
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The immunostaining of the different versions of the XNTA gene in the XntA1 mutant
show almost no change in the distribution of the protein within the cells, even though the protein
is not full length. We might infer from these results that if there is a signal sequence that targets
the XntA protein to the cilia, that this sequence would be found somewhere in the later 2/3 of the
C-terminus of the protein. However, better evidence would be needed to make such a statement
of a signal sequence or ciliary targeting sequence. So far, signal sequences are unknown in P.
tetraurelia. One such sequence important for ciliary targeting in mammalian cells is the VxPx
motif, necessary for engaging the Arf4 protein for ciliary trafficking (Mazelova et al., 2009).
However, this was demonstrated in photoreceptor cells which contain a modified cilium. A
VxPx motif is found at position V382 of XntA, between the sixth and seventh transmembrane
sequences, which may target the protein to the cilia. We have no proof that this sequence is
important for tagging XntA or any other Paramecium protein for ciliary localization. But if the
VxPx motif does target the XntA protein to the cilia, expressing the N-term of XNTA with the
FLAG tag should show no ciliary staining of the epitope tagged protein since the N-term
sequence does not include the VxPx motif. Also, mutation of this site may prevent the full-length
protein from trafficking to the cilia. The notion of a ciliary targeting sequence is not far-fetched
and has not been closely examined before in P. tetraurelia.
Our Western blots of whole cell extract IP eluates from cells expressing both XNTA-myc
and PKD2-FLAG suggest these two proteins interact, either directly or indirectly. However, the
LC-MS/MS data do not support the IP of XntA-myc because no peptides from XntA were
identified. These findings were surprising since we observed XntA-myc bands in the Western
blots. Conversely, identifying peptides for Pkd2 selectively in the lanes where we anticipated
finding them (based on where the silver stained gel lined up with the Western blot), suggests we
were not miss-interpreting where to identify the proteins. However, that is not to say that we did
not miss the sections of gel that contained the XntA protein. As we have mentioned, the XntA
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protein is cleaved into smaller fragments and could have been missed. In the future, using the
entire gel would be more beneficial to ensure no proteins were inadvertently excluded. It is also
possible that the proteins present in the gel were too weak or in too low of a concentration to
identify by LC-MS/MS. Although the XntA-myc protein was identified on a Western blot, ECL is
able to detect proteins in the low picogram range. LC-MS/MS is also able to detect proteins
around 50 pg, however, this becomes complicated when the sample is not pure, but is instead a
mixture of proteins in a tryptic digest (Bronsema et al., 2013). It is possible that XntA was in too
low of a concentration to have peptides identified via LC-MS/MS.
The results from these experiments differ from our other IP results in Chapter 3 where
we were able to IP Pkd2-FLAG when we targeted XntA-myc for IP, but we were unsuccessful at
IP’ing XntA-myc when we targeted Pkd2-FLAG for IP. We proposed in Chapter 3 that this is due
to the occlusion of the FLAG peptide on the C-terminus of Pkd2-FLAG from direct or indirect
interactions with the XntA-myc protein. However, the IP’s in Chapter 3 were from cell
membrane and whole cilia. We are showing here the results from whole cell extract. It is possible
that the interaction between XntA and Pkd2 when Pkd2-FLAG is targeted for IP was not
maintained when using solubilized membranes for IP as in Chapter 3. Perhaps by using whole
cell extract, there were more proteins accessible for IP because we have access to many of the
vesicles being trafficked within the cell. Because of the amount of accessible proteins in a whole
cell extract, weak interactions may be maintained, sustaining interactions between the XntA-myc
protein and Pkd2-FLAG when Pkd2 is IP’d. It is also possible that the IP of Pkd2-FLAG from
whole cell extract has pulled proteins collectively that are in a vesicle being trafficked to the cell
membrane or the cilia, yielding a “false positive.” This could appear as a co-IP of these proteins,
when in fact, they are simply in the same vesicle.
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We have ensured that the myc beads are not recognizing the FLAG epitope on the Pkd2FLAG protein by performing a necessary control experiment. We have demonstrated using
solubilized whole cilia that the myc affinity agarose does not IP Pkd2-FLAG. This supports our
findings that the co-IP results we observe here and in Chapter 3, where XntA-myc and Pkd2FLAG co-IP using the myc affinity agarose. That the co-IP is not because the myc agarose is
attaching to the FLAG epitope. This control experiment was done later, once the cell membrane
and whole cilia were being used for IPs as in Chapter 3. However, it is still an important
experiment demonstrating that the IP results we have observed are not due to the myc affinity
agarose recognizing the FLAG epitope yielding a false positive result.
The electrophysiology findings support the XntA protein being involved in processes
other than Mg2+-induced behavior. The XntA1 mutants did not hyperpolarize in 2.5 mM K2folate like the wild type cells. This finding was extremely interesting since the Paramecium folate
receptor is a glycosophosphatidyl inositol (GPI)- anchored protein (Weeraratne, 2007). We would
expect GPI-anchored proteins to be enriched in membrane microdomains, or lipid rafts. If the
XntA protein is stabilizing proteins in membrane microdomains, as we have proposed it does for
the Pkd2 protein, perhaps these domains are interrupted without the XntA protein leading to
altered chemoresponse to attractants. Further testing would be necessary, but examining the
response of these cells further to attractants would be important and could be extremely
informative as to the possible other functions of the XntA protein.
When the cells were deciliated and their membrane potentials measured in the
attractants, we did not expect to see a difference in the acetate or folate hyperpolarization
response based on previous work (Preston and Van Houten, 1987). Although we did not observe
changes in the wild type cells or the mutant that were significant in folate, we did observe that
deciliated XntA1 mutants depolarize (positive change in membrane potential) as opposed to
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hyperpolarize in acetate, which was significantly different than the wild type cells. Acetate is
expected to bind a surface receptor activating a calcium/calmodulin kinase which in turn
hyperpolarizes the cell by activating a potassium conductance to release potassium and the
plasma membrane calcium ATPases (PMCA) to expel calcium to maintain the hyperpolarization
(Preston and Van Houten, 1987). We would expect these receptors to be located both on the cell
surface and probably on the cilia because deciliation does not change the hyperpolarization of the
cell in acetate, shown here and elsewhere (Preston and Van Houten, 1987). Also, the channels
necessary for this behavior are expected to be localized in the cilia (Machemer and Eckert, 1973,
Machemer and Ogura, 1979). Other research does suggest that the XntA1 mutants may have an
altered response to Mg2+ which demonstrated the XntA1 mutants are not as attracted to acetate as
wild type cells (Bell et al., 2007). However, why the XntA1 mutant is depolarizing in acetate
when the cell is deciliated is unknown, and further investigation is needed.
Another important finding to point out was the loss of membrane hyperpolarization of
the membrane in 5 mM K-L-glutamate when wild type cells were deciliated. The responses of
the cells to D-Glutamate, both wild type and XntA1 mutants, were not robust. However, the lack
of hyperpolarization of the membrane of wild type cells to L-glutamate when they were
deciliated was significant. Work in the 1980’s on the glutamate receptors on Paramecium using
3H-L-glutamate

showed the binding sites to be on the cilia (Preston and Usherwood, 1988). Other

work in our lab has produced conflicting results on the location of the glutamate receptors.
However, these data confirm the location of the L-glutamate receptors in the cilia, which is
important for glutamate chemoresponse and membrane hyperpolarization.
It is clear from our work presented in this Appendix as well as Chapter 3 that we have
uncovered more questions than answers concerning the XntA1 mutant and the XntA protein. We
know that XntA is important for Mg2+-induced behavior and that it most likely interacts with the
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Pkd2 protein, either directly or indirectly (Chapter 3). We also now know that there are
deficiencies in this mutant in its ability to respond to attractants with a sustained membrane
hyperpolarization. We have shown that the XntA protein, although truncated when we IP it in
many cases, needs to be full length in order to be functional. Further investigation into
membrane potentials of the XntA1 mutant, both ciliated and deciliated, in attractants is needed to
better establish the differences between the wild type cells and the mutant. As we have become
more proficient with electrophysiology, we may be able to obtain more consistent measurements.
It is not a far-fetched proposal that the XntA protein is in fact a stabilizer of membrane
microdomains. The instability of these microdomains could explain the multitude of pathways
that seem to be affected in this mutant.
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Table II.I: Table of primers.
Name

Forward Primer (5’ – 3’)

pPXV 5’

TAAGATGAATCCAATATAATG

pPXV 3’

TTATTTAAGTGTTGTTCATTTA

XNTA F

CTTGAAATGCCTAAAGAATC

XNTA R

GTAAATCCTTTAGCTAATGC

XntA 3’UTR

AGATATTGTTCTTAAATCAAC

XntA N-term F (Spe I)

GCGACTAGTATGACCTACAGAGAATTAGTCCC

XntA N-term R (Nhe I)

CGCGCTAGCAGATTCTTTAGGCATTTCAAGTTTTG

XntA C-term F (Spe I)

GCGACTAGTATGGAATGGCTGACCCTCAATAATG

C-term +2N XntA F (Spe I)

GCGACTAGTATGCCTAATTCGCATCATGGAGTC

XntA C-term R (Nhe I)

CGCGCTAGCCTTTAAAATATTCAATCC

XntA Ubiq mut F

CAAAGTGCAATAAG(A)ATAAAGAAATG

XntA Mut R

TTATTCATCATTTAGTTATTATCTTTACTTCTATTTTGG
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Table II.II: Table of primers used to create fragments of XNTA for microinjection.
Sequence
Construct

Forward Primer

Reverse Primer

Position

N-term XntA

XntA N-term F (Spe I)

XntA N-term R (Nhe I)

+1 - +1125

C-term XntA

XntA C-term F (Spe I)

XntA C-term R (Nhe I)

+586 - +1704

C-term+2N XntA

C-term +2N XntA F (Spe I)

XntA C-term R (Nhe I)

+390 - +1704

K300R

XntA N-term F (Spe I)

XntA C-term R (Nhe I)

+1 - +1704
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Table II.III: Proteins identified in the XntA-myc IP from WCE that were unique to the test
lane.
Accession
Gel

number

slice

(GSPATG…)

1

00012163001

Protein Description
Hypothetical protein, Pyruvate

# of

Molecular

Peptides

Mass

2

82 kD

2

123 kD

162 kD

phosphate dikinase
1

00028373001

Hypothetical protein, Amylo-alpha1,6-glucosidase family protein

5

00039636001

Hypothetical protein

3

7

00013616001

Glyceraldehyde 3-phosphate

2

dehydrogenase
7

00005516001

Ribosomal protein L5

2

40 kD

7

00031832001

Ribosomal protein L10

2

35 kD
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Table II.IV: Proteins identified in the Pkd2-FLAG IP from WCE that were unique to the test
lane.
Gel Slice

1,2,3,4,5,6
1
2

Accession
Number
(GSPATG…)
00005599001
00006907001
00038320001

2
2

00037951001
00017485001

3

00020752001

3

00027959001

3

PTETP3300001001

4

00031542001

4,5
4

00024718001
00029670001

4
4

00020796001
00029765001

5

00021392001

6

00015732001

6

00035998001

6
7

00029912001
00023050001

7

00012130001

8

00012567001

8

00012836001

Protein Description

# of
Peptides

Molecular
Mass

Pkd2
Hypothetical Protein
Hypothetical Protein, HSP70domain containing protein
Hypothetical Protein,
Hypothetical Protein, HSP70domain containing protein
Hypothetical Protein,
transitional ER ATPase
Hypothetical Protein, ERtype HSP70
Hypothetical Protein,
Cytosol-type HSP70
Hypothetical Protein,
Proteosome/cyclosome 26s
subunit protein, chaperone
Hypothetical Protein, HSP70
Hypothetical Protein,
Vacuolar protein sortingassociated protein 35
containing protein
Piwi-related protein PAP
Hypothetical Protein, W-40
repeat containing protein,
possible cytoplasmic dynein
COPII vesicle coat, ER-Golgi
transport, potential Sec23/24
Hypothetical Protein, GroEL
conserved domain,
chaperonin-like
Hypothetical Protein,
succinate dehydrogenase
Arginine tRNA ligase
Hypothetical Protein,
isocitrate dehydrogenase
Hypothetical Protein, Zndependent alcohol
dehydrogenase
Hypothetical Protein,
possible myosin heavy chain
kinase
Hypothetical Protein

5,3,8,9,6,6
3
6

99 kD
412 kD
93 kD

2
2

102 kD
93 kD

2

91 kD

2

72 kD

2

72 kD

3

98 kD

2,3
2

35 kD
89 kD

2
2

87.5 kD
82 kD

3

87.5 kD

3

61 kD

2

70 kD

2
3

69 kD
38 kD

2

41 kD

2

36 kD

2

43 kD
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8

00030068001

9
10

00006971001
00027576001

10, 11

00035275001

11
11
11

00029689001
00001379001
00032074001

11

00009904001

Hypothetical Protein,
Probable 26s proteasome
non-ATPase regulatory
subunit 6
Hypothetical Protein
Hypothetical Protein, 40s
Ribosomal protein, S4e
Hypothetical Protein,
Ribosomal S3Ae family
protein
Hypothetical Protein
Hypothetical Protein
Hypothetical Protein,
fibrillarin non-specific
Ser/Thr kinase
14-3-3
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2

37 kD

2
3

43 kD
33 kD

2,2

31 kD

3
2
2

27 kD
31.5 kD
30 kD

2

28 kD

Table II.V: Changes in membrane potential (∆Vm) of ciliated cells when changed from 5 mM
KCl to testing solution. Positive values indicate a depolarization of the membrane and negative
values indicate a hyperpolarization of the membrane compared to the resting membrane
potential in the resting solution (5 mM KCl).

Cell Type

5 mM K-acetate

5 mM K-L-

5 mM K-D-

2.5 mM K2-

Glutamate

Glutamate

Folate

Wild Type

-5.3 ± 2.1 (13)

-4.8 ± 1.6 (10)

-2.4 ± 2 (12)

-5.8 ± 2.9 (17)

XntA1 mutant

-0.9 ± 3.5 (5)

-1.8 ± 3.1 (4)

-0.4 ± 1.8 (4)

-1.9 ± 1.3 (6)

0.07

0.19

0.11

0.0006

P-Value (T-test)
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Table II.VI: Changes in membrane potential (∆Vm) of deciliated cells when changed from 5
mM KCl to testing solution. Positive values indicate a depolarization of the membrane and
negative values indicate a hyperpolarization of the membrane compared to the resting membrane
potential in the resting solution (5 mM KCl). * Indicates significantly less hyperpolarization
compared to ciliated wild type cell (P<0.01, T-test).

5 mM K-L-

5 mM K-D-

2.5 mM K2-

5 mM K-acetate

Glutamate

Glutamate

Folate

Wild Type

-3.9 ± 2.7 (4)

-0.32 ± 2.6 (8)*

-0.65 ± 2 (7)

-2.4 ± 0.7 (2)

XntA1 mutant

3.4 ± 2.6 (5)

-1.6 ± 2.0 (4)

1.3 ± 1.3 (3)

-2.0 ± 2.9 (3)

0.01

0.43

0.18

0.86

Cell Type

P-Value (T-test)
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Figure II.1: Chart of XntA1 mutants expressing epitope-tagged versions of XNTA with
backward swimming times in 25 mM TEA with 5 mM MgCl2. Cells were examined for Mg2+induced behavior in Mg/TEA solution. First row shows wild type cells expressing the FLAG
epitope as a positive control for Mg2+-induced behavior. Lower rows are the different versions of
XNTA being expressed by the XntA1 mutant cells. Included are depictions of the different XNTA
constructs. Grey blocks represent transmembrane domains, green star represents potential
ubiquitination site (pink star is the K300R mutated ubiquitination site). Purple oval represents
PEST sequence and also the position of the FLAG (blue rectangle) and myc (dark purple oval)
epitope tag placement. Backward swimming times are average seconds ± standard deviation.
Asterisks indicated statistical significance compared to all other expressing cell types (P<0.001,
multiple T-tests), with one exception, there is no significant difference between XntA1 mutants
expressing N-term and the XntA1 mutants expressing FLAG.
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Figure II.2: Graph of backward swimming in 25 mM TEA with 5 mM MgCl2 of XntA1 mutants
expressing tagged versions of the XNTA gene. Backward swimming times (seconds) ± standard
error of the mean (N=43 to 433 cells). Cell type is shown below the graph and injected plasmid
shown below each bar. Red asterisks indicate the four cell types that are statistically different
from all others. Significance between the other expressing cell types are described in the results
section. No statistical difference between C-term and C+2N. No difference between XNTAFLAG and K300R. See Figure II.1 for constructs and backward swimming times (sec) ± standard
deviation and N.
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Figure II.3: Immunostaining of XntA1 mutants expressing epitope-tagged XNTA, truncated
XNTA or mutated XNTA. Immunostaining of XntA1 mutants expressing FLAG (Control),
FLAG-XNTA, XNTA-FLAG, C+2N-FLAG, or K300R-FLAG. Cells were immunostained with
Anti-centrin to mark the basal bodies below the cell surface (green) and Anti-FLAG to show the
expressed protein (red). Merged images are also shown, scale bar = 10 µm. Cells shown are
representative of the population.
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Figure II.4: Western blot and silver stained gel for whole cell extract XntA-myc IP. Wild type
cells expressing myc and FLAG (Control; C) or XntA-myc and Pkd2-FLAG (Test; T) were
homogenized, solubilized with Triton X-100 for IP using Anti-myc affinity agarose. (A) Western
blot of one-tenth of anti-myc agarose eluate separated by SDS-PAGE and transblotted. Blot was
first developed with Anti-myc to demonstrate the presence of the XntA-myc protein (purple
arrow heads.) (B) The same blot was stripped and re-probed using Anti-FLAG to detect Pkd2FLAG protein (blue arrow heads). Orange arrows indicate the heavy (upper) and light (lower)
chain of the antibody. Primary and secondary antibodies used were both produced in rabbit. (C)
The silver stained gel of the remaining eluate from the Anti-myc affinity agarose showing the
approximate gel slices that were removed for tryptic digest and LC-MS/MS analysis (brackets
with numbers). The molecular masses are shown on the left, these same masses do not
correspond to the molecular masses on the immunoblots. Blue and purple arrow heads mark
approximate regions of the gel where we would expect Pkd2-FLAG or XntA-myc to be found,
respectively. (D) Blot developed with Anti-tubulin to demonstrate that the test and control
samples were approximately the same concentration when solubilization began.
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Figure II.5: Western blot and silver stained gel for whole cell extract Pkd2-FLAG IP. Wild type
cells expressing myc and FLAG (Control; C) or XntA-myc and Pkd2-FLAG (Test; T) were
homogenized, solubilized with Triton X-100 for IP using Anti-FLAG affinity agarose. (A)
Western blot of one-tenth of anti-FLAG agarose eluate separated by SDS-PAGE and transblotted.
Blot was first developed with Anti-FLAG to visualize the presence of the Pkd2-FLAG protein
(blue arrow heads.) (B) The same blot was stripped and re-probed using Anti-myc to detect the
XntA-myc protein (purple arrow heads). (C) The silver stained gel of the remaining eluate from
the Anti-FLAG affinity agarose showing the approximate gel slices that were removed for tryptic
digest and LC-MS/MS analysis (Brackets with numbers). The molecular masses are shown on
the left, these same masses do not correspond to the molecular mass markers on the
immunoblots. Blue and purple arrow heads mark approximate regions of the gel where we
would expect Pkd2-FLAG or XntA-myc, respectively. (D) Blot developed with Anti-tubulin to
demonstrate that the test and control samples were approximately the same concentration when
solubilization began.
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Figure II.6: Control Western blot using myc affinity agarose on cells expressing PKD2-FLAG.
Whole cilia were collected from cells expressing PKD2-FLAG and FLAG and solubilized. Two
separate IPs were performed using FLAG affinity agarose (left) and myc affinity agarose (right).
Molecular masses are shown on the left hand side, kD. Multiple Pkd2-FLAG bands are observed
in the positive control lane (FLAG IP of PKD2-FLAG expressing cells), white arrow heads (~120,
100, and 70 kD). No bands other than non-specific bands and the heavy and light chain of the
antibody are observed in the lanes using the myc affinity agarose.
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Appendix III: LC-MS/MS Data from Cell Membrane and Cilia Pkd2-FLAG
Immunoprecipitations with Accompanying RNAi for Potential Interacting
Partners

322

Overview and Materials and Methods
All information pertinent to the preparation of the Pkd2-FLAG plasmid, microinjection,
isolation of cell membranes and cilia were done as previously described in Chapter 3 and
(Valentine et al., 2012). Immunoprecipitation and LC-MS/MS analysis were performed as
previously described in Chapter 3. The sequences chosen for RNAi construct creation were done
so based on predicted function, prevalence, and number of times found in the analysis. Primers
used to create the RNAi constructs are shown in Table III.I along with a brief description below.
All relevant instructions for creating each of the RNAi constructs is included along with the
restriction enzymes used. Amplification of each sequence was done using standard PCR
protocols as preciously described using genomic DNA. All PCR products were ligated into the
pCR®-2.1 TOPO® vector (Invitrogen/Life technologies), removed using restriction enzymes
(New England BioLabs) and ligated into the double-T7 promoter RNAi plasmid L4440 (Addgene)
as previously described (Chapter 2 and 3).
Feeding paramecia by RNAi was done as previously described (Chapter 2 and 3). The
PKD2 RNAi construct was also described previously in Chapter 3. Backward swimming assays
were done as previously described (Chapter 3, (Valentine et al., 2012)) using 30 mM KCl to test
the voltage-gated calcium channel function and potassium channel function. Also
tetraethylammonium (TEA) with 10 mM NaCl or 5 mM MgCl2 was used to examine the depleted
cells for Mg2+-specific behavior and potassium channel function. A description of all of these
solutions, what channels are being examined in each solution, as well as how the cells are tested
can be seen in Appendix I and in (Valentine et al., 2012).
Small Hypothetical Protein (SHyP) (PTETG10700002001): This sequence was chosen because it
was identified in both of the buffers used for the cilia IPs (Lap200 and IP500 buffers). This gene
has one paralog from the recent whole genome duplication (GSPATG00035837001) which is
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87.2% identical at the nucleic acid level. The RNAi construct that was designed targets both
paralogs. PCR Annealing temperature used was 52°C and extension time was 2 minutes 30
seconds. Restriction enzymes used to remove the sequence from pCR® 2.1-TOPO® vector and
ligate into the L4440 plasmid were Sac I and Xho I.
Large Hypothetical Protein (LHyP) (GSPATG00012627001): This sequence was chosen because if
was found in both of the Pkd2-FLAG cilia IPs in the different buffers. Four unique peptides were
identified in the Lap200 IP and six peptides in the IP500 buffer IP. This proteins was one of the
most abundant proteins identified in the Triton X-114 phase separation of the ciliary membrane
proteins in P. tetraurelia (Yano et al., 2013). This protein is listed as a hypothetical protein of
unknown function with 6 or 8 predicted transmembrane spanning domains. There are no offtarget sequences for the RNAi construct for this gene and the sequence has no paralogs. It is a
very large sequence, 11,458 nucleotides (nt) in length with a predicted protein length of 3,780
amino acids (438 kD). The PCR annealing temperature used was 52°C and extension time was 2
minutes 30 seconds (PCR was done at the same time as the SHyP). Restriction enzymes used to
remove the sequence from pCR® 2.1-TOPO® vector and ligate into the L4440 plasmid were Sac I
and Xho I.
Hypothetical adhesion protein (AHyP) (GSPATP00034716001): This protein was identified in the
whole cilia Lap200 IP with two unique peptides. The protein is considered hypothetical with a
distant relation to cell adhesion proteins in bacteria. The sequence was chosen for RNAi because
we did not anticipate any involvement in Mg2+-induced behavior based on the sequence and the
predicted function of the protein. The gene is 3,465 nucleotides long coding for a protein of 1,146
amino acids in length with a predicted molecular mass of 128.3 kD. There is one recent whole
genome duplication paralog for this gene (GSPATG00037540001). The paraogs are 88.1%
identical and the protein sequences are 89% identical. The sequence used to create the RNAi
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vector targets both paralogs. The PCR annealing temperature used was 52°C and extension time
was 2 minutes. Restriction enzymes used to remove the sequence from pCR® 2.1-TOPO® vector
and ligate into the L4440 plasmid were Sac I and Xho I.
WD40 hypothetical protein (WD40) (GSPATG00029765001): This sequence was chosen because
the amino acid sequence for this protein has some similarities to cytoplasmic dynein with
conserved WD40 repeats found between amino acids 212-620 (e-value: 1.7 e-9). Six peptides were
identified from this protein unique to the test lane from the whole cilia Lap200 IP. There are two
intermediate whole genome duplication paralogs related to this sequence, GSPATG00007648001
(75% identical at the nucleic acid level and 86.6% identical at the amino acid level) and
GSPATG00021536001 (74% identical at the nucleic acid level and 86.5% identical at the amino
acid level). The gene sequence is 2,353 nucleotides long and codes for a predicted protein of 714
amino acids in length. The predicted molecular mass is 81.6 kD. The section of gene sequence
used for RNAi has no off-target sequences and will not target the two paralogs. PCR Annealing
temperature used was 50°C and extension time was 1 minute. Restriction enzymes used to
remove the sequence from pCR® 2.1-TOPO® vector and ligate into the L4440 plasmid were Sac I
and Xho I.
Hypothetical Tetrahymena cation channel protein (TtCC) (GSPATG00005132001): Two peptides
from this protein were obtained in the IP500 whole cilia IP for Pkd2-FLAG. The closest
homologous sequences found was for a putative Tetrahymena cation channel family protein
sequence (e-values: 3e-18 and 2e-15). The protein has no predicted transmembrane domains and no
conserved domains. The gene sequence is 1,681 nucleotides in length coding for a 61.1 kD protein
of 536 amino acids. There is one recent whole genome duplication paralog for this sequence
(GSPATG000027079001) which is 87.5% identical at the nucleic acid level and 92.6% identical at
the amino acid level. The RNAi construct targets both paralogs. The PCR annealing temperature
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used was 52°C and extension time was 2 minutes. Restriction enzymes used to remove the
sequence from pCR® 2.1-TOPO® vector and ligate into the L4440 plasmid were Sac I and Xba I.
Predicted Lost Boys/CG34110/Ccdc135 protein (LOBO) (GSPATG00001683001): This protein
was identified in the whole cilia IP500 Pkd2-FLAG IP. Four unique peptides were identified
from this protein. The amino acid sequence for his protein (830 amino acids) was used in a
BLAST search. The lobo homologues of Crassostrea gigas (Pacific Oyster) (2e-100) and Homo sapiens
(2e-93) were identified. The Drosophila lobo homologue was a little more distant with an e-value of
2e-39. There are two intermediate whole genome duplication paralogs for this sequence
(GSPATG00009014001 and GSPATG00025242001). These genes are both 82.6% identical to the
Paramecium lobo sequence and neither is targeted using the sequence used to create the RNAi
construct. The PCR annealing temperature used was 43°C and extension time was 1 minute.
Restriction enzymes used to remove the sequence from pCR® 2.1-TOPO® vector and ligate into
the L4440 plasmid were Sac I and Xba I.

Results
To further investigate other potential interacting partners of the Pkd2 protein other than
XntA, we used feeding RNAi to deplete paramecia of proteins that were co-IP’d with Pkd2. We
focused our efforts on proteins that were identified in the cilia IPs because we were interested in
finding out more about the functions of Pkd2 in the cilia. We chose proteins to target with RNAi
based on their abundance in the IP, if they were identified in IPs from both the buffers that were
used (Lap200 and IP500, see Chapter 3), and also proteins that had interesting conserved
domains or homologous proteins in other organisms. One gene, AHyP (GSPATP00034716001),
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had predicted cell adhesion properties and we did not anticipate observing changes in swimming
behavior in Mg2+ solutions or other solutions when this protein was depleted from the cells.
Figures III.1A-1C show the peptides that were identified in the different IPs and the
peptide locations within the Pkd2 sequence. For the most part, identified tryptic peptides were
distributed throughout the Pkd2 sequence, however, no peptides were identified in the first 73
amino acids of the Pkd2 protein in any of the IPs. Because the Pkd2-FLAG protein was being
over-expressed in the cells, it was not surprising to find peptides throughout the gels. The fewest
Pkd2 peptides were identified in the whole cilia IP500 IP, however, the most co-IP proteins were
also idenitified in the same prep.
Once the constructs for RNAi were created, we began to examine the RNAi depleted cells
for behavior changes in 30 mM KCl, 25 mM tetraethylammonium (TEA) with 10 mM NaCl, and
25 mM TEA with 5 mM MgCl2. As discussed in other chapters, we are able to use changes in the
ionic environment to examine paramecia cells. Changes in their swimming behavior can then be
used to infer alterations in ion channels in the cilia or in the membrane (Eckert and Brehm, 1979,
Kung and Saimi, 1982, Preston and Kung, 1994b, Preston and Kung, 1994a, Ling and Kung, 1980).
Paramecium depolarizes in high ionic conditions, such as 30 mM KCl, which will cause the voltage
gated calcium channels found exclusively in the cilia (Dunlap, 1977) to open. The transient
increase in calcium will cause a reversal of the ciliary power stroke and the cell will be propelled
backward. As long as Ca2+ remains high in the cilia, the cell will swim backward. The presence of
TEA in the bath will block the corrective action of the fast-acting voltage-dependent K+
conductance (Satow and Kung, 1976) forcing the cell to rely on the slower Ca2+-dependent K+
conductance to correct the membrane potential. The TEA in combination with the high Mg2+ or
Na+ allows for backward swimming of the cell that is easily timed using a stop watch. The
presence of 5 mM MgCl2 or 10 mM NaCl in the bath will prolong the backward swimming
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further by activating the Ca2+-dependent Mg2+-conductance or Na+-conductance, respectively.
All statistical comparisons were done using a one-way ANOVA followed by non-parametric
multiple comparison tests.
When we examined our different depleted cells in 30 mM KCl to examine the function of
the voltage gated calcium channels, the WD40, TtCC and LOBO depleted cells showed short
backward swimming compared to the control cells (asterisk, P<0.001). Interestingly, the doublefed cells depleted in both PKD2 and SHyP showed short backward swimming in this solution
(asterisk, P<0.001) while the individually depleted PKD2 or SHyP cells showed no change in their
swimming behavior in high K+. All of these depleted cells, WD40, TtCC, LOBO, and PKD2 and
SHyP, swam backward for significantly less time in high K+ than the PKD2 depleted cells (caret,
P<0.001).
Very few changes in backward swimming were observed in 25 mM TEA with 10 mM
NaCl. Only cells depleted in LHyP and the cells double-fed to deplete both PKD2 and SHyP
showed shorter backward swimming in this solution. None of the depleted cells were statistically
different than the PKD2 depleted cells. However, in 25 mM TEA with 5 mM MgCl2, we saw far
more changes in the backward swimming behavior of the depleted cell types. In fact, all the
depleted cell types showed shorter backward swimming in Mg/TEA compared to the control
cells (asterisk, P<0.001) except for the AHyP depleted cells. The control cells, AHyP, and WD40
depleted cells were significantly different than the PKD2 depleted cells (caret, P<0.001). All
backward swimming times, number of cells tested (N), and standard deviations can be seen in
Table III.II.
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Discussion
In this Appendix, we attempted to further investigate potential interacting partners of the
Pkd2 protein identified in the LC-MS/MS analysis of cilia Pkd2-FLAG IPs presented in Chapter
3. We identified one protein that when depleted showed changes in Mg2+-induced behavior
specifically, which was SHyP. We were able to demonstrate that some of the proteins that were
depleted may contribute to the function of other ion channels, the trafficking or stabilization of
proteins in the cilia, or proteins that may contribute to beating patterns of the cilia. It is
important to remember that this was a preliminary study and that all depleted proteins would
require extensive further testing to determine their true function in our ciliated model organism,
Paramecium tetraurelia.
Our IP from the cell membrane and the two IPs from the cilia using different
immunoprecipitation buffers did not have many proteins in common. We chose to focus on the
proteins identified in the whole cilia IPs as opposed to the cell membrane because we felt those
proteins would have more influence on backward swimming of Paramecium due to their location
in cilia. We chose the proteins based on their abundance in the IPs as well as their conserved
domains or potential proposed function. One of the proteins we chose to study was AHyP.
When we depleted this proposed adhesion protein we did not expect any changes in behavior,
that this depleted cell line would behave the same as the control cells, which was the case.
However, it would be possible that this protein may be involved in conjugation. During
conjugation, two cells of opposite mating types join to exchange genetic material. When the two
cells come in contact with one another, the cilia are resorbed along both sides of the anterior
suture and on the right side of the posterior suture. The cells are then able to come in close
contact and conjoin to exchange genetic material (Watanabe, 1978). It is possible that the AHyP
protein is involved in the adhesion, or conjoining of the two mating-reactive cells. It is feasible
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that Pkd2 is important for this process. Pkd2 has been shown to be increased four-fold in
gametogenesis of Chlamydomonas reinhardtii and is vital for the calcium-dependent coupling of
flagellar adhesion during mating for these cells (Huang et al., 2007).
We included the depletion of PKD2 as a positive control. We knew what to expect of the
cells depleted in Pkd2 protein which was short backward swimming in Mg2+ solutions. Sure
enough, Mg/TEA was the only solution where a change was observed in swimming behavior of
PKD2 depleted cells, not Na/TEA or high K+. Interestingly, the depletion of SHyP only showed a
change in backward swimming in Mg/TEA. However, when both PKD2 and SHyP were
depleted, we observed changes in all the swimming solutions, Na/TEA and high K+ as well as
Mg/TEA. The SHyP has no predicted transmembrane spanning domains but is significantly
upregulated during reciliation (based on Microarray data, see ParameciumDB:
http://paramecium.cgm.cnrs-gif.fr/cgi/). It is possible that when both SHyP and PKD2 were
depleted from the cells, that other channel pathways were affected. Another possibility is that
these two channels together affect the backward swimming mechanisms of the cell. When both
SHyP and PKD2 were depleted, the shortening of the backward swimming times were not
additive in Mg/TEA. It is unclear why the double-depletion of PKD2 and SHyP would shorten
the backward swimming times in all solutions. Possibly these two proteins are needed for the
reversal of the ciliary beat or perhaps they act in microdomains with other channels that are
important for backward swimming. If SHyP is important during reciliation of cells, it is feasible
that SHyP has an important function in the construction, trafficking, regulation, or maintenance
of proteins in the cilia. IPs using cells expressing an epitope-tagged version of SHyP may lead to
the identification of other proteins that potentially interact with SHyP. The identification of more
protein could bring clarity to the function or role of SHyP.
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The depletion of LHyP showed short backward swimming in both solutions containing
TEA compared to the control cells. Although this suggests a deficiency in the Ca2+-dependent K+
conductance which would be used to correct the depolarization of the cell membrane, we are not
suggesting that LHyP is a Ca2+-dependent K+ channel. These K+ channels typically consist of four
subunits each consisting of 6 transmembrane spanning regions. These subunits would not
correspond to the large size of the LHyP protein (438 kD). The LHyP protein has no conserved
domains. It was one of the only proteins identified with potential transmembrane spanning
domains. LHyP was also one of the most abundant proteins, based on the number of unique
peptides identified, in the Triton X-114 phase separation and proteomic analysis of the ciliary
membrane (Yano et al., 2013). It is possible that because of the abundance of this protein, it was
immunoprecipitated based on its abundance in the cilia. LHyP may be found in close proximity
to Pkd2, perhaps in the same microdomain. The protein was not identified in any of the control
IPs from whole cilia of cells expressing FLAG so we can assume the result is not due to nonspecific binding by the FLAG beads. We do not hypothesize that this protein is important for
Mg2+-induced behavior, however, based on its abundance in the cilia, the further investigation of
LHyP is encouraged.
The depletion of WD40 was very dramatic in the Mg/TEA and high K+ solutions. This
protein shows some homology to cytoplasmic dynein. Cytoplasmic dynein is known for its
importance in retrograde transport as a part of intraflagellar transport system that move proteins
and cargo from the tip of cilia and flagella to the base (Pazour et al., 1999, Porter et al., 1999). The
predicted size of the WD40 protein is approximately 81 kD, which is an appropriate size for an
intermediate chain dynein. Intermediate chains are expected to be important for binding the
motor subunits, which are much larger, to the cargo the motor subunits are transporting. There
are also the inner dynein arms of the cilia which are attached at specific points on the A tubule of
the A and B outer ring of microtubule doublets (Smith and Sale, 1992). This WD40 Paramecium
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predicted dynein does show homology to the Chlamydomonas flagellar inner arm intermediate
dynein (1e-55) (accession number XP_00195786.1). Defects in the inner dynein arms of
Chlamydomonas leads to decreased beat frequency and motility (Brokaw and Kamiya, 1987). It is
feasible that depletion in WD40 may contribute to an inability of the cells to swim backward for
prolonged periods of time. However, depletion of WD40 showed shortened backward
swimming duration in solutions to test the voltage gated calcium channels (high K+) and Mg2+induced behavior (Mg/TEA) and not Na/TEA. The data support a deficient transportation of
channels to the cilia, namely the voltage-gated calcium channels (VGCCs) and the proposed Mg2+
channel, Pkd2. On the other hand, if there were deficient VGCCs in the cilia, backward
swimming in all ionic solutions, including Na/TEA, would be expected. Further research is
clearly required, the swimming assays of these depleted cells were only a preliminary
examination. Immunofluorescence, electrophysiology, and numerous other studies would be
required to further investigate the function of this protein in Paramecium.
The depletion of TtCC also led to short backward swimming in Mg/TEA and high K+.
This gene appears to be specific to Tetrahymena and Paramecium, much like the protein XntA.
TtCC is a proposed cation channel protein in Tetrahymena, but it has no conserved domains and
serves an unknown function in Paramecium. There are no predicted transmembrane spanning
regions for this protein. It is feasible that TtCC, like WD40, may play some role in transporting
proteins to the cilia or perhaps in the regulation of specific channels in the cilia. Again, however,
far more research is needed before any conclusions can be made.
One of the most interesting finds was the protein with homology to the Drosophila lost
boys, Lobo or CG34110. There is also a homologue for Lobo in mammals (Ccdc135) as well as in
Chlamydomonas (FAP50). The Lobo/Ccdc135/FAP50 protein is highly conserved with tight
associations to the microtubule outer doublets. The tight association with the axoneme, the
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inability to solubilize the protein with NP-40, and the lack of both calcium and calmodulin
binding domains led to the hypothesis that CG34110/Ccdc135/FAP50 is an intermediary protein
(Yang et al., 2011). Knockout studies of CG34110 in Drosophila led to sperm that were unable to
properly chemotax in the female reproductive track. Specifically, they were unable to move to
the uterus through the seminal receptacle tubule. Pkd2 knockout sperm had the same phenotype
while double knockouts were no worse. The authors suggested CG34110 (Lobo) was important
for wave form stabilization in Drosophila sperm (Yang et al., 2011). Our work to deplete the
Paramecium homologue of CG34110 showed short backward swimming in Mg2+ solutions and
high K+. If the lobo protein were important ciliary beating, we might have expected short
backward swimming in all ionic stimuli. Regardless, the co-IP of these two proteins was exciting.
Future studies would be useful to determine the subcellular location of Lobo in Paramecium. It
would also be interesting to examine LOBO depleted cells in T-mazes. Although Paramecium
does not chemotax, these cells are able to respond to ionic stimuli, including attractants, by
hyperpolarizing their membrane and swimming fast and smooth forward (Kung et al., 1975). If a
protein that is important for ciliary beat patterns is depleted, it is possible those depleted cells
may show inappropriate chemoresponse.

Conclusion
The sequences used for depletion by feeding RNAi in Paramecium were chosen because of
their possible interactions with the Pkd2 protein. We examined the backward swimming
behavior of these depleted cells in Mg/TEA, Na/TEA, and high K+ compared to control cells fed
the empty RNAi vector to briefly investigate the possible functions of these genes in Mg2+
behavior. Only the SHyP depleted cells showed short backward swimming specific to Mg/TEA.
Most of the depleted cells showed short backward swimming in Mg/TEA and high K+, except
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the AHyP depleted cells which we did not anticipate observing any differences in swimming
behavior. The combined depletion of SHyP and PKD2 showed dramatic changes in backward
swimming in all solutions used for testing when the single depleted cell types showed only short
backward swimming in Mg/TEA. At no point did any of the depleted cell types show longer
backward swimming in any of the ionic stimuli. Further investigation into the location and
function of Lobo in Paramecium would be of interest because of the connection of this protein to
the axoneme in other systems. We have investigated further numerous co-IP proteins that may
interact with the Pkd2 protein directly or indirectly. The function of these proteins may be
important for other ion channels other than Pkd2. These potential interacting partners may also
contribute to trafficking or stabilizing ciliary proteins or in proper ciliary beat form. Further
investigation is needed in all cases, but as a preliminary screen of potential Pkd2 interacting
partners, this screen was productive.
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Table III.I: Table of the gene name, primers, sequence position and percent coverage of the
gene used to create the RNAi construct.
SHyP
GGAGGCATTCTTGGCGTGGT

CACTGCACCAGTGTAATTGATG

CAACTTTAGGAGCTATTCCAAG

GATTTCAATTTCTCTTCTGTCGC

GACTACCACTGAAGGCTTGTC

+1946 - +3442 (1496 nt)

+1637 - +2318 (681 nt)

+10,013 - +11347 (1335 nt)

+30 - +2033 (2003 nt)

79.4%

43.2%

29%

11.7%

97.1%

% of the
gene

LHyP

AGTCACAACGATATGGCAGTAG

GTGATAACTACCTGACTTGCTC

+27 - +1362 (1335 nt)

25%

Position

WD40

CAGAGTCTTTGCCACAAAAGAG

GATAAGGTGGTTTGTTGTACTCA

+1880 - +2525 (645 nt)

Reverse Primer

AHyP

CTTTTAAGGGAACACTCC

CCTAAGATTCAAATCTTATAG

Forward Primer

TtCC

CAATCCATAATTCAAAGAGC

Name

LOBO
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Table III.II: Backward swimming times for all depleted cells in the different ionic stimuli.
25 mM TEA with

25 mM TEA with

30 mM KCl

10 mM NaCl

5 mM MgCl2

13.8 ± 3.6 (221)^

19.3 ± 6.6 (148)

7.3 ± 3.1 (224)^

AHyP

14.3 ± 3.6 (65)

20.7 ± 7.1 (60)

6.9 ± 2.9 (70)^

PKD2

14.0 ± 4.9 (102)

17.6 ± 5.9 (98)

4.0 ± 3.1 (110)*

LHyP

13.8 ± 2.9 (81)

15.0 ± 4.7 (89)*

4.6 ± 3.2 (98)*

SHyP

15.0 ± 4.7 (96)

17.9 ± 6.3 (100)

3.3 ± 2.5 (106)*

PKD2 and SHyP

10.1 ± 3.4 (64)*,^

13.5 ± 6.8 (64)*

3.9 ± 3.3 (64)*

WD40

2.1 ± 3.4 (66)*,^

21.6 ± 21.6 (66)

1.1 ± 2.6 (68)*,^

TtCC

8.6 ± 5.8 (61)*,^

17.2 ± 8.0 (61)

2.9 ± 3.2 (63)*

LOBO

6.4 ± 5.1 (63)*,^

20.9 ± 11.0 (60)

3.1 ± 2.7 (59)*

Cell Type
Control
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Figure III.1A-C: Pkd2 peptides identified in IPs from cell membrane and whole cilia. Peptides
were identified in silver stained gels from the FLAG IP of solubilized cell membrane or whole
cilia of cells expressing Pkd2-FLAG (test) or FLAG (control). Silver stained gels were processed
for trypsin digestion and LC-MS/MS analysis. For full Materials and Methods and list of unique
proteins identified in the test lanes, see Chapter 3. Peptides, their location within the Pkd2
sequence and the number of times they were found are shown for the cell membrane IP500 buffer
IP (III.1A); the whole cilia IP500 buffer IP (III.1B); and the whole cilia Lap200 buffer IP (III.1C).
The Pkd2 amino acid sequence is shown on the right and the peptides identified in the IP are
shown on the left. Arginines (R) and Lysines (K) where trypsin cut are included in the peptides
shown in the table. Peptides are highlighted within the sequence (blue). The number of times
each peptide was identified is shown in the table as well as in the sequence (pink number near
each highlighted peptide). Peptides were identified throughout the gel.
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Figure III.1A: Cell membrane IP500 IP.
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Figure III.1B: Whole cilia IP500 IP.
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Figure III.1C: Whole cilia Lap200 IP.
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Figure III.2: Backward swimming times of depleted cells in 30 mM KCl. Backward swimming
time (seconds) ± standard error of the mean, N=61-221. Asterisk indicates statistical significance
compared to the control cells, caret indicates significantly different compared to PKD2 depleted
cells (ANOVA, multiple comparison tests, P<0.001).
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Figure III.3: Backward swimming times of depleted cells in 25 mM TEA with 10 mM NaCl.
Backward swimming time (seconds) ± standard error of the mean, N=60-148. Caret and asterisk
indicates statistical significance, ANOVA, multiple comparison tests, P<0.05 and P<0.01,
respectively.
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Figure III.4: Backward swimming times of depleted cells in 25 mM TEA with 5 mM MgCl2.
Backward swimming time (seconds) ± standard error of the mean, N=59-224. Asterisk indicates
statistical significance compared to the control cells, caret indicates significantly different
compared to PKD2 depleted cells (ANOVA, multiple comparison tests, P<0.001).
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